text stringlengths 46 525k | url stringlengths 24 420 | crawl_date timestamp[us, tz=UTC]date 2022-04-01 00:01:42 2022-09-25 07:27:13 | id stringlengths 24 420 | label bool 2 classes |
|---|---|---|---|---|
WFO MEDFORD Warnings, Watches and Advisories for Wednesday, August 10, 2022
_____
RED FLAG WARNING
URGENT - FIRE WEATHER MESSAGE
National Weather Service Medford OR
121 PM PDT Wed Aug 10 2022
.Strong winds aloft will gradually mix downward to all elevations
Wednesday this afternoon and evening, and are likely to do so again
Thursday. Gusty south to southwest winds combined with low RH and
recent fire starts will lead to critical fire weather conditions
Wednesday afternoon and evening and Thursday afternoon and evening
in south central Oregon and northeast California.
...RED FLAG WARNING REMAINS IN EFFECT UNTIL 9 PM PDT THIS EVENING
FOR STRONG GUSTY WIND WITH LOW RH FOR FIRE WEATHER ZONE 284 and 285...
...RED FLAG WARNING IN EFFECT FROM 2 PM TO 9 PM PDT THURSDAY FOR
STRONG GUSTY WIND WITH LOW RH FOR FIRE WEATHER ZONES 284 AND 285...
The National Weather Service in Medford has issued a Red Flag
Warning...which is in effect from 2 PM to 9 PM PDT Thursday. The
Fire Weather Watch has been upgraded.
* Impacts: Strong, gusty wind with low relative humidity and
critically dry vegetation will greatly increase the spread
potential of any new and existing fires.
* Affected area:
In Northern CA...Portions of Fire Weather Zones 284 and 285,
including Alturas, Canby, Davis Creek, Newell, Tulelake, and
portions of Lava Beds National Monument and Modoc National Forest.
* Wind: Southwest 10 to 20 mph with gusts up to 35 mph.
* Humidity: As low as 8 percent.
* View the hazard area in detail at:
https://www.wrh.noaa.gov/mfr/HAZARD
Precautionary/preparedness actions...
Avoid tossing burning cigarettes on the ground, parking hot
vehicles on dry vegetation, and using equipment that can cause
sparks. Follow all fire restrictions. Find links to restrictions
at weather.gov/medford/wildfire. One less spark, one less
wildfire.
Gather your fire evacuation kit now. Collect essentials you don't
want to lose and prioritize your checklist. Visit ready.gov/kit
for more information.
Familiarize yourself with your evacuation plan. Where will you go?
How will you get there? Who will you call to let others know your
are safe? Visit ready.gov/wildfires for more information.
A Red Flag Warning does not mean there is a fire. It means that
critical fire weather conditions are either occurring now or will
shortly. These conditions promote rapid spread of fire which may
become life threatening. Evacuate if ordered to, or if a fire
threatens.
_____
Copyright 2022 AccuWeather | https://www.seattlepi.com/weather/article/CA-WFO-MEDFORD-Warnings-Watches-and-Advisories-17365147.php | 2022-08-10T20:48:08Z | https://www.seattlepi.com/weather/article/CA-WFO-MEDFORD-Warnings-Watches-and-Advisories-17365147.php | true |
WFO NEW YORK CITY Warnings, Watches and Advisories for Wednesday, August 10, 2022
_____
COASTAL FLOOD STATEMENT
Coastal Hazard Message
National Weather Service New York NY
341 PM EDT Wed Aug 10 2022
...COASTAL FLOOD ADVISORY IN EFFECT UNTIL 11 PM EDT THIS
EVENING...
...COASTAL FLOOD ADVISORY IN EFFECT FROM 7 PM THURSDAY TO
MIDNIGHT EDT THURSDAY NIGHT...
* WHAT...Up to one and a half foot of inundation above ground
level expected in vulnerable areas near the waterfront and
shoreline for tonight and Thursday night high tides. .
* WHERE...Southern Queens and Southern Nassau Counties.
* WHEN...For the first Coastal Flood Advisory, until 11 PM EDT
this evening. For the second Coastal Flood Advisory, from 7 PM
Thursday to midnight EDT Thursday night.
* IMPACTS...Minor flooding is expected in the most vulnerable
locations near the waterfront and shoreline. Expect around 1 to
1 1/2 feet of inundation above ground level in low lying,
vulnerable areas. Some roads and low lying property including
parking lots, parks, lawns and homes/businesses with basements
near the waterfront will experience shallow flooding.
* ADDITIONAL DETAILS...Additional minor flooding is likely Friday
Night and Saturday Night.
PRECAUTIONARY/PREPAREDNESS ACTIONS...
If travel is required, allow extra time as some roads may be
closed. Do not drive around barricades or through water of
unknown depth. Take the necessary actions to protect flood-prone
property.
Time of high total tides are approximate to the nearest hour.
ROCKAWAY INLET NY NEAR FLOYD BENNETT FIELD NY
MLLW CATEGORIES - MINOR 7.3 FT, MODERATE 8.3 FT, MAJOR 9.3 FT
MHHW CATEGORIES - MINOR 1.7 FT, MODERATE 2.7 FT, MAJOR 3.7 FT
TOTAL TOTAL DEPARTURE
DAY/TIME TIDE TIDE FROM NORM WAVES FLOOD
FT MLLW FT MHHW FT FT IMPACT
-------- --------- --------- --------- ------- --------
10/07 PM 7.2/ 7.7 1.6/ 2.0 0.6/ 1.1 1 MINOR
11/08 AM 6.0/ 6.5 0.4/ 0.9 0.6/ 1.1 1 NONE
11/08 PM 7.5/ 8.0 1.9/ 2.3 0.8/ 1.3 1 MINOR
12/09 AM 6.2/ 6.8 0.7/ 1.1 0.6/ 1.1 1 NONE
JAMAICA BAY AT INWOOD NY
MLLW CATEGORIES - MINOR 7.5 FT, MODERATE 8.2 FT, MAJOR 9.0 FT
MHHW CATEGORIES - MINOR 1.6 FT, MODERATE 2.3 FT, MAJOR 3.1 FT
10/08 PM 7.6/ 8.1 1.7/ 2.2 0.4/ 0.9 0 MINOR
11/08 AM 6.6/ 7.1 0.7/ 1.1 0.6/ 1.1 0 NONE
11/09 PM 7.6/ 8.1 1.7/ 2.2 0.2/ 0.7 0 MINOR
12/09 AM 6.9/ 7.4 1.0/ 1.5 0.6/ 1.1 0 NONE
EAST ROCKAWAY INLET AT ATLANTIC BEACH NY
MLLW CATEGORIES - MINOR 6.0 FT, MODERATE 7.0 FT, MAJOR 8.0 FT
MHHW CATEGORIES - MINOR 1.0 FT, MODERATE 2.0 FT, MAJOR 3.0 FT
10/07 PM 6.0/ 6.5 1.0/ 1.5 0.2/ 0.8 2 MINOR
11/08 AM 5.1/ 5.6 0.1/ 0.6 0.4/ 0.9 2 NONE
11/08 PM 6.4/ 6.9 1.4/ 1.9 0.6/ 1.1 2 MINOR
12/08 AM 5.2/ 5.7 0.2/ 0.8 0.4/ 0.9 2 NONE
REYNOLDS CHANNEL AT POINT LOOKOUT NY
MLLW CATEGORIES - MINOR 5.8 FT, MODERATE 6.8 FT, MAJOR 7.8 FT
MHHW CATEGORIES - MINOR 1.1 FT, MODERATE 2.1 FT, MAJOR 3.1 FT
10/07 PM 5.7/ 6.2 1.0/ 1.5 0.9/ 1.4 2 MINOR
11/07 AM 4.7/ 5.2 0.0/ 0.5 0.7/ 1.1 2 NONE
11/08 PM 6.1/ 6.6 1.4/ 1.9 1.2/ 1.7 2 MINOR
12/08 AM 5.0/ 5.5 0.2/ 0.8 0.8/ 1.3 2 NONE
HUDSON BAY AT FREEPORT NY
MLLW CATEGORIES - MINOR 6.0 FT, MODERATE 6.5 FT, MAJOR 7.2 FT
MHHW CATEGORIES - MINOR 1.4 FT, MODERATE 1.9 FT, MAJOR 2.6 FT
10/08 PM 5.7/ 6.2 1.2/ 1.7 1.8/ 2.2 0 MINOR
11/08 AM 5.2/ 5.7 0.7/ 1.1 2.0/ 2.5 0 NONE
11/09 PM 6.0/ 6.5 1.4/ 1.9 1.9/ 2.3 0 MINOR
12/09 AM 5.5/ 6.0 0.9/ 1.4 2.0/ 2.5 1 NONE
...COASTAL FLOOD ADVISORY IN EFFECT FROM 9 PM THIS EVENING TO
MIDNIGHT EDT TONIGHT...
...COASTAL FLOOD ADVISORY IN EFFECT FROM 11 PM THURSDAY TO 1 AM
EDT FRIDAY...
* WHAT...Up to one foot of inundation above ground level expected
in vulnerable areas near the waterfront and shoreline for
tonight and Thursday night high tides.
* WHERE...Southern Westchester County.
* WHEN...For the first Coastal Flood Advisory, from 9 PM this
evening to midnight EDT tonight. For the second Coastal Flood
Advisory, from 11 PM Thursday to 1 AM EDT Friday.
locations near the waterfront and shoreline. Expect up to 1 foot
of inundation above ground level in low lying, vulnerable
areas. Some roads and low lying property including parking lots,
parks, lawns and homes/businesses with basements near the
waterfront will experience shallow flooding.
* ADDITIONAL DETAILS...Additional minor flooding is possible
Friday Night and Saturday Night.
HUDSON RIVER AT PIERMONT NY
MLLW CATEGORIES - MINOR 6.4 FT, MODERATE 7.4 FT, MAJOR 8.4 FT
MHHW CATEGORIES - MINOR 2.4 FT, MODERATE 3.4 FT, MAJOR 4.4 FT
10/09 PM 4.9/ 5.4 0.9/ 1.4 0.5/ 1.0 0 NONE
11/10 AM 4.2/ 4.7 0.2/ 0.8 0.6/ 1.1 0 NONE
11/10 PM 5.1/ 5.6 1.1/ 1.6 0.5/ 1.0 0 NONE
12/11 AM 4.4/ 4.9 0.4/ 0.9 0.6/ 1.1 0 NONE
LITTLE NECK BAY AT KINGS POINT NY
MLLW CATEGORIES - MINOR 10.0 FT, MODERATE 10.5 FT, MAJOR 13.0 FT
MHHW CATEGORIES - MINOR 2.2 FT, MODERATE 2.7 FT, MAJOR 5.2 FT
10/11 PM 9.4/ 9.9 1.6/ 2.0 0.6/ 1.1 0 NONE
11/12 PM 8.8/ 9.3 1.0/ 1.5 0.8/ 1.3 0 NONE
12/12 AM 9.5/10.0 1.7/ 2.2 0.6/ 1.1 0-1 NONE
12/12 PM 9.1/ 9.6 1.3/ 1.8 0.8/ 1.3 1 NONE
STAMFORD HARBOR AT STAMFORD CT
MLLW CATEGORIES - MINOR 9.4 FT, MODERATE 11.0 FT, MAJOR 12.4 FT
MHHW CATEGORIES - MINOR 1.5 FT, MODERATE 3.1 FT, MAJOR 4.5 FT
10/11 PM 9.5/10.0 1.6/ 2.0 0.7/ 1.1 0 MINOR
11/11 AM 8.9/ 9.4 1.0/ 1.5 0.8/ 1.3 0 NONE
12/12 AM 9.6/10.1 1.7/ 2.2 0.7/ 1.1 0-1 MINOR
...COASTAL FLOOD STATEMENT IN EFFECT UNTIL 10 PM EDT THIS
* WHAT...For the Coastal Flood Advisory, up to one and a half
feet of inundation above ground level expected in vulnerable
areas near the waterfront and shoreline. For the Coastal Flood
Statement, up to a half foot of inundation above ground level
expected in vulnerable areas near the waterfront and shoreline.
* WHERE...In New Jersey, Hudson, Eastern Essex and Eastern Union
Counties. In New York, Richmond (Staten Island) and Kings
(Brooklyn) Counties.
* WHEN...For the Coastal Flood Advisory, from 7 PM Thursday to
midnight EDT Thursday night. For the Coastal Flood Statement,
until 10 PM EDT this evening.
* IMPACTS...Brief and localized minor flooding of the more
vulnerable locations near the waterfront and shoreline tonight.
Minor flooding is expected in the most vulnerable locations near
the waterfront and shoreline Thursday Night, with up to 1 1/2
feet of inundation above ground level in low lying, vulnerable
KILL VAN KULL AT BERGEN POINT NY
MLLW CATEGORIES - MINOR 7.2 FT, MODERATE 8.5 FT, MAJOR 9.6 FT
MHHW CATEGORIES - MINOR 1.7 FT, MODERATE 3.0 FT, MAJOR 4.1 FT
10/08 PM 7.0/ 7.5 1.5/ 2.0 0.4/ 0.9 0-1 MINOR
11/08 AM 5.9/ 6.4 0.4/ 0.9 0.4/ 0.9 0 NONE
11/09 PM 7.3/ 7.8 1.8/ 2.2 0.6/ 1.1 0-1 MINOR
12/09 AM 6.1/ 6.6 0.6/ 1.1 0.4/ 0.9 1 NONE
NEW YORK HARBOR AT THE BATTERY NY
MHHW CATEGORIES - MINOR 2.2 FT, MODERATE 3.5 FT, MAJOR 4.6 FT
10/08 PM 6.6/ 7.1 1.6/ 2.0 0.6/ 1.1 0-1 NONE
11/08 AM 5.6/ 6.1 0.6/ 1.1 0.6/ 1.1 0 NONE
11/09 PM 6.8/ 7.3 1.8/ 2.2 0.7/ 1.1 0-1 NONE
12/09 AM 5.7/ 6.2 0.7/ 1.1 0.5/ 1.0 1 NONE
GREAT KILLS HARBOR AT GREAT KILLS NY
MLLW CATEGORIES - MINOR 7.2 FT, MODERATE 8.2 FT, MAJOR 9.2 FT
MHHW CATEGORIES - MINOR 1.9 FT, MODERATE 2.9 FT, MAJOR 3.9 FT
10/07 PM 6.8/ 7.3 1.5/ 2.0 0.4/ 0.9 1 NONE
11/08 AM 5.7/ 6.2 0.4/ 0.9 0.4/ 0.9 1 NONE
11/08 PM 7.1/ 7.6 1.8/ 2.2 0.6/ 1.1 1 MINOR
12/09 AM 6.1/ 6.6 0.8/ 1.3 0.5/ 1.0 1 NONE
_____
Copyright 2022 AccuWeather | https://www.seattlepi.com/weather/article/NY-WFO-NEW-YORK-CITY-Warnings-Watches-and-17365029.php | 2022-08-10T20:48:31Z | https://www.seattlepi.com/weather/article/NY-WFO-NEW-YORK-CITY-Warnings-Watches-and-17365029.php | false |
The son of the man suspected of shooting Muslim men around the city has been federally charged with providing a false address when he bought a gun last year.
Shaheen Syed, who used to go by “Maiwant Syed,” was arrested Wednesday.
His father, 51-year-old Muhammad Syed, was arrested Monday night and has been charged with two counts of murder in the deaths of Aftab Hussein on July 26 and Muhammad Afzaal Hussain on Aug. 1.
According to a criminal complaint filed in U.S. District Court for New Mexico, when Shaheen Syed bought two guns from a Federal Firearms Licensee (FFL) gun store in Albuquerque in June 2021 he listed his address as being in Broward County, Florida.
When an agent with the Bureau of Alcohol, Tobacco, Firearms and Explosives checked the address the resident said he had lived there for several years and Shaheen Syed never had lived there. Shaheen Syed told an Albuquerque homicide detective he had lived in Albuquerque since 2016.
The agent said it was important to provide a correct address so that the ATF can determine whether it was legal for an FFL to sell the gun to that person.
The guns Shaheen Syed is accused of buying while using a false address are not mentioned in the criminal complaint charging his father with murder. That complaint does list several other guns Shaheen Syed and his father bought. | https://www.abqjournal.com/2523431/son-of-man-suspected-of-killing-muslim-men-arrested-on-federal-gun-violation.html | 2022-08-10T20:49:03Z | https://www.abqjournal.com/2523431/son-of-man-suspected-of-killing-muslim-men-arrested-on-federal-gun-violation.html | false |
WFO SHREVEPORT Warnings, Watches and Advisories for Wednesday, August 10, 2022
_____
SPECIAL WEATHER STATEMENT
Special Weather Statement
National Weather Service Shreveport LA
230 PM CDT Wed Aug 10 2022
...Strong thunderstorms will impact portions of southeastern
Nacogdoches, Angelina, southern San Augustine and southwestern Sabine
Counties through 315 PM CDT...
At 230 PM CDT, Doppler radar was tracking strong thunderstorms along
a line extending from near Hudson to near Etoile to near Macune.
Movement was south at 35 mph.
HAZARD...Winds in excess of 40 mph.
SOURCE...Radar indicated.
IMPACT...Gusty winds could knock down tree limbs and blow around
unsecured objects.
Locations impacted include...
Lufkin, Diboll, Hudson, Huntington, Burke, Zavalla, Broaddus,
Shawnee, Homer and Dolan.
PRECAUTIONARY/PREPAREDNESS ACTIONS...
If outdoors, consider seeking shelter inside a building.
Frequent cloud to ground lightning is occurring with these storms.
Lightning can strike 10 miles away from a thunderstorm. Seek a safe
shelter inside a building or vehicle.
These storms may intensify, so be certain to monitor local radio
stations and available television stations for additional information
and possible warnings from the National Weather Service.
LAT...LON 3110 9465 3109 9467 3110 9474 3115 9485
3123 9486 3126 9490 3128 9488 3134 9491
3134 9496 3139 9497 3132 9452 3139 9409
3114 9399 3114 9404 3111 9406 3103 9447
TIME...MOT...LOC 1930Z 346DEG 32KT 3136 9483 3131 9447 3136 9411
MAX HAIL SIZE...0.00 IN
MAX WIND GUST...40 MPH
...A SEVERE THUNDERSTORM WARNING REMAINS IN EFFECT UNTIL 245 PM CDT
FOR NORTHWESTERN ELLIS COUNTY...
At 231 PM CDT, a severe thunderstorm was located near Waxahachie,
moving southeast at 5 mph.
HAZARD...60 mph wind gusts.
IMPACT...Expect damage to roofs, siding, and trees.
Waxahachie, Ennis, Midlothian, Palmer, Italy and Maypearl.
Continuous cloud to ground lightning is occurring with this storm.
Move indoors immediately.
_____
Copyright 2022 AccuWeather | https://www.seattlepi.com/weather/article/TX-WFO-SHREVEPORT-Warnings-Watches-and-17364999.php | 2022-08-10T20:49:15Z | https://www.seattlepi.com/weather/article/TX-WFO-SHREVEPORT-Warnings-Watches-and-17364999.php | false |
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:
Alcon Inc., down $3.53 to $71.94.
The eye care company trimmed its profit and revenue forecasts for the year.
Trade Desk Inc., up $19.74 to $74.24.
The digital-advertising platform operator gave investors an encouraging revenue forecast.
Akamai Technologies Inc., up 91 cents to $95.99.
The cloud services provider beat Wall Street's second-quarter financial forecasts.
Rackspace Technology Inc., down $1.08 to $5.80.
The cloud technology company cut its earnings and revenue forecasts for the current quarter.
CyberArk Software Ltd., up $11.29 to $149.74.
The information security company beat analysts' second-quarter earnings and revenue forecasts.
Axon Enterprise Inc., up $14.45 to $126.07.
The maker of stun guns and body cameras raised its revenue forecast for the year.
OptimizeRx Corp., down $6.68 to $15.57.
The digital health company reported weak second-quarter earnings and gave investors a discouraging revenue forecast.
Repay Holdings Corp., down $2.70 to $10.25.
The payment technology and processing company reported disappointing second-quarter earnings and revenue. | https://www.expressnews.com/business/article/Axon-Trade-Desk-rise-Alcon-Rackspace-fall-17365116.php | 2022-08-10T20:50:45Z | https://www.expressnews.com/business/article/Axon-Trade-Desk-rise-Alcon-Rackspace-fall-17365116.php | false |
Ryan Giggs 'used psychological game' from self-help book 'How to Win Friends and Influence People' to 'reel in vulnerable girlfriend'
- Giggs is charged with using controlling and coercive behaviour towards his ex
- Kate Greville told day three of trial that she was stuck in a 'controlling marriage'
- She noticed Giggs was interested in her in 2013, before pair started relationship
- Ms Greville told assault trial that he used her name a great deal when they met
- She said it was a technique she has read about in the popular psychology book
Ryan Giggs 'used a psychological game' from the self-help book 'How to Win Friends and Influence People' to 'reel in vulnerable girlfriend Kate Greville', a court has heard.
The former Manchester United star, 48, is on on trial accused of controlling and coercive behaviour against his ex-girlfriend between August 2017 and November 2020. He is also charged with assaulting Ms Greville and her sister Emma.
Ms Greville told day three of the trial today that she was not happy and was stuck in a 'controlling marriage' when she notice Giggs was interested in her in 2013.
She said Giggs used her name a great deal, a technique she had read and learned about from the popular psychology book.
Chris Daw QC, representing Giggs, asked: 'The impression you give is you only really had an affair with Ryan because you were unhappy and he basically reeled you in?'
Ms Greville replied: 'I'm not saying it was all one-sided. I was fully involved in that.
'There was things about him that definitely were luring me into a relationship.'
The barrister added: 'The truth is it's a complete fiction Ryan was using psychological techniques on your vulnerabilities. It's just rubbish?'
Ms Greville said: 'Absolutely not. I felt like he was using techniques. I was vulnerable, that's a fact.
'I was in a controlling relationship. That's a fact.'
The former Manchester United star (pictured) is on on trial accused of controlling and coercive behaviour
Ms Greville told day three of the trial today that Giggs used her name a great deal, a technique she had read and learned about from the popular psychology book
She also today told jurors that she was initially attracted to Giggs 'not because of his money and not because he was a footballer' but because he was 'very inspiring'.
In cross examination by the former Manchester United star's lawyer, Chris Daw QC, Ms Greville was asked: 'Did you tell your friend you weren't going to walk away from Mr Giggs with nothing?'
Ms Greville confirmed: 'Yes.' However the PR executive said she was not after compensation from the former Wales midfielder. Asked if she was seeking damages from the 48-year-old, she said: 'Absolutely not.'
Ms Greville, 36, also told the court how she and Giggs were both still married when the affair started, but, 'if anything was put off by the fact that he was a footballer.'
The barrister asked her: 'Did Ryan's public profile and wealth have anything to do with your interest in him?
Ms Greville said: 'He was very inspiring, I looked up to him in terms of a business sense, who had worked hard…'
'He was more attractive because he was successful and had done well for himself, not because of his money and not because he was a footballer, if anything that put me off, him being a footballer.'
She admitted to having sex with the former Manchester United star two months before leaving her husband, who she alleged in court was 'controlling'.
Ms Greville claimed initially her and Giggs' relationship had been 'amazing', but had then deteriorated before becoming 'relentlessly awful' while they lived together during the Covid pandemic.
She said Giggs preyed on her 'vulnerability' and damaged relations with her friends and family and that she became 'a slave to his every need and every demand'.
Ms Greville told the court Giggs would sometimes show her affection but was 'aggressive' a lot of the time and would sometimes use violence against her.
Former Manchester United footballer Ryan Giggs arriving at Manchester Crown Court today
'He damaged relationships with my friends and isolated me from certain people. He had a negative impact on relations with my family. '
Asked about her claims of violence against her, Ms Greville, who today told the court she is now the mother of 12-week baby with her new partner, said: 'It wasn't consistent violence, he wasn't regularly violent but there were times in our relationship when he was violent.'
Giggs denies all charges against him.
The trial continues. | https://www.dailymail.co.uk/news/article-11100017/Ryan-Giggs-used-psychological-game-self-help-book-reel-vulnerable-girlfriend.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 | 2022-08-10T20:51:18Z | https://www.dailymail.co.uk/news/article-11100017/Ryan-Giggs-used-psychological-game-self-help-book-reel-vulnerable-girlfriend.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 | false |
Man acquitted in deadly shooting at Stryker Sports Complex
WICHITA, Kan. (KWCH) - A Wichita man is found not guilty in the deadly shooting at Stryker Sports Complex.
Maurice Hall was charged with first-degree murder in the October 2020 death of 31-year-old Marquell Nolen. Police alleged Hall and Nolen were arguing at the sports complex behind the bleachers during a youth football game, when a handgun was pulled out and multiple shots were fired, striking Nolen.
An affidavit from the district attorney’s office explained that Hall’s bright yellow jumpsuit and a cup he had dropped at the scene led to his arrest in connection to the shooting.
During the trial, the defense raised self-defense in the case. Late Tuesday afternoon, jurors acquitted Hall of the first-degree murder charges but found him guilty of criminal possession of a weapon by a convicted felon.
Copyright 2022 KWCH. All rights reserved. | https://www.wibw.com/2022/08/10/man-acquitted-deadly-shooting-stryker-sports-complex/ | 2022-08-10T20:51:24Z | https://www.wibw.com/2022/08/10/man-acquitted-deadly-shooting-stryker-sports-complex/ | false |
-- Phase 3 RAPID study reached the target of 180 confirmed PSVT events treated with double-blind study medication required to initiate primary efficacy analysis; topline data readout for RAPID study remains on track for mid-second half 2022
-- Phase 3 PSVT study initiated in China
MONTREAL and CHARLOTTE, N.C., Aug. 10, 2022 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the second quarter ended June 30, 2022, and provided a clinical and corporate update.
"Progress continues across our Phase 3 PSVT clinical program. Notably with the recent crossing of the 180th event in the RAPID trial, we now focus on the final stages of data cleaning and analysis and look forward to reporting top line data in the middle of the second half of this year," said Joseph Oliveto, President and Chief Executive Officer of Milestone Pharmaceuticals.
Recent Updates
- Achieved Required Number of PSVT Events Treated with Double Blind Study Medication to Initiate Preparation for the Primary Efficacy Analysis for RAPID Trial; Company Remains on Track to Report RAPID Topline Data in Mid-Second Half 2022. In July 2022, the RAPID trial, in which patients are randomized 1:1 to receive either etripamil or placebo, reached the pre-specified target of 180 confirmed PSVT events, adjudicated by a blinded, independent expert committee, required for the primary efficacy analysis. Data from RAPID is now in the process of being cleaned, verified, and analyzed, and the Company continues to expect to unblind RAPID results and report topline data in the middle of the second half of 2022. The primary efficacy analysis for the RAPID trial and the post hoc analysis of the NODE-301 trial will be time to conversion of supraventricular tachycardia (SVT) over the first 30 minutes following initial study drug administration. The RAPID and NODE-301 trials could potentially serve to fulfill the efficacy requirement for a future New Drug Application submission to the United States Food and Drug Administration for etripamil in patients with PSVT.
- Milestone's Partner, Ji Xing Pharmaceuticals Limited, Enrolled First Patient in Phase 3 Study of Etripamil in China. In July 2022, Milestone's partner, Ji Xing Pharmaceuticals Limited (Ji Xing), announced that it enrolled its first patient in its Phase 3 study of etripamil for the treatment of PSVT in China. The study is designed to evaluate the efficacy and safety of self-administered etripamil nasal spray as a treatment for PSVT with the eventual goal of generating clinical data potentially supportive of a new drug application in China. In May 2021, Milestone and Ji Xing entered into an exclusive license agreement to develop and commercialize etripamil for PSVT in Greater China.
- Data from Phase 3 NODE-302 Open-Label Extension Study of Etripamil for the Treatment of PSVT Presented at Heart Rhythm 2022. In April 2022, data from NODE-302, Milestone's Phase 3 open-label extension of the NODE-301 study evaluating a single, 70 mg dose of self-administered, intranasal etripamil in patients with PSVT, was presented at the Heart Rhythm Society's Heart Rhythm 2022 conference. The data demonstrated the potential for patients to self-treat recurrent SVT episodes with etripamil. Of 188 positively-adjudicated episodes observed in the trial, the PSVT conversion rate at 30 minutes following etripamil administration was 60.2%, and the need for emergency department (ED) intervention to terminate a PSVT episode was low (13% of patients and 8.5% of positively adjudicated PSVT episodes). Etripamil was generally well-tolerated, with adverse events (AEs) consistent with those observed in previous trials and largely confined to local and brief nasal AEs at the administration site. A copy of the presentation is available on request from Milestone Pharmaceuticals.
- Hosted Virtual KOL Event on Etripamil for the Treatment of PSVT. In April 2022, Milestone hosted a virtual Key Opinion Leader (KOL) event focused on etripamil for the possible treatment of PSVT. Members of management were joined by Bruce Stambler, M.D., FHRS, Director of Cardiac Arrhythmia Research and Education, Piedmont Heart Institute, Atlanta, GA, and Sean Pokorney, M.D., MBA, Director of the Arrhythmia Core Laboratory, Duke Clinical Research Institute, Assistant Professor of Medicine, Duke University School of Medicine, Durham, NC. The event featured an overview of PSVT, including disease prevalence, the current treatment landscape, patient and healthcare system burdens and a discussion of the potential commercial opportunity. A recording of the event is currently available under the News & Events of Milestone's website at www.milestonepharma.com.
- New Clinical Analysis Evaluating the Drug Characteristics and Safety of Etripamil Presented at the American College of Cardiology (ACC) 71st Annual Scientific Session and Expo. In April 2022, new analyses on the safety, tolerability, pharmacokinetics, and pharmacodynamics of etripamil in healthy Japanese and non-Japanese adults was presented at the ACC 71st Annual Scientific Session and Expo. The data demonstrate a comparable safety and tolerability profile in both Japanese and non-Japanese male and female adults, indicating no ethnic differences, and treatment-related AEs consistent with the safety and tolerability profile of etripamil seen to date. A copy of the presentation is available in the Publications section of the Milestone Pharmaceuticals website.
Second Quarter 2022 Financial Results
- As of June 30, 2022, Milestone had cash, cash equivalents, and short-term investments of $86.2 million and 29.9 million common shares and 12.3 million common shares issuable upon exercise of pre-funded warrants outstanding.
- Research and development (R&D) expense for the second quarter of 2022 was $10.7 million, compared with $9.4 million for the prior year period. The difference is primarily the result of an increase in clinical personnel related costs, clinical consulting fees and contract research organization (CRO) costs due to advancing the RAPID Phase 3 efficacy and safety trial in etripamil for the treatment of PSVT. For the six months ended June 30, 2022, R&D expense was $19.4 million compared with $18.0 million for the prior year period. The $1.4 million increase in R&D expense in the six months ended June 30, 2022 is the result of clinical personnel related costs, clinical consulting fees and CRO costs due to advancing the RAPID Phase 3 efficacy and safety trial in etripamil for the treatment of PSVT. These increases were offset by lower drug formulation and manufacturing costs. Additionally, regulatory costs increased primarily due to personnel-related costs.
- General and administrative (G&A) expense for the second quarter of 2022 was $3.9 million, compared with $3.0 million for the prior year period. The difference is primarily the result of an increase in personnel-related costs and consulting fees for general and administrative expenses. For the six months ended June 30, 2022, G&A expense was $7.6 million compared with $5.7 million for the prior year period. The $1.9 million increase in G&A expense in the six months ended June 30, 2022 is primarily the result of personnel-related costs and consulting fees for general and administrative expenses.
- Commercial expense for the second quarter of 2022 was $2.2 million, compared with $1.8 million for the prior year period. The difference is primarily the result of an increase in consulting and marketing analytics. For the six months ended June 30, 2022, commercial expense was $3.9 million compared with $3.2 million for the prior year period. The $0.7 million increase in commercial expense in the six months ended June 30, 2022 is the result of personnel-related costs.
- For the second quarter of 2022, operating loss was $16.8 million, compared to operating income of $0.7 million for the prior year period. For the six months ended June 30, 2022, Milestone's operating loss was $30.9 million, compared to $11.9 million in the prior year period. Included in the operating income for the second quarter of 2021 and operating loss for the six months ended June 30, 2021 was primarily the one-time upfront payment of $15.0 million, recognized as revenue, generated from Milestone's License Agreement with Ji Xing.
About Paroxysmal Supraventricular Tachycardia
Paroxysmal supraventricular tachycardia (PSVT) is a condition characterized by intermittent episodes of a rapid heartbeat that starts and stops suddenly that affects approximately two million Americans. Episodes of supraventricular tachycardia (SVT) are often associated with symptoms including palpitations, sweating, chest pressure or pain, shortness of breath, sudden onset of fatigue, lightheadedness or dizziness, fainting, and anxiety. Certain intravenous medications, including adenosine, beta-blockers and calcium channel blockers, have long been used for the acute treatment of PSVT. However, these medications must be administered under medical supervision, usually in an emergency department or other acute care setting.
About Atrial Fibrillation with Rapid Ventricular Rate
Atrial fibrillation (AFib) is a common arrhythmia marked by an irregular and often rapid heartbeat. AFib is estimated to affect five million patients in the United States, a prevalence projected by the Centers for Disease Control to increase to twelve million patients within the next 10 years. Atrial fibrillation with rapid ventricular rate (AFib-RVR) is a condition that some patients with AFib experience and includes episodes of abnormally high heart rate, often with symptoms such as palpitations, shortness of breath, dizziness and weakness. Oral calcium channel blockers and/or beta blockers are commonly used to reduce the heart rate in this condition. When AFib-RVR occurs, symptoms often cause patients to seek acute care in the emergency department, where standard-of-care procedures include intravenous administration of calcium channel blockers or beta blockers under medical supervision. Milestone's market research indicates that 30-40% of patients with AFib experience one or more symptomatic episodes of RVR per year that require treatment, suggesting a target addressable market of approximately three to four million patients in 2030 for etripamil in patients with AFib.
About Etripamil
Etripamil, a new chemical identity being Milestone's lead investigational product, is a novel calcium channel blocker designed to be a rapid-response therapy for episodic cardiovascular conditions. As a nasal spray that is self-administered by the patient, etripamil has the potential to shift the current treatment experience for many patients from the emergency department to a medically-unsupervised setting. Milestone is conducting a comprehensive development program for etripamil, with Phase 3 trials ongoing in paroxysmal supraventricular tachycardia (PSVT) and a Phase 2 proof-of-concept trial underway in patients with atrial fibrillation with rapid ventricular rate (AFib-RVR).
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone's lead product candidate etripamil is currently in a Phase 3 clinical-stage program for the treatment of paroxysmal supraventricular tachycardia (PSVT) and in a Phase 2 proof-of-concept trial for the treatment of patients with atrial fibrillation with rapid ventricular rate (AFib-RVR). Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow Milestone on Twitter at @MilestonePharma.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "will," "expect," "continue," "estimate," "potential," "progress" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on Milestone's expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from these forward-looking statements. Forward-looking statements contained in this press release include statements regarding the potential of etripamil to serve as a promising therapy for PSVT patients, the design, progress, timing, scope and results of the RAPID and ReVeRA trials; Milestone's ability to execute on the remainder of the PSVT program; the timing of release of unblind RAPID results and topline data with respect to the Company's RAPID trial; Milestone's ongoing plans to study etripamil in atrial fibrillation patients, the sufficiency of Milestone's current cash resources to support its operations, and estimates about the addressable market and commercial potential for treatments of atrial fibrillation with rapid ventricular rate. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, the risks inherent in biopharmaceutical product development and clinical trials, including the lengthy and uncertain regulatory approval process; uncertainties related to the timing of initiation, enrollment, completion and evaluation of clinical trials; risks and uncertainty related to the complexity inherent in cleaning, verifying and analyzing trial data; and whether the clinical trials will validate the safety and efficacy of etripamil for PSVT or other indications, among others, as well as risks related to pandemics and public health emergencies, including those related to the ongoing COVID-19 pandemic, and risks related the sufficiency of Milestone's capital resources and its ability to raise additional capital. These and other risks are set forth in Milestone's filings with the U.S. Securities and Exchange Commission, including in its annual report on Form 10-K for the year ended December 31, 2021, under the caption "Risk Factors," as such discussion may be updated from time to time by subsequent filings we may make with the U.S. Securities & Exchange Commission. Except as required by law, Milestone assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.
Contact:
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com
View original content to download multimedia:
SOURCE Milestone Pharmaceuticals, Inc. | https://www.kalb.com/prnewswire/2022/08/10/milestone-pharmaceuticals-reports-second-quarter-2022-financial-results-provides-clinical-corporate-update/ | 2022-08-10T20:51:49Z | https://www.kalb.com/prnewswire/2022/08/10/milestone-pharmaceuticals-reports-second-quarter-2022-financial-results-provides-clinical-corporate-update/ | false |
When the first lesion appeared on Jeffrey Todd's right cheek in mid-July, the 43-year-old didn't pay too much attention to it.
"I noticed I had like a pimple or like a blemish on my cheek and it had this very odd-looking raised white circle around the outside of the blemish and it felt indented a little bit like a crater," Todd, who lives in Hollywood, California, told ABC News.
Being aware of the monkeypox outbreak spreading across the U.S., Todd said he did a Google search of what monkeypox rashes look like and "one of the images looked exactly like my blemish."
He thought, however, the blemish would disappear by morning.
Over the next two days, Todd developed a series of bumps on the back of his right arm and back and a lesion appeared on his neck. He was itchy and had backaches, fatigue and shooting pain down his legs -- all telltale signs of monkeypox.
Being diagnosed
Todd was first tested on July 13 but it took a while to get his results. He didn't know at the time that the first clinic he visited sent the sample to a lab. The sample though was spoiled by the time it got there so it couldn't be tested, he said.
As his condition continued to worsen, he went to the emergency room at Cedars-Sinai Medical Center, where staff performed an in-house test. The next day, Todd got his test results back and found out he was positive for monkeypox.
He is one of the more than 8,900 Americans who have tested positive for the disease across 48 states, the District of Columbia and Puerto Rico as of Tuesday, according to the Centers for Disease Control and Prevention.
Last week, the U.S. Department of Health and Human Services declared the outbreak a public health emergency, 78 days after the first case was detected in the country in mid-May.
The outbreak has mostly affected men who identify as gay, bisexual or other men who have sex with men, although the CDC has warned it is not a sexually transmitted disease and anyone is at risk of infection.
Todd, who identifies as gay, said he was contacted by the Los Angeles County Department of Public Health. The nurse assigned to his case believes he contracted monkeypox at an event during Pride weekend in Los Angeles in late June.
"I was at a dance party," he said. "It was enclosed. It was hot, sweaty. I was shirtless. It was really jam-packed -- a lot of physical touching and close proximity to people. So that seems very much like where it probably happened."
The CDC has said most cases in this outbreak have occurred from skin-to-skin contact or direct contact with a patient's rash, lesions or body fluids.
The disease can also spread from prolonged contact of objects or fabrics used by a monkeypox patient, but it is a lower risk form of transmission, according to the CDC.
'Traumatizing' lesions
There are no treatments specifically for monkeypox. The disease is a cousin of smallpox, so antiviral drugs developed to treat smallpox may be used.
Tecovirimat, known as TPOXX, which is a two-week course of pills, can be considered for people at high risk of severe illness, such as those with weakened immune systems.
Todd said he heard about this treatment from friends of his in New York but it was difficult for him to access it.
After being tested for monkeypox the first time, he asked his physician if he could get on the antiviral medication. He said his physician referred him to an infectious disease specialist.
"He called me immediately and was like, 'You know, I will try to get you on this medication but it's a lot of red tape. Only the county is able to prescribe it but I'll do the paperwork and get this going for you,'" Todd said.
After the county received his positive test from Cedars Sinai, Todd said he was approved for TPOXX two weeks after his symptoms first began.
Although his condition has improved since starting treatment, Todd said his lesions have caused him some pain. In late July, the lesion on his face scabbed over and fell off, leaving behind a small hole.
"My doctor said that the lesion was killing the tissue inside of my face," he said. "It literally was so traumatizing to me."
He continued, "I was expecting that to happen ... I was excited that the scab was falling off and then part of my face was coming out."
Todd said his doctor told him that hole will eventually heal but he will be left with a scar.
Raising awareness about monkeypox
Todd has made several videos showing the progress of his condition, including the "gruesome" nature of his lesions, which he has shared to social media platforms such as Instagram and TikTok.
While he says some of the messages have not been kind, he said the overwhelming majority have been positive. He's also encouraged some of his friends to get vaccinated.
Vaccines are recommended for those who have been exposed to monkeypox and for those who may be more likely to get it.
Data from Africa has shown two doses of vaccination with the smallpox vaccine, JYNNEOS, is at least 85% effective in preventing monkeypox infection.
Todd, who is officially ending his 28-day quarantine on Tuesday, said he wants to raise awareness of what it can be like to have a case of monkeypox.
"Please know that this can happen and I think that's the dialogue that needs to be out there," he said. "When I see people don't take it seriously, they think, 'Oh, it's like Chickenpox.' But no, it's horrible and now I have a hole in my face."
He went on, "I don't want anyone else to go through what I've been going through." | https://6abc.com/moneypox-symptoms-treatments-jeffrey-todds/12115319/ | 2022-08-10T20:51:53Z | https://6abc.com/moneypox-symptoms-treatments-jeffrey-todds/12115319/ | false |
BATON ROUGE, La. (BRPROUD) — A man who is accused of streaming an attack on social media is now formally charged with murder, kidnapping, and other crimes.
According to the Baton Rouge Police Department (BRPD), Earl Lee Johnson, 35, allegedly stabbed 34-year-old Janice David as she was tied to a steering wheel with jumper cables on April 18. The brutal attack was streamed on Facebook.
BRPD found the body of David inside a vehicle on S. Sherwood Forest Boulevard.
An East Baton Rouge Parish grand jury returned the indictment on Wednesday, charging Johnson with the following offenses:
- First-degree murder
- Second-degree kidnapping
- Obstruction of justice in a homicide investigation
- Unlawful posting of criminal activity for notoriety and publicity
- Theft of a motor vehicle valued at more than $25,000
- Aggravated flight from an officer | https://www.myarklamiss.com/crime/louisiana-man-formally-charged-with-murder-in-stabbing-death-streamed-on-social-media/ | 2022-08-10T20:52:15Z | https://www.myarklamiss.com/crime/louisiana-man-formally-charged-with-murder-in-stabbing-death-streamed-on-social-media/ | true |
NEW ORLEANS (WGNO) — School is back in session and former Saints quarterback Drew Brees wanted to help fathers tackle the first day of school in style. Great Clips partnered with “MVP” dads in a back-to-school campaign for the 2022-2023 school year. The former NFL player and father of four, along with other popular influencer dads and families shared the importance of looking and feeling their best going into a new school year.
In the campaign video, Brees broke down a game plan on how dads can feel more confident and empowered when it comes to the first day of school. In the Dad’s back-to-school playbook, Brees talked about the importance of nutrition and self-confidence. The former All-Pro football player’s children were also included in the campaign.
Great Clips said that they believe dads like to hear tips from others to up their game, and that’s why Drew Brees was chosen for the campaign. “With experienced parents like Drew Brees, Dumb Dads, Adam Busby, The Bramfam, and Burton B. Buffaloe, Great Clips is providing dads and moms with the inspiration, information, and tools they need to succeed in back-to-school prep.”
During the past few years since the pandemic, more dads have been at home and are getting to spend more time with their children said a spokesperson from Great Clips. “As many dads have spent more time at home over the past two years, they’ve re-evaluated their work-life balance and have formed tighter connections with their kids,” said Lisa Hake, vice president of marketing and communications at Great Clips, Inc. “More and more, dads see parenting as a key part of their identity, so we wanted to support them as they head into the back-to-school season.”
Those parents who want their students to get a haircut for the first weeks of classes can sign their child up for a check-in online. All you have to do is the following:
- Find a Great Clips near you in the salon locator.
- Tap the check-in pin, enter your name and phone number, and tap ‘check me in’
- Show up to the salon near the end of your estimated wait time and let the stylist who greets you know you checked in online. | https://www.myarklamiss.com/louisiana-news/drew-brees-teams-up-with-great-clips-to-tackle-the-first-day-of-school/ | 2022-08-10T20:52:27Z | https://www.myarklamiss.com/louisiana-news/drew-brees-teams-up-with-great-clips-to-tackle-the-first-day-of-school/ | false |
NEWPORT NEWS, Va., Aug. 10, 2022 /PRNewswire/ -- For the second year, the BayPort Foundation is excited to team with J&A Racing to serve as the title sponsor and official charity partner of the premier, family-friendly fundraising event, the BayPort Foundation Crawlin' Crab Half Marathon Weekend. This year, the Foundation is honored to partner with Newport News Shipbuilding and Zogo as its official race sponsors.
The Crawlin' Crab Race Weekend takes place in Hampton on October 1-2, 2022. The festive event has a race distance for all abilities and all ages: Half Marathon, 5K, and Kids 1K. The Half Marathon course shows off the best of Hampton. The flat, fast course takes runners from the Hampton Coliseum into the historic downtown, and along the Hampton Roads Harbor. Once participants cross the finish line, they are invited to celebrate their success at a post-race celebration. With nearly 3,000 participants each year, a portion of every race registration will go directly to the Foundation.
Runners of all ages and paces are invited to join BayPort and J&A Racing at two community group run events on both the Peninsula and Southside in preparation for race weekend. Local runners will enjoy a casual 3-mile run and are encouraged to stay afterwards to enjoy food and beverages, redeem swag and giveaway items, win gift card prizes, and possibly walk away with free Crawlin' Crab race registration codes to be used at any of the race weekend's events. BayPort will be providing all participating runners (21+) 1 complimentary beer and food ticket per person at each event. Please visit BayPort's Facebook page @bayportcu to learn more and RSVP today.
The two upcoming community group run events are scheduled as follows:
- Monday, August 22 at 6 p.m. at local, veteran-owned 1700 Brewing in Newport News, in partnership with Point 2 Running Company
- Wednesday, September 14 at 6 p.m. at local O'Connor Brewing Company in Norfolk, in partnership with Norfolk Run Club
Registration for the 2022 BayPort Foundation Crawlin' Crab Race Weekend is currently open. More information can be found at crawlincrabhalf.com.
About BayPort Foundation
BayPort Foundation is the charitable arm of BayPort Credit Union and was established to extend the credit union's philosophy of "people helping people." The BayPort Foundation's mission focuses on four philanthropic efforts: educational scholarships, financial literacy education, promoting family health and wellness, and hardship and emergency assistance in communities where BayPort members live and work. For more information, visit bayportfoundation.org.
About J&A Racing
J&A Racing is a nationally recognized race management company based in Virginia Beach, Virginia. With a portfolio of seven events and virtual challenges, J&A Racing's mission is to promote and support healthy lifestyles and the sport of running through all stages of life. Since 2003 when J&A Racing owners, Amy and Jerry Frostick, took over the Shamrock Sportsfest, the Yuengling Shamrock Marathon Weekend has become one of the most popular running events in the country growing from 3,000 participants to a record 30,000 in 2015. Additionally, J&A Racing organizes the Old Point National Bank Wicked 10K Weekend; Big Blue 5K; BayPort Credit Union Surf-N-Santa 5 Miler; BayPort Foundation Crawlin' Crab Half Marathon Weekend; Chartway Norfolk Harbor Half Marathon Weekend; and the ADP Corporate 5K. For more information on J&A Racing's events, visit jandaracing.com.
View original content to download multimedia:
SOURCE BayPort Credit Union | https://www.kwch.com/prnewswire/2022/08/10/bayport-foundation-announces-official-crawlin-crab-half-marathon-weekend-sponsors/ | 2022-08-10T20:53:27Z | https://www.kwch.com/prnewswire/2022/08/10/bayport-foundation-announces-official-crawlin-crab-half-marathon-weekend-sponsors/ | false |
This is a carousel. Use Next and Previous buttons to navigate
MEMPHIS, Tenn. (AP) — Ralph Prater, one of the first Black students to enroll at then-Memphis State University in 1959, has died. He was 81.
“Prater’s impact on our institution and community is immeasurable, and we will forever celebrate his remarkable courage and legacy,” the University of Memphis said on social media Tuesday.
The university confirmed his death on its website but did not reveal the cause. He died Sunday.
The group of students who integrated the university became known as the Memphis State Eight. Also in the group were Eleanor Gandy, Sammie Burnett Johnson, Marvis Kneeland Jones, Bertha Rogers Looney, Rose Blakney Love, Luther McClellan and John Simpson. Looney and McClellan still survive.
McClellan said he had recently talked to Prater.
“It was quite a shock to me when I had talked to him about a week ago,” McClellan told the Commercial Appeal on Tuesday. “We used to talk periodically and see how each other was doing. I’m going to miss him.”
McClellan said he rarely saw Prater during the day other than commuting to campus and back.
“There were only eight of us, so we were pretty much segregated from each other during the day,” McClellan said. “I was a math major, he was in political science, so we went to different classes. We didn’t really see each other when we were on campus.”
Prater would take them to school and back in his Chrysler during their first year, McClellan said.
“I have very fond memories of Ralph, ... ” he said. “He was a very giving person. He was kindhearted and was never ever, ever, ever mean-spirited.” | https://www.sfchronicle.com/news/article/One-of-8-students-who-integrated-Memphis-State-17365130.php | 2022-08-10T20:53:49Z | https://www.sfchronicle.com/news/article/One-of-8-students-who-integrated-Memphis-State-17365130.php | true |
Heart ailment doesn’t mean end to physical activity
HYDERABAD August 11, 2022 01:02 ISTESIC Hospital’s cardiac rehab programme improves fitness levels, changes lives
For those who fear having to live with limited mobility and less physical activity after suffering a heart attack or heart failure, ESIC Medical College and Hospital’s Cardiac Rehab Programme (CRP), a first of its kind, comes as a ray of hope.
According to doctors, patients such as 19-year-old Lokith, who was diagnosed with pulmonary arterial hypertension, and had an exercise capacity of only 33 seconds, and 47-year-old Lingam, a welder who suffered a heart failure earlier this year, after taking the CRP, have shown a dramatic change, and are now running up to 21 km.
The programme is physician-supervised and aimed at improving heart pumping capacity and physical fitness.
Ignored aspect
Describing CRP as the first such initiative, ESIC Hospital doctors opined that the rehabilitation process after suffering a heart attack is largely ignored. “After three or four months of the structured rehabilitation process, the heart starts to adapt to the programme, the pumping capacity improves, and the patient becomes fitter and stronger,” said Dr Muralidhar Babi, Assistant Professor, ESIC Medial College Hospital.
Doctors shared the progress of a 34-year-old plumber who suffered a heart attack in 2018 and had a stent placed. But, on account of heart damage, the pumping capacity had dropped to 30%. This affected his professional efficiency. Things began looking up after he enrolled in the programme. He now runs 5 km with ease.
Dr kalyan Pal, Medical Superintendent, Dr Shailaja, Deputy Medical Superintendent, Dr Sadanand Reddy, Head of the Cardiology Department, and Dr Sushma, HOD, PMR also spoke. | https://www.thehindu.com/news/national/telangana/heart-ailment-doesnt-mean-end-to-physical-activity/article65754349.ece/amp/ | 2022-08-10T20:56:18Z | https://www.thehindu.com/news/national/telangana/heart-ailment-doesnt-mean-end-to-physical-activity/article65754349.ece/amp/ | false |
Goldendoodles, Maltipoos, Morkies – mixed dog breeds are hugely popular these days. But finding a local breeder can be challenging. That’s why some eager pet owners start looking online. But NBC4's I-Team has a warning before you do.
Tracey Gilchrist was smitten with some Morkie puppies, a mix of Maltese and Yorkie, that she found online.
“This is exactly what I wanted,” she said.
Gilchrist found the dogs on a website called Charley Morkie Pups. The breeder offered to sell Gilchrist a pup named Nina for $700. So she sent him the money through Zelle. Days later, the breeder made Gilchrist another offer.
“‘We still have other pups available, and would you be interested in her sister, because they’re very close,’” she remembers the breeder saying. “Why wouldn’t I jump on the opportunity?”
Gilchrist Zelled the breeder $600 for that pup. But not long after that, he ghosted her.
“And now crickets, now I never hear from him,” she said.
U.S. & World
Stories that affect your life across the U.S. and around the world.
Gilchrist thought the breeder was legitimate, based on the customer reviews on his website. But the I-Team found those exact same reviews, word for word, on similar-looking sites selling different dog breeds. The dog Gilchrist bought, Nina, is still listed for sale on Charley Morkie Pups, but we also found this exact same picture of her for sale on a different site under the name Joules.
“How dare you take advantage of people and really play on their emotions,” said Gilchrist.
The I-Team reached out to Charley Morkie Pups but didn’t get a response. Steve McFarland with the Better Business Bureau isn’t surprised.
“Every year I think we break records in the number of complaints we’re getting about breeders and pet scams,” said McFarland.
He says in 60% of the complaints he gets about breeders, the consumer never got the puppy they bought and never got their money back.
McFarland says before buying a dog from any breeder, you need to do a lot of research. Ask the breeder to connect you with past clients, to see a veterinarian report for the puppy you’re interested in buying, and to meet with you via Zoom if they can’t meet in person.
“In those conversations you should be asking, ‘Hey can you put me on cam so I can see Fluffy? You want to have live conversations with this breeder who can give you references and historical facts about the pet,” said McFarland.
As for Gilchrist, she’s decided to adopt a dog from a local shelter.
“I’m just going to go there and get a second-chance dog, for sure,” she said. | https://www.nbcphiladelphia.com/news/national-international/buying-puppies-online-scams/3331730/ | 2022-08-10T20:56:23Z | https://www.nbcphiladelphia.com/news/national-international/buying-puppies-online-scams/3331730/ | true |
Daniel Uhlfelder, the Walton County lawyer who gained a modicum of fame dressing as the Grim Reaper to bash Gov. Ron DeSantis’ COVID-19 policies, is donning the hooded black cape and grabbing his sickle again.
At least, he did for five minutes last week outside a Circle K on Thomasville Road in Tallahassee before a pair of police officers politely requested the Democratic candidate for attorney general and the handful of assembled reporters to leave the property.
Uhlfelder said he wanted to bring attention to high gas prices, insurance premiums and shady tactics of Florida Power & Light, and the lack of action by Attorney General Ashley Moody, a Republican.
“[FPL] needs to be investigated. On Day One I’m going to investigate Florida Power & Light,” Uhlfelder said after rattling off a series of FPL’s scandals in recent years, involving connections and payments to political consultants involved in a scheme to dupe voters through “ghost candidates” and trailing a Jacksonville columnist.
He shrugged off questions asking what the attorney general could do about inflation and high gas prices – the attorney general can investigate violations of price gouging by gas stations but only during a declared state of emergency, usually before a tropical storm or hurricane hits – by noting the vast powers of the office to investigate.
“People don’t understand the power of the attorney general’s office,” Uhlfelder said. “I plan to use the full weight of the attorney general’s office to investigate abuses by utility companies, insurance companies (and) developers who are jacking up rents.”
Before he can take on Moody in the general election, Uhlfelder must defeat former Orange-Osceola State Attorney Aramis Ayala in the Aug. 23 primary.
Uhlfelder argued his status as a resident in a deep-red swath of the state means he’s best positioned to face Moody in the general election.
“I am a North Florida Democrat. I know how to communicate with folks who may not agree with me,” Uhlfelder said. “I have great bipartisan appeal. I’m going to be talking about utilities, gas prices, rent, reproductive rights. … Whether you’re Republican, Democrat or independent it’s affecting all of us.”
Uhlfelder also defended wearing the Grim Reaper outfit as he bids to gain coverage as the primary race heads into the final stretch.
“Would you all be here right now if I was not wearing this?” he asked the reporters. | https://www.miamitimesonline.com/business/daniel-uhlfelder-said-hell-investigate-fpl-on-day-one-if-he-is-elected-attorney-general/article_d163583e-1887-11ed-903b-db12065f86d8.html | 2022-08-10T20:56:35Z | https://www.miamitimesonline.com/business/daniel-uhlfelder-said-hell-investigate-fpl-on-day-one-if-he-is-elected-attorney-general/article_d163583e-1887-11ed-903b-db12065f86d8.html | false |
LOS ANGELES (AP) — 1. “America’s Got Talent” (Tuesday), NBC, 6.24 million.
2. “60 Minutes Presents,” CBS, 5.93 million.
3. NFL Pre-Season Hall of Fame Game (Raiders vs. Jaguars), NBC, 5.48 million.
4. “Celebrity Family Feud,” ABC, 4.73 million.
5. NFL weather delay, NBC, 4.16 million.
6. “The $100,000 Pyramid,” ABC, 4.14 million.
7. “Big Brother” (Sunday), CBS, 3.96 million.
8. CMA Fest, ABC, 3.86 million.
9. “Big Brother” (Wednesday), CBS, 3.83 million.
10. “FBI,” CBS, 3.82 million.
11. “Press Your Luck,” ABC, 3.71 million.
12. “America’s Funniest Home Videos,” ABC, 3.71 million.
13. “Big Brother” (Thursday), CBS, 3.59 million.
14. “Generation Gap,” ABC, 3.34 million.
15. “FBI: International,” CBS, 3.31 million.
16. “The Neighborhood,” CBS, 3.22 million.
17. “Young Sheldon,” CBS, 3.20 million.
18. “Tucker Carlson Tonight” (Monday), Fox News, 3.19 million.
19. “NCIS,” CBS, 3.13 million.
20. “The Bachelorette,” ABC, 3.12 million. | https://www.pahomepage.com/entertainment-news/prime-time-network-cable-viewership-for-the-week-of-aug-1/ | 2022-08-10T20:56:34Z | https://www.pahomepage.com/entertainment-news/prime-time-network-cable-viewership-for-the-week-of-aug-1/ | true |
A 17-year-old from Nebraska and her mother are facing criminal charges for performing an illegal abortion after police obtained from Facebook the pair’s private chat history, in which the mother says she bought her daughter abortion pills. What do you think?
“Are you suggesting Facebook is providing sensitive user data to a third party?”
Randy Greenwood, Tastemaker
“It’s cool, I do all my illegal stuff on Snapchat.”
Paola Hilo, Scientific Illustrator
“I’ve long accepted that every time I log into Facebook I’m asking to get arrested.”
Ross Boykins, Professional Rollerblader | https://www.theonion.com/facebook-gave-private-messages-to-police-in-teen-s-abor-1849397420 | 2022-08-10T20:56:40Z | https://www.theonion.com/facebook-gave-private-messages-to-police-in-teen-s-abor-1849397420 | false |
LOS ANGELES (AP) — Homeless encampments that have proliferated in nearly every neighborhood of Los Angeles will no longer be allowed within 500 feet (152 meters) of schools and day care centers under a sweeping ban approved Tuesday during a City Council meeting disrupted by protesters who said the law criminalizes homelessness.
The council voted 11-3 to broadly expand an existing prohibition on sitting, sleeping or camping that previously only applied to schools and day cares specified by the council.
The meeting was recessed before the vote when dozens of demonstrators shouted their opposition to the measure and police officers cleared the council chamber. One person was arrested, said Los Angeles Police Department Officer Annie Hernandez said.
Protesters also gathered outside City Hall, chanting “Abolish 41.18,” a reference to the law prohibiting encampments on freeway overpasses, around railroad tracks, near loading docks, at libraries and other locations.
The final vote, which applies to the city’s public and private schools, came after two previous votes, including one last week that was also interrupted by a raucous protest.
Los Angeles is among many cities struggling to deal with a surge in homelessness and large encampments scattered along sidewalks that have sparked public outcry.
Supporters of the blanket ban said homeless camps pose health and safety threats to schoolchildren, especially because of the disruptive presence of people with drug addictions or mental illness.
“This is something to protect kids in our city,” Councilmember Paul Koretz said before voting for the measure. He said “asking folks in an encampment to move a couple hundred feet” should be be an easy decision if it means children have a safer walk to and from school.
About 750 public school sites are within Los Angeles and nearly 1,000 commercial day care businesses are registered with the city. The new public school year starts next Monday.
Opponents of the ban, including homeless advocates, said it would further criminalize homelessness and waste resources better spent on outreach and connecting people in need to services.
Homeless residents are far more likely to be victims of violence than perpetrators, the nonprofit People Assisting The Homeless, or PATH, said in a statement opposing the measure.
“Enforcement of anti-camping ordinances, then, only displaces people and makes it harder for trained outreach staff to establish trust again. Residents of cleared encampments, unless connected to stable permanent housing through a trauma-informed case management process, often return to unsheltered homelessness,” PATH said in a statement.
The measure must be signed by Los Angeles Mayor Eric Garcetti before it takes effect and his office didn’t immediately respond to phone and email messages seeking comment.
The ban comes as several hotels are set to end their involvement in the state’s Project Roomkey, which paid the hotels to provide hundreds of rooms to unsheltered people. | https://www.pahomepage.com/news/national/los-angeles-oks-sweeping-ban-on-homeless-camps-near-schools-2/ | 2022-08-10T20:56:56Z | https://www.pahomepage.com/news/national/los-angeles-oks-sweeping-ban-on-homeless-camps-near-schools-2/ | true |
Tire-chalking found unconstitutional by federal judge
By Stephen Borowy
Click here for updates on this story
BAY CITY, Michigan (WNEM) — A federal judge found it unconstitutional for the city of Saginaw to mark vehicle tires with chalk without a warrant or suspicion of wrongdoing.
On Monday, U.S. District Judge Thomas Ludington declared it unconstitutional under the Fourth Amendment to the U.S. Constitution.
Ludington also ordered the city of Saginaw to pay $1 in nominal damages to each member of the class action lawsuit’s subclass for each time their vehicle was marked with chalk.
The city of Saginaw used tire chalking as a way to enforce parking limits. The lawsuit began in 2017 when Alison Taylor sued to challenge 14 parking tickets.
Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform. | https://kion546.com/cnn-regional/2022/08/10/tire-chalking-found-unconstitutional-by-federal-judge/ | 2022-08-10T20:57:03Z | https://kion546.com/cnn-regional/2022/08/10/tire-chalking-found-unconstitutional-by-federal-judge/ | false |
BENGALURU, India (AP) — India took another step toward meeting its climate goals Tuesday when lawmakers in parliament’s lower house approved legislation that would require greater use of renewable energy and force industrial polluters to pay a price for the carbon they emit.
The bill sets out a minimum requirement for renewable energy use for corporations and residential buildings. It also grants clean energy users carbon-saving certificates that can be sold or traded and lays out a new energy efficiency standard in homes, which account for 24% of India’s electricity use.
There are also penalties for corporations who aren’t using an adequate amount of renewable energy sources to power their operations.
The legislation will now go through parliament’s upper house.
The bill is “a positive step” towards India’s climate targets, said Madhura Joshi, India energy transitions lead at E3G, a climate change think tank.
“The share of clean energy sources powering India’s industries and homes will definitely increase as a result of this bill,” she said.
Last week, India committed to reducing emissions caused by activities for the nation’s economic growth by 45% by 2030 from 2005 levels. The country also plans to get half of its energy requirements from non-fossil fuel-based energy sources by 2030, and promote a federal government program that encourages people to make green lifestyle changes.
“Every unit of energy saved or conserved is critical for reducing emissions,” said Bharath Jairaj who leads the World Resources Institute’s India energy program. Including large residential buildings into building codes that require energy conservation is a key highlight of the bill and reducing emissions, he said.
Scientists say cutting greenhouse gases is essential for limiting the effects of climate change, which has already brought hotter weather and more devastating floods to India.
The bill is also the first time the Indian government has proposed a carbon trading system. Unlike in a few other parts of the world, the so-called carbon market is still a fledgling idea in India, Jairaj said.
It is “bound to become an important tool to reduce greenhouse gas emissions in India,” he added.
___
Associated Press climate and environmental coverage receives support from several private foundations. See more about AP’s climate initiative here. The AP is solely responsible for all content. | https://www.pahomepage.com/news/technology/lawmakers-in-india-pass-energy-conservation-bill/ | 2022-08-10T20:57:55Z | https://www.pahomepage.com/news/technology/lawmakers-in-india-pass-energy-conservation-bill/ | false |
OKLAHOMA CITY, Aug. 10, 2022 /PRNewswire/ -- Riley Exploration Permian, Inc. (NYSE American: REPX) ("Riley Permian" or the "Company"), today reported financial and operating results for the fiscal third quarter ended June 30, 2022.
HIGHLIGHTS FOR THE FISCAL THIRD QUARTER ENDING JUNE 30, 2022
- Averaged oil production of 8.4 MBbls per day, which exceeds the high end of guidance and represents an increase of 24% as compared year-over-year to the fiscal third quarter 2021 and 12% as compared quarter-over-quarter to the fiscal second quarter 2022
- Reported net income of $39 million, which includes $13 million of non-cash gain on derivative contracts and income from operations of $63 million
- Generated $45 million of Adjusted EBITDAX(1) and $44 million of operating cash flow, representing an increase of 29% and 47%, respectively, over the prior quarter
- Incurred total accrual (activity-based) capital expenditures of $34 million and total cash capital expenditures of $37 million
- Paid dividends of $0.31 per share for a total of $6 million
- Reported proved reserves of 79 MMBoe (64% oil) with a standardized measure of future discounted cash flows of $1,046 million
- PV-10 value(1) of total proved reserves and total proved developed reserves of $1,098 million and $807 million, respectively, as of June 30, 2022 based on NYMEX strip pricing
"In the fiscal third quarter, we generated record oil production, revenue and operating cash flow," said Riley Permian Chairman and CEO, Bobby Riley. "Our cash flow benefited from a decreased impact of financial hedges this past quarter, and we see a continuation of that trend for the quarters and year ahead. We are experiencing increased costs like many other companies in our industry, but we are proud of our team's efforts to control costs where we can. Based on the strength of our fiscal third quarter production, and given modest increased activity plans, we are increasing previously released midpoint guidance for oil production for the fiscal fourth quarter by 6% and for the fiscal year by 4%. Related, we are increasing our midpoint guidance for fiscal year capital expenditures by approximately 5%, driven by increased activity and cost increases. We continue to return a substantial portion of our cash flow to shareholders in the form of dividends, and we see opportunity to pay down our debt in the coming quarters, further strengthening our balance sheet."
(1) Non-GAAP financial measure, which is defined and reconciled below.
OPERATIONS AND DEVELOPMENT ACTIVITY UPDATE
Riley Permian averaged oil production of 8.4 MBbls per day for the three months ended June 30, 2022, representing an increase of 24% as compared year-over-year to the fiscal third quarter 2021 and 12% as compared quarter-over-quarter to the fiscal second quarter 2022. The Company averaged total equivalent production of 10.2 MBoe per day for the three months ended June 30, 2022, an increase of 12% as compared to the same period in 2021 and 4% as compared to the prior quarter.
Oil production represented 82% of the total equivalent production for the fiscal third quarter of 2022, which compares to 77% of the total in the fiscal second quarter of 2022 and 74% in the fiscal third quarter of 2021. Such changes are not indicative of changing reservoir properties but rather reflect the impact of curtailed natural gas production. Beginning in February 2022 and continuing through the fiscal third quarter, the Company's primary midstream gas gathering and processing counterparty underwent a temporary curtailment and shutdown of their primary plant as part of an overall capacity expansion project. While the processing plant project was expected, the duration of the curtailment lasted longer than originally anticipated, which negatively impacted sales of natural gas and NGLs during this period and led to lower growth in natural gas and NGL sales volumes as compared to oil sales volumes.
The Company's development activity during the fiscal third quarter included drilling 5 gross (3.0 net) horizontal wells (scheduled for completion in fiscal fourth quarter 2022), turning to sales 5 gross (5.0 net) horizontal wells, drilling and completing 1 gross (1.0 net) saltwater disposal well and preparatory activity for 1 gross (1.0 net) horizontal well to be drilled and completed during the fiscal fourth quarter. This activity corresponds with previously provided guidance, with the exception that 1 gross (1.0 net) well previously planned for completion during the fiscal third quarter was officially completed and brought online during the fiscal fourth quarter, while capital expenditures were incurred for the well completion during the third quarter. Such activity corresponds with $30.8 million in accrual basis drilling, completions and facility capital expenditures, which also includes capitalized workovers, midstream infrastructure and minor additions to land and working interests.
The Company advanced its EOR pilot project in Yoakum County, Texas during the fiscal third quarter, completing an additional three of the remaining five injection wells. Such activity corresponded with $3.6 million of accrual basis capital expenditures for the quarter. Subsequent to quarter end, in July 2022, the Company completed the remaining two injection wells with water injection initiated on all six injection wells.
The Company incurred $34 million in total accrued capital expenditures for the three months ended June 30, 2022, which compares to the Company's previously released guidance of $28 million to $33 million. Overages on accrued capital expenditures compared to the Company's previously released guidance are primarily related to the accelerated timing of the saltwater disposal well drilled during the quarter, in addition to higher costs being realized. During the quarter, the average completed lateral length on the 5.0 horizontal wells turned to sales was approximately 7,100 feet, with drilling and completion costs of approximately $800 per completed lateral foot. The current costs per completed lateral length on similar wells has increased approximately 26% since the start of this fiscal year, with the largest increase being associated with completion costs. On a cash basis, the Company had total capital expenditures of $37 million for the three months ended June 30, 2022.
FINANCIAL RESULTS
For the three months ended June 30, 2022, the Company reported net income of $39 million and operating income of $63 million. The Company generated Adjusted EBITDAX(1) of $45 million, operating cash flow from continuing operations of $44 million and Free Cash Flow(1) of $7 million.
For the nine months ended June 30, 2022 (fiscal year to date), the Company reported net income of $53 million and operating income of $137 million. The Company generated Adjusted EBITDAX(1) of $106 million, operating cash flow from continuing operations of $97 million (inclusive of negative changes in working capital of $2 million) and Free Cash Flow(1) of $22 million. The pattern of the Company's development activity affects cash capital expenditures and may continue to cause fluctuations in Free Cash Flow(1) from quarter to quarter with longer periods more representative of Free Cash Flow(1) generation potential than an individual quarter.
(1) Non-GAAP financial measure, which is defined and reconciled below.
FINANCIAL RESULTS, Continued
Fiscal third quarter 2022 average realized prices, before derivative settlements were $108.41 per barrel of oil, $4.98 per Mcf of natural gas and $34.71 per barrel of natural gas liquids, resulting in a total equivalent price, before derivative settlements, of $94.80 per Boe. The Company benefited from a favorable $1.65 per barrel positive differential to the WTI index for the quarter. Adjusted for derivative settlements, total equivalent price was $66.97 per Boe, corresponding to realized derivative settlement losses of $27.83 per Boe or $25.8 million. The Company reported a $12.4 million loss on derivatives, which includes the $25.8 million loss on settlements and a $13.4 million non-cash gain due to changes in the fair value of derivatives. Total oil and natural gas sales revenue was $88 million for the fiscal third quarter 2022 with $62 million of oil and natural gas sales revenue net of derivative settlements, representing quarter-over-quarter increases of 32% and 28%, respectively, and year-over-year increases of 111% and 83%, respectively. For the quarter, oil revenue represented 94% of total revenue.
Riley Permian's total Cash Costs(1) for the fiscal third quarter of 2022 were $18.2 million, representing an increase of 25% compared to the fiscal second quarter of 2022. Lease operating expense ("LOE") was $8.1 million, corresponding to the low end of guidance and an 18% increase quarter-over-quarter. Workover activity was unusually high during the fiscal third quarter of 2022 with workover expense (a component of LOE) approximately $1.4 million higher than the average of the prior three quarters. Excluding workover expense, LOE was lower than the prior two quarters, despite materially increasing production. Cash G&A expense(1) was $3.9 million, which was at the low end of guidance. Interest expense was $0.7 million, essentially flat with interest expense for the fiscal second quarter of 2022. Production and ad valorem taxes increased 58% quarter-over-quarter as a result of higher commodity prices and an increase in our estimated property values, which increased our ad valorem tax estimate. Accordingly, increases in production and ad valorem taxes accounted for 55% of the total increase in Cash Costs quarter-over-quarter. Excluding production and ad valorem taxes, Cash Costs(1) increased 15% quarter-over-quarter, which is consistent with the 13% quarter-over-quarter increase in oil production.
Riley Permian increased margins significantly for the fiscal third quarter of 2022, as compared to prior periods. Higher production volumes and realized commodity prices more than offset the impacts from the natural gas curtailment, loss on settlements of derivatives and increased Cash Costs(1). Adjusted EBITDAX(1) increased 29% quarter-over-quarter while operating cash flow from continuing operations increased 47% quarter-over-quarter. Compared to the fiscal third quarter of 2021, Adjusted EBITDAX(1) increased by 98% and operating cash flow from continuing operations increased by 113%.
During the fiscal third quarter 2022, the Company paid common dividends of $0.31 per share or $6 million. Subsequent to the quarter end, the Company paid common dividends of $0.31 per share in August 2022.
The Company completed an amendment to its credit facility during the quarter which extended the maturity to April 2026 and increased the borrowing base to $200 million. As of August 8, 2022, we had $61 million drawn and $139 million, or approximately 70%, of availability on the credit facility.
(1) Non-GAAP financial measure, which is defined and reconciled below.
REVISED FISCAL FOURTH QUARTER 2022 OUTLOOK AND GUIDANCE
Based on current market conditions, the Company forecasts drilling 4 gross (3.2 net), completing 7 gross (4.2 net) and turning to production 7 gross (4.2 net) horizontal wells during the fiscal fourth quarter 2022. Additional scheduled activity includes capital workovers and midstream infrastructure. Management forecasts accrual basis capital expenditures related to such development activity of approximately $24 million to $28 million, which also includes estimates for anticipated non-operated drilling and completions, capital workovers, infrastructure, preparatory work for the fiscal 2023 development program and minor additions to land and existing working interests.
The Company forecasts fiscal fourth quarter 2022 oil production to average 8.2 MBbls per day to 8.6 MBbls per day, with the midpoint average representing 21% year-over-year growth. The midstream gas gathering and processing expansion project has been fully commissioned. Following completion of the expansion project in mid July, the Company has realized a larger volume of contractual, firm capacity, which has led to increased sales for natural gas and NGLs and reduced flaring. However, despite the physical and contractual increases in processing capacity, the Company is currently producing natural gas in excess of our contractual minimum processing capacity, which will lead to continued, partial curtailment. Based on estimates of available gas processing capacity, we forecast total equivalent production to average 11.1 MBoe per day to 11.6 MBoe per day for the fiscal fourth quarter.
The Company forecasts fiscal fourth quarter 2022 LOE of approximately $8.0 million to $10.0 million, with the low end corresponding to fiscal third quarter actual results and the high end accounting for costs associated with increased production volumes and inflationary pressures. We forecast Cash G&A expenses(1) for the fiscal fourth quarter of approximately $4.1 million to $4.7 million.
For its EOR pilot project, management forecasts spending approximately $4 million to $6 million of accrual basis capital expenditures in the fiscal fourth quarter related to completion of the remaining injection wells and the CO2 tap installation. Based on anticipated delivery timing of compressors needed for CO2 injection, the Company forecasts beginning CO2 injection during late 2022 (calendar fourth quarter 2022). Approximately $4 million of anticipated, accrual basis capital expenditures for our EOR program, previously estimated to be incurred during fiscal 2022, are now anticipated to be incurred in fiscal 2023.
In total, management forecasts total accrual basis capital expenditures of $28 million to $34 million for the fiscal fourth quarter 2022.
REVISED FISCAL YEAR 2022 OUTLOOK AND GUIDANCE
Incorporating actual, accrual basis capital expenditures to date for the fiscal year, and combined with revised fiscal fourth quarter guidance above, the Company forecasts full-year fiscal 2022 accrual basis capital expenditures to total approximately $109 million to $115 million, with modest upward revisions from previously provided estimates of $102 million to $111 million.
This total includes estimates of $93 million to $97 million for drilling and completions, which compares to previous guidance of $84 million to $89 million. We are forecasting an annual total of 19 gross (15.0 net) wells drilled, completed and brought online during fiscal year 2022. The forecasted capital expenditures include $16 million to $18 million for our EOR program, down from $18 million to $22 million forecasted previously.
We forecast full-year fiscal 2022 oil production to average 7.8 MBbls per day to 7.9 MBbls per day (corresponding to approximately 2.9 MMBbls), representing 22% to 24% growth from fiscal year 2021 average oil production and corresponding with upward revisions from previously provided growth estimates of 17% to 22% during the prior quarter. Further, we forecast that full-year fiscal 2022 total equivalent production could average 10.3 MBoe per day to 10.4 MBoe per day.
(1) Non-GAAP financial measure, which is defined above.
CONFERENCE CALL
Riley Permian management will host a conference call for investors and analysts on August 11, 2022 at 10:00 a.m. CT to discuss the Company's results. Interested parties are invited to participate by calling:
- U.S./Canada Toll Free, (888) 330-2214
- International, +1 (646) 960-0161
- Conference ID number 5405646
An updated company presentation, which will include certain items to be discussed on the call, will be posted prior to the call on the Company's website (www.rileypermian.com). A replay of the call will be available until August 25, 2022 by calling:
- (800) 770-2030 or (647) 362-9199
- Conference ID number 5405646
About Riley Exploration Permian, Inc.
Riley Permian is a growth-oriented, independent oil and natural gas company focused on the acquisition, exploration, development and production of oil, natural gas and natural gas liquids. For more information, please visit www.rileypermian.com.
Investor Contact:
Rick D'Angelo
405-438-0126
IR@rileypermian.com
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The statements contained in this release that are not historical facts are forward-looking statements that represent management's beliefs and assumptions based on currently available information. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, need for financing, competitive position and potential growth opportunities. Our forward-looking statements do not consider the effects of future legislation or regulations. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words "believes," "intends," "may," "should," "anticipates," "expects," "could," "plans," "estimates," "projects," "targets," "forecasts" or comparable terminology or by discussions of strategy or trends. You should not place undue reliance on these forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this release are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved or occur, and actual results could differ materially and adversely from those anticipated or implied by the forward-looking statements.
Among the factors that could cause actual future results to differ materially are the risks and uncertainties the Company is exposed to. While it is not possible to identify all factors, we continue to face many risks and uncertainties including, but not limited to: the volatility of oil, natural gas and NGL prices; the scope, duration, and reoccurrence of any epidemics or pandemics (including, specifically, the coronavirus disease 2019 ("COVID-19") pandemic and any related variants), including reactive or proactive measures taken by governments, regulatory agencies and businesses related to the pandemic, and the effects of COVID-19 on the oil and natural gas industry, pricing and demand for oil and natural gas and supply chain logistics; regional supply and demand factors, any delays, curtailment delays or interruptions of production, and any governmental order, rule or regulation that may impose production limits; cost and availability of gathering, pipeline, refining, transportation and other midstream and downstream activities; severe weather and other risks that lead to a lack of any available markets; our ability to successfully complete mergers, acquisitions and divestitures; the risk that the Company's EOR project may not perform as expected or produce the anticipated benefits; risks relating to our operations, including development drilling and testing results and performance of acquired properties and newly drilled wells; any reduction in our borrowing base on our revolving credit facility from time to time and our ability to repay any excess borrowings as a result of such reduction; the impact of our derivative strategy and the results of future settlement; our ability to comply with the financial covenants contained in our credit agreement; conditions in the capital, financial and credit markets and our ability to obtain capital needed for development and exploration operations on favorable terms or at all; the loss of certain tax deductions; risks associated with executing our business strategy, including any changes in our strategy; inability to prove up undeveloped acreage and maintain production on leases; risks associated with concentration of operations in one major geographic area; legislative or regulatory changes, including initiatives related to hydraulic fracturing, emissions, and disposal of produced water, which may be negatively impacted by regulation or legislation; the ability to receive drilling and other permits or approvals and rights-of-way in a timely manner (or at all), which may be restricted by governmental regulation and legislation; risks related to litigation; evolving geopolitical and military hostilities in other areas of the world; and cybersecurity threats, technology system failures and data security issues. Additional factors that could cause results to differ materially from those described above can be found in Riley Permian's Annual Report on Form 10-K for the year ended September 30, 2021 filed with the SEC and available from the Company's website at www.rileypermian.com under the "Investor" tab, and in other documents the Company files with the SEC.
The forward-looking statements in this press release are made as of the date hereof and are based on information available at that time. The Company does not undertake, and expressly disclaims, any duty to update or revise our forward-looking statements based on new information, future events or otherwise.
Cautionary Statement Regarding Guidance
The estimates and guidance presented in this release are based on assumptions of current and future capital expenditure levels, prices for oil, natural gas and NGLs, available liquidity, indications of supply and demand for oil, well results, and operating costs. The guidance provided in this release does not constitute any form of guarantee or assurance that the matters indicated will be achieved. While we believe these estimates and the assumptions on which they are based are reasonable as of the date on which they are made, they are inherently uncertain and are subject to, among other things, significant business, economic, operational, and regulatory risks, and uncertainties, some of which are not known as of the date of the statement. Guidance and estimates, and the assumptions on which they are based, are subject to material revision. Actual results may differ materially from estimates and guidance. Please read the "Cautionary Statement Regarding Forward-Looking Information" section above, as well as "Risk Factors" in our annual report on Form 10-K and our quarterly reports on Form 10-Q, which are incorporated herein.
Cautionary Statement Regarding Reserves
The reserves information as of June 30, 2022 in this press release, including standardized measure of future discounted cash flows and PV-10 value are preliminary estimates that have not been audited or reviewed by Netherland, Sewell & Associates, Inc. or BDO USA, LLP and are subject to material revision. These are estimates that should not be regarded as a representation. Investors should not place undue reliance on these estimates.
Source: Riley Exploration Permian, Inc.
OIL, NATURAL GAS AND NGL RESERVES
The Company prepared estimates of reserves using an average price equal to the unweighted arithmetic average of the first day of each month within the 12-month period ended June 30, 2022 of $85.82 per Bbl for oil and $4.13 per Mcf for gas in accordance with SEC guidelines. The Company also prepared estimates of proved reserves as of June 30, 2022 using NYMEX pricing. Netherland, Sewell & Associates, Inc. ("NSAI") is the Company's third-party reservoir engineer, which prepares estimates of the Company's proved reserves annually as of its fiscal year-end, in accordance with the rules and regulations of the SEC. NSAI has not reviewed our proved reserves at June 30, 2022 using SEC or NYMEX pricing. A summary of these internal estimates as of June 30, 2022 is presented below.
OIL, NATURAL GAS AND NGL RESERVES, Continued
Estimates of reserves were prepared using an average price equal to the unweighted arithmetic average of the first day of each month within the 12-month period ended September 30, 2021 of $57.64 per Bbl for oil and $2.94 per Mcf for gas in accordance with SEC guidelines. Additionally, the Company prepared estimates of proved reserves as of September 30, 2021 using NYMEX pricing. The table below presents a summary of our proved reserves as of September 30, 2021.
Reserve estimates above do not include any value for probable or possible reserves that may exist, nor do they include any value for undeveloped acreage. The reserve estimates represent our net revenue interest in our properties, all of which are located within the continental United States. NYMEX pricing does not comport with the reporting requirements of the SEC and should not be used as a substitute for or compared with estimates of proved reserves using SEC pricing.
DERIVATIVE CONTRACTS
The following table summarizes the open financial derivatives as of August 8, 2022, related to oil and natural gas production. Derivative positions in the table for calendar Q3 2022 are as of June 30, 2022(1).
NON-GAAP MEASURES
The Company presents certain non-GAAP financial measures to supplement its financial statements prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). The non-GAAP financial measures include Adjusted Net Income, Adjusted EBITDAX, Cash G&A, Cash Costs and Cash Margin per Boe, Free Cash Flow and PV-10. A reconciliation of each non-GAAP measure to the most directly comparable GAAP financial measure is presented below.
We believe that these non-GAAP measures presented, in conjunction with our financial and operating results prepared in accordance with GAAP, provide a more complete understanding of the Company's performance. We use these non-GAAP measures to compare our financial and operating performance with that of other companies in the oil and natural gas industry as well as our financial and operating performance for current and historical periods. These non-GAAP measures should not be considered in isolation or as a substitute for GAAP measures, such as net income (loss), operating income (loss), total costs and expenses, general and administrative expenses, net cash provided by operating activities or standardized measure of discounted future net cash flows or any other GAAP measure of financial position or results of operations.
As not all companies use the same calculation, our non-GAAP measures may not be comparable to similarly titled measures presented by other companies.
Adjusted Net Income: We define Adjusted Net Income as net income (loss) plus loss on discontinued operations, non-cash (gain) loss on derivatives, transaction costs and other, income tax expense related to our change in tax status and the changes in estimated income tax as a result of these adjustments. We believe that Adjusted Net Income is a widely followed measure of operating performance and is one of many metrics used by investors as well as our management team. For example, Adjusted Net Income can be used to assess our operating performance and return on capital in comparison to other independent exploration and production companies without regard to financial or capital structure and to assess the financial performance of our assets and our company without regard to capital structure or historical cost basis. The following table provides a reconciliation of Net Income (Loss) to Adjusted Net Income for the periods indicated:
Adjusted EBITDAX: We define Adjusted EBITDAX as net income (loss) adjusted for loss on discontinued operations, exploration costs, depletion, depreciation, amortization and accretion, equity-based compensation expense, interest expense, non-cash (gain) loss on derivatives, income taxes and transaction costs and other. We believe Adjusted EBITDAX is useful to investors because it provides an effective way to evaluate our operating performance and compare the results of our operations from period to period as well as to other companies in the oil and natural gas industry without regard to our financing methods or capital structure. The following table provides a reconciliation from the GAAP measure of Net Income (Loss) to Adjusted EBITDAX.
Cash G&A: Cash G&A is defined as general and administrative expense, excluding equity-based compensation, plus cost of contract services–related parties less contract services–related parties revenue. We believe Cash G&A is used by analysts and others in valuation, comparison and investment recommendations of companies in our industry to allow for analysis of Cash G&A spend without regard to equity-based compensation programs or amounts related to contract services. Administrative costs exclude equity-based compensation as those expenses are presented separately as components of general and administrative expense on our condensed consolidated statement of operations. The following table provides a calculation of Cash G&A for the periods indicated:
Cash Costs and Cash Margin per Boe: Cash Costs is a non-GAAP financial measure that we use as an indicator of our total cash-based cost of production and operations. We define Cash Costs as lease operating expenses plus production and ad valorem taxes, Cash G&A(1), and interest expense. Management believes that Cash Costs is an important financial measure for use in evaluating the Company's operating and financial performance and for comparison to other companies in the oil and natural gas industry. We also believe this is a useful measure for investors in evaluating our results against other oil and natural gas companies. Cash Costs should be considered in addition to, rather than as a substitute for, Total Costs and Expenses on our condensed consolidated statement of operations. The following table provides a calculation of Cash Costs and Cash Margin for the periods indicated:
Free Cash Flow: Free Cash Flow is a measure that we use as an indicator of our ability to fund our development activities and generate excess cash for other corporate purposes. We define Free Cash Flow as Net Cash Provided by Operating Activities, before changes in working capital and reduced by capital expenditures before acquisitions. Free Cash Flow should be considered in addition to, rather than as a substitute for, net cash provided by operating activities as a measure of our liquidity. The following table provides a reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow for the periods indicated:
PV-10: PV-10 is derived from the standardized measure of discounted future net cash flows ("Standardized Measure"), which is the most directly comparable financial measure under GAAP. PV-10 is a computation of the Standardized Measure on a pre-tax basis. PV-10 is equal to the Standardized Measure at the applicable date, before deducting future income taxes, discounted at an annual rate of 10%, determined in accordance with GAAP. We believe that the presentation of PV-10 is relevant and useful to investors because it presents the discounted future net cash flows attributable to our estimated net proved reserves prior to taking into account future corporate income taxes, and it is a useful measure for evaluating the relative monetary significance of our oil and natural gas properties. We believe that securities analysts and rating agencies use PV-10 in similar ways. Further, investors may utilize the measure as a basis for comparison of the relative size and value of our estimated reserves to other companies. We use this measure when assessing the potential return on investment related to our oil and natural gas properties. PV-10, however, is not a substitute for the Standardized Measure. Our PV-10 and the Standardized Measure do not purport to present the fair value of our estimated oil and natural gas reserves.
The following table provides a reconciliation of the Standardized Measure to PV-10 of the Company's estimated total proved reserves as of June 30, 2022 and September 30, 2021:
View original content to download multimedia:
SOURCE Riley Exploration Permian, Inc. | https://www.kwch.com/prnewswire/2022/08/10/riley-permian-reports-fiscal-third-quarter-2022-financial-operating-results/ | 2022-08-10T20:58:21Z | https://www.kwch.com/prnewswire/2022/08/10/riley-permian-reports-fiscal-third-quarter-2022-financial-operating-results/ | false |
New research highlights the importance of reviewing non-cancer chronic medications linked with frailty in older adults with blood cancers based on NCCN Guidelines list of inappropriate medications, in order to prevent dangerous interactions that may lead to falls or other adverse events.
PLYMOUTH MEETING, Pa., Aug. 10, 2022 /PRNewswire/ -- A new study in the August 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests a new way for hematologic oncologists to protect older patients from the risks of medication interactions. As part of the Older Adult Hematologic Malignancies Program, gerontology researchers teamed up with hematologic-oncology investigators from Brigham and Women's Hospital and the Dana-Farber Cancer Institute to look at the association between older patients with blood cancers who were taking multiple medications and their corresponding frailty. They also created a new scale based on a list of Potentially Inappropriate Medications (PIMs) from the NCCN Guidelines® for Older Adult Oncology—called the Geriatric Oncology-Potentially Inappropriate Medications (GO-PIMs) Scale—and found it to be more effective at predicting frailty than conventional methods.
"A large portion of research for older adults identifies patients as 'having polypharmacy' (i.e. taking multiple medications at the same time, leading to a higher risk of adverse events) based on a cutoff of five or more medications; but they don't specify which medications. Unfortunately, 50% of Americans 75-and-older meet this definition for polypharmacy, making it challenging for busy oncology teams to adequately review chronic medications in order to prevent potential problems," explained co-lead author Tammy T. Hshieh, MD, MPH, of Dana-Farber Cancer Institute,Brigham and Women's Hospital and Harvard Medical School. "We were interested in the NCCN list of medications of concern because, in contrast to other lists, it was developed by geriatricians and oncologists to be specific for older adults with cancer. We found the GO-PIMs scale we created based on this list carried the strongest association with frailty and can be used by oncology teams to help decrease inappropriate medication usage in an effective way to potentially improve patients' overall health.
"The health risks from these specifically identified medications—including falls and fatigue—often outweigh their benefits, especially in older adults whose ability to tolerate side effects are reduced," said co-lead author Clark DuMontier, MD, MPH, also with Brigham and Women's Hospital and Harvard Medical School. "Our GO-PIMs tool makes it easier for oncology teams to identify these medications and consider deprescribing them. This scale can also be easily converted into an automated tool that identifies high-risk medications within an electronic health record."
The researchers examined 785 transplant-ineligible blood cancer patients age 75-and-older treated at Dana-Farber Cancer Institute between February 2015 and November 2019. Frailty was defined by combining two approaches well-established in aging research: the "phenotypic approach," based on slow gait speed, weakness measured by grip strength, self-reported exhaustion, low physical activity, and weight loss, and the "cumulative deficit approach," based on the presence of multiple health deficits spanning comorbidity, cognition, and function. Each additional 'unspecified' medication in general increased the relative odds of being pre-frail or frail by 8%, while each additional medication on the GO-PIMs scale increased the relative odds by 65%. Compared to robust patients, frail and pre-frail patients were more likely to be taking benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), or corticosteroids.
The study was cross-sectional and it was not possible to determine which came first, the medications or the frailty. However, the researchers did control for conditions that are known to contribute to frailty, and they adjusted for comorbidity severity to reduce the possibility that the association was due to underlying issues rather than the medications themselves.
"The GO-PIMs scale may allow for targeted deprescribing in older adults with blood cancer and could reduce adverse outcomes," commented Tracey O'Connor, MD, Roswell Park Comprehensive Cancer Center, a Member of the NCCN Guidelines Panel for Older Adult Oncology, who was not involved in this research. "Additional studies are warranted to better define the optimal utilization of this scale and its potential benefits for older adults with cancer."
To read the entire study, visit JNCCN.org. Complimentary access to "The Association of Polypharmacy and Potentially Inappropriate Medications with Frailty among Older Adults with Blood Cancer" is available until November 10, 2022.
More than 25,000 oncologists and other cancer care professionals across the United States read JNCCN—Journal of the National Comprehensive Cancer Network. This peer-reviewed, indexed medical journal provides the latest information about innovation in translational medicine, and scientific studies related to oncology health services research, including quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship. JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), review articles elaborating on guidelines recommendations, health services research, and case reports highlighting molecular insights in patient care. JNCCN is published by Harborside. Visit JNCCN.org. To inquire if you are eligible for a FREE subscription to JNCCN, visit NCCN.org/jnccn/subscribe. Follow JNCCN on Twitter @JNCCN.
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg, and Twitter @NCCN.
Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org
View original content to download multimedia:
SOURCE National Comprehensive Cancer Network | https://www.kbtx.com/prnewswire/2022/08/10/theres-better-way-detect-high-risk-medications-older-adults-with-cancer-according-new-study-jnccn/ | 2022-08-10T20:58:29Z | https://www.kbtx.com/prnewswire/2022/08/10/theres-better-way-detect-high-risk-medications-older-adults-with-cancer-according-new-study-jnccn/ | true |
WFO NORMAN Warnings, Watches and Advisories for Wednesday, August 10, 2022
_____
SPECIAL WEATHER STATEMENT
Special Weather Statement
National Weather Service Norman OK
237 PM CDT Wed Aug 10 2022
...A strong thunderstorm will impact portions of southeastern Wichita
County through 300 PM CDT...
At 237 PM CDT, Doppler radar was tracking a strong thunderstorm 4
miles west of Wichita Falls, moving east at 10 mph.
HAZARD...Wind gusts up to 50 mph.
SOURCE...Radar indicated.
IMPACT...Gusty winds could knock down tree limbs and blow around
unsecured objects.
Locations impacted include...
Wichita Falls, Iowa Park, Sheppard AFB, Lakeside City and Pleasant
Valley.
PRECAUTIONARY/PREPAREDNESS ACTIONS...
If outdoors, consider seeking shelter inside a building.
LAT...LON 3400 9872 3402 9848 3384 9847 3383 9860
3384 9871
TIME...MOT...LOC 1937Z 269DEG 11KT 3392 9860
MAX HAIL SIZE...0.00 IN
MAX WIND GUST...50 MPH
...THE SEVERE THUNDERSTORM WARNING FOR NORTHWESTERN ELLIS COUNTY WILL
EXPIRE AT 245 PM CDT...
The storm which prompted the warning has weakened below severe
limits. Therefore the warning will be allowed to expire. However
gusty winds are still possible with this thunderstorm.
_____
Copyright 2022 AccuWeather | https://www.expressnews.com/weather/article/TX-WFO-NORMAN-Warnings-Watches-and-Advisories-17365028.php | 2022-08-10T20:58:31Z | https://www.expressnews.com/weather/article/TX-WFO-NORMAN-Warnings-Watches-and-Advisories-17365028.php | false |
Closing prices for crude oil, gold and other commodities
The Associated Press
Benchmark U.S. crude oil for September delivery rose $1.43 to $91.93 a barrel Wednesday. Brent crude for October delivery rose $1.09 to $97.40 a barrel.
Wholesale gasoline for September delivery rose 11 cents to $3.07 a gallon. September heating oil rose 8 cents to $3.41 a gallon. September natural gas rose 37 cents to $8.20 per 1,000 cubic feet.
Gold for December delivery rose $1.40 to $1,813.70 an ounce. Silver for September delivery rose 26 cents to $20.74 an ounce and September copper rose 6 cents to $3.65 a pound.
The dollar fell to 132.89 Japanese yen from 135.18 yen. The euro rose to $1.0304 from $1.0205. | https://kion546.com/news/ap-national-business/2022/08/10/closing-prices-for-crude-oil-gold-and-other-commodities-249/ | 2022-08-10T20:59:10Z | https://kion546.com/news/ap-national-business/2022/08/10/closing-prices-for-crude-oil-gold-and-other-commodities-249/ | true |
AUSTIN, Texas, Aug. 10, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, announced earlier today at the Canaccord Genuity 42nd Annual Growth Conference in Boston that the company has proactively filed a pre-submission to the FDA for its Panorama® non-invasive prenatal test (NIPT) as part of the Q-Sub process. The company filed its pre-submission in June 2022 for fetal chromosomal aneuploidies and for 22q11.2 deletion syndrome.
"NIPT has become the standard of care for prenatal screening," said Steve Chapman, CEO of Natera. "We have a track record of proactively engaging with the FDA and believe there are benefits to working with the Agency on this technology."
The pre-submission to the FDA follows the publication of results earlier this year from the SNP-based Microdeletion and Aneuploidy Registry Trial (SMART), the largest prospective NIPT study with confirmation of genetic outcomes, with more than 20,000 patients enrolled at 21 global medical centers. In addition to SMART, Natera has a significant body of evidence supporting the performance of its Panorama test, including 26 peer-reviewed papers, studying over 1.3 million patients.
About Panorama
Panorama screens for severe genetic disorders as early as nine weeks into pregnancy. The test uses a unique single-nucleotide polymorphism (SNP)-based technology to analyze fetal/placental DNA obtained through a blood draw from the mother. It is the only commercially available test that differentiates between maternal and fetal DNA to assess the risk of aneuploidies. Natera has published 26 papers, studying over 1.3 million patients, since the launch of Panorama. Panorama has been developed and its performance characteristics determined by Natera, the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified.
About Natera
Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.
Forward-Looking Statements
All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera's plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera's expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, or our expectations of the benefits of our tests and product offerings to patients, providers and payers. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera's recent filings on Forms 10-K and 10-Q and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.
Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Brian Symmons, SVP of Marketing and Corporate Affairs, Natera, Inc., pr@natera.com
View original content to download multimedia:
SOURCE Natera, Inc. | https://www.kfyrtv.com/prnewswire/2022/08/10/natera-announces-q-sub-filing-with-fda-its-panorama-nipt/ | 2022-08-10T21:01:37Z | https://www.kfyrtv.com/prnewswire/2022/08/10/natera-announces-q-sub-filing-with-fda-its-panorama-nipt/ | false |
Agriculture companies are desperate for workers. Many of the jobs are in cities and open to scientists and data engineers. Some can even be filled by people without a bachelor's degree.
Copyright 2022 Harvest Public Media
Agriculture companies are desperate for workers. Many of the jobs are in cities and open to scientists and data engineers. Some can even be filled by people without a bachelor's degree.
Copyright 2022 Harvest Public Media | https://www.kbia.org/2022-08-10/encore-agriculture-companies-are-desperate-for-workers | 2022-08-10T21:03:08Z | https://www.kbia.org/2022-08-10/encore-agriculture-companies-are-desperate-for-workers | false |
SACRAMENTO (AP) _ The winning numbers in Wednesday afternoon's drawing of the California Lottery's "Daily 3 Midday" game were:
2-8-2
(two, eight, two)
SACRAMENTO (AP) _ The winning numbers in Wednesday afternoon's drawing of the California Lottery's "Daily 3 Midday" game were:
2-8-2
(two, eight, two) | https://www.sheltonherald.com/lottery/article/Winning-numbers-drawn-in-Daily-3-Midday-game-17365128.php | 2022-08-10T21:03:58Z | https://www.sheltonherald.com/lottery/article/Winning-numbers-drawn-in-Daily-3-Midday-game-17365128.php | true |
You need to enable JavaScript to run this app. | https://sportspyder.com/nfl/buffalo-bills/articles/40356520 | 2022-08-10T21:04:39Z | https://sportspyder.com/nfl/buffalo-bills/articles/40356520 | false |
DALLAS (KDAF) — A little bit of rain never truly hurt anybody but North Texas could use a lot of it. However, a little will do for now but that doesn’t change the hot temperatures forecasted for the end of the work week and weekend for the region.
Wednesday could see some scattered storms throughout the region as the same goes for Thursday and Friday along with seasonably hot temps.
“The rest of the workweek will feature seasonably hot temperatures under partly cloudy skies with isolated to scattered showers and thunderstorms each afternoon. Rain chances are highest Wednesday along and south of the I-20 corridor, then across Central Texas Thursday and Friday. Not everyone will see rain. The primary threats with the storms will be gusty winds, brief downpours, and lightning,” NWS Fort Worth says.
The center also says, “Rain may be in the forecast in the next few days, but not much relief for drought conditions and lake levels is expected. As population grows, so will resource demand. Please visit http://waterisawesome.com as a useful conservation resource for the region.”
As Saturday may serve as the last chance for some rain anytime soon, Sunday through Wednesday of next week could see temps back in the triple-digits across the region as a warming trend is expected for the next work week.
“Low rain chances will continue across Central Texas Saturday afternoon, but North Texas should remain rain-free. The ridge will continue to build southward and result in a warming trend and dry weather across the region. Triple digit heat will return by Monday,” NWS Fort Worth said. | https://cw33.com/news/local/little-rain-continued-heat-in-store-for-north-texas-heres-what-you-need-to-know-about-end-of-work-week-weekend-weather-in-north-texas/ | 2022-08-10T21:05:08Z | https://cw33.com/news/local/little-rain-continued-heat-in-store-for-north-texas-heres-what-you-need-to-know-about-end-of-work-week-weekend-weather-in-north-texas/ | false |
Health officials urge caution after blue-green algae reported on Hillsborough River
TAMPA, Fla. - A water sample taken along the Hillsborough River north of Morris Bridge Road and West of I-75 showed the presence of blue-green algae, Hillsborough County health officials said.
Blue-green algae is common in Florida's freshwater environments. It can make people and pets sick and can negatively impact the surrounding ecosystem.
"The public should exercise caution in and around this area of the river," said Ryan L. Terry, a public information officer for the Hillsborough division of the Florida Department of Health.
TJ Mallard, a regular visitor to the Hillsborough River, said the wildlife keeps him coming back. He said he's going to be more cautious in the area after the reports of blue-green algae.
RELATED: Blue-green algae bloom reported on Hillsborough River, health officials say
"I mean it kind of freaks me out a little bit," Stallard said. "I fish, sometimes my kids like to dip their toes in the water, it's alarming for sure."
Terry said blooms can happen when a rapid growth of algae lends to an accumulation of cells that discolor water and emits an odor. Officials are advising against swimming, boating and eating shellfish from the affected area.
"Definitely wash your clothing and skin with soap and water if you come in contact with the algae, keep pets away from the area, definitely don’t drink water," Terry said. | https://www.fox13news.com/news/health-officials-urge-caution-after-blue-green-algae-reported-on-hillsborough-river | 2022-08-10T21:05:36Z | https://www.fox13news.com/news/health-officials-urge-caution-after-blue-green-algae-reported-on-hillsborough-river | false |
HOUSTON (AP) _ U.S. Well Services, Inc. (USWS) on Wednesday reported a loss of $9.3 million in its second quarter.
The Houston-based company said it had a loss of 82 cents per share.
The company posted revenue of $68.8 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on USWS at https://www.zacks.com/ap/USWS | https://www.sfgate.com/business/article/U-S-Well-Services-Q2-Earnings-Snapshot-17365190.php | 2022-08-10T21:08:30Z | https://www.sfgate.com/business/article/U-S-Well-Services-Q2-Earnings-Snapshot-17365190.php | true |
Adorable adoption: Puppy finds forever home after officers rescue dog from hot car at casino
LAS VEGAS (KVVU/Gray News) - The dog who was locked in a car while her owner gambled at a Las Vegas Strip casino has found a new home.
The Animal Foundation shared on Wednesday that the dog named Dutchess has been adopted since the incident and is living with her forever family.
The animal shelter said the officer who helped rescue the puppy back in July also visited her before her new family adopted her.
Las Vegas police said they were called to the Bellagio hotel-casino on July 20 regarding a dog locked in a parked car with summer temperatures nearing 115 degrees that afternoon.
Responding officers reported finding the dog locked in a car with its mouth taped shut while the owner was inside gambling. Police said the dog was without food, water and air conditioning while the owner gambled for nearly two hours.
According to the Animal Foundation, Dutchess enjoys going for walks, playing with her new toys and spending time with her new dog sibling, Tobey.
Copyright 2022 KVVU via Gray Media Group, Inc. All rights reserved. | https://www.wkyt.com/2022/08/10/adorable-adoption-puppy-finds-forever-home-after-officers-rescue-dog-hot-car-casino/ | 2022-08-10T21:09:45Z | https://www.wkyt.com/2022/08/10/adorable-adoption-puppy-finds-forever-home-after-officers-rescue-dog-hot-car-casino/ | false |
ATLANTA, Aug. 10, 2022 /PRNewswire/ -- The Aaron's Company, Inc. (NYSE: AAN), a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.1125 per share and declared such dividend payable October 4, 2022, to shareholders of record as of the close of business on September 15, 2022.
Headquartered in Atlanta, The Aaron's Company, Inc. is a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions of appliances, electronics, furniture, and other home goods across its brands, Aaron's, BrandsMart U.S.A., BrandsMart Leasing, and Woodhaven. Aaron's offers a direct-to-consumer lease-to-own solution through its approximately 1,300 company-operated and franchised stores in 47 states and Canada, as well as its e-commerce platform. BrandsMart U.S.A. is one of the leading appliance and consumer electronics retailers in the southeast United States and one of the largest appliance retailers in the country with ten retail stores in Florida and Georgia. BrandsMart Leasing offers lease-to-own solutions to customers of BrandsMart U.S.A. Woodhaven is our furniture manufacturing division.
For more information, visit investor.aarons.com.
View original content to download multimedia:
SOURCE The Aaron's Company, Inc. | https://www.kmvt.com/prnewswire/2022/08/10/aarons-directors-declare-cash-dividend/ | 2022-08-10T21:09:54Z | https://www.kmvt.com/prnewswire/2022/08/10/aarons-directors-declare-cash-dividend/ | true |
UNICEF-supported nutrition specialist Aminata Zabré has screened and treated thousands of malnourished children in Burkina Faso. Lately, that number has been rising fast.
Worried mothers with babies on their laps fill all available floor space at the Sector 6 health center in the district of Kaya in north central Burkina Faso, where Aminata Zabré, the center's longtime Head of Nutrition, is conducting a mass screening for malnutrition.
"We found many, many malnourished children, malnourished breastfeeding mothers and malnourished pregnant women," Zabré says. "Today, we have many new cases that we will treat."
Escalating violence in Burkina Faso has pushed almost 2 million people out of their homes in search of safety. Water scarcity and food insecurity are on the rise, making it harder and harder for parents to feed their children.
Ten years ago, Zabré treated approximately 100 children annually for acute malnutrition. In the first quarter of 2022 alone, that number jumped to more than 600. “I love children and I dedicate a lot of my time and energy to do my work and to make sure no child that comes to me is left unattended, even if it means I have less time for my own family,” she says.
A second chance for malnourished children in Burkina Faso:
At the health center, each child is weighed and their upper arm circumference measured. If the tape is in the red, the child is suffering from severe acute malnutrition (SAM) and needs immediate treatment with Ready-to-Use Therapeutic Food (RUTF), a nutritious peanut paste that can restore a malnourished child to health in a matter of weeks.
UNICEF is by far the largest supplier of RUTF in Burkina Faso. Supply has been uninterrupted in previous years, but with the growing number of children and rising prices of therapeutic food, UNICEF needs additional resources to make sure no malnourished child is left behind.
UNICEF and partners are aiming to reach hundreds of thousands of acutely malnourished children with lifesaving treatment this year in Burkina Faso. Your contribution can make a difference. Please donate. | https://www.forbes.com/sites/unicefusa/2022/08/10/bringing-malnourished-children-back-to-health-in-burkina-faso/ | 2022-08-10T21:12:11Z | https://www.forbes.com/sites/unicefusa/2022/08/10/bringing-malnourished-children-back-to-health-in-burkina-faso/ | true |
SCOTTSDALE, Ariz., Aug. 10, 2022 /PRNewswire/ -- Axon (NASDAQ: AXON), the global leader in connected public safety technologies, today announced that it has named Brittany Bagley as its new Chief Financial Officer and the newly created position of Chief Business Officer, effective September 26, 2022. Ms. Bagley replaces Jim Zito, who has been serving as interim Chief Financial Officer since May 4, 2022. Zito will resume his prior role as Senior Vice President of Accounting.
"Brittany's broad experience as a public company CFO, Board member and investor position her well to lead Axon's finance organization through our next phase of growth," says Axon founder and CEO Rick Smith. "We believe Brittany will be a valuable thought partner as we continue to execute against our mission and deliver for our customers and shareholders."
Josh Isner, Axon COO, adds, "Brittany brings to our bench 17 years of financial industry experience and we look forward to leveraging her analytical rigor, expertise in investing for strategic growth and keen ability to lead finance organizations in highly dynamic industries. Brittany will be a fundamental contributor across Axon's entire business and I am thrilled she chose to join our team in this extremely competitive market for top tier talent."
Ms. Bagley joins Axon from Sonos (NASDAQ:SONO), where she served as Chief Financial Officer, with oversight of financial, accounting, corporate development, investor relations, real estate, facilities organizations and the CIO and data organizations. Ms. Bagley joined Sonos in 2019 after having served as an investor and board member. Previously, she spent 12 years at KKR & Co., most recently serving as Managing Director, TMT Private Equity, where she was immersed in wide-ranging technology businesses, including semiconductors, consumer electronics and software. Ms. Bagley began her career at Goldman Sachs and holds a B.A. from Brown University.
Ms. Bagley is a current member of the Board of Directors of self-driving technology company Aurora (NASDAQ: AUR), where she also serves as Audit Committee Chair.
"I am excited and humbled to join Axon and play a role in the company's inspiring mission to protect life," says Ms. Bagley. "With a model of rapid software growth and annual recurring revenue, the company is uniquely positioned to deliver strong growth, build scale and drive long-term profitability. I look forward to partnering with this great team and building upon their outstanding track record of execution and delivering shareholder value."
About Axon
Axon is a network of devices, apps and people that helps public safety personnel become smarter and safer. With a mission of protecting life, our technologies give customers the confidence, focus and time they need to keep their communities safe. Our products impact every aspect of a public safety officer's day-to-day experience with the goal of helping everyone get home safe.
We work hard for those who put themselves in harm's way for all of us. To date, more than 270,000 lives and countless dollars have been saved with the Axon Network of devices, apps and people. Learn more at www.axon.com or by calling (800) 978-2737. Axon is a global company with headquarters in Scottsdale, Ariz. and global software engineering hub in Seattle, Wash., as well as additional offices in Australia, Canada, Finland, Vietnam, the UK and the Netherlands.
Brown University is a trademark of Brown University; Facebook is a trademark of Facebook, Inc.; Goldman Sachs is a trademark of Goldman Sachs & Co. LLC; Sonos is a trademark of Sonos, Inc. and Twitter is a trademark of Twitter, Inc. Axon, Axon Network, Protect Life and the Delta Logo are trademarks of Axon Enterprise, Inc., some of which are registered in the US and other countries. For more information, visit www.axon.com/legal. All rights reserved.
Follow Axon here:
- Axon on Twitter: https://twitter.com/axon
- Axon on Facebook: https://www.facebook.com/Axon.ProtectLife/
Note to Investors
Please visit http://investor.axon.com, https://www.axon.com/press, www.twitter.com/axon_us and https://www.facebook.com/Axon.ProtectLife/ where Axon discloses information about the company, its financial information and its business.
MEDIA CONTACT:
Corinne Clark
Public Relations Manager
Press@axon.com
View original content to download multimedia:
SOURCE Axon | https://www.weau.com/prnewswire/2022/08/10/axon-names-brittany-bagley-new-chief-financial-officer-chief-business-officer/ | 2022-08-10T21:13:36Z | https://www.weau.com/prnewswire/2022/08/10/axon-names-brittany-bagley-new-chief-financial-officer-chief-business-officer/ | false |
-- Phase 3 RAPID study reached the target of 180 confirmed PSVT events treated with double-blind study medication required to initiate primary efficacy analysis; topline data readout for RAPID study remains on track for mid-second half 2022
-- Phase 3 PSVT study initiated in China
MONTREAL and CHARLOTTE, N.C., Aug. 10, 2022 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the second quarter ended June 30, 2022, and provided a clinical and corporate update.
"Progress continues across our Phase 3 PSVT clinical program. Notably with the recent crossing of the 180th event in the RAPID trial, we now focus on the final stages of data cleaning and analysis and look forward to reporting top line data in the middle of the second half of this year," said Joseph Oliveto, President and Chief Executive Officer of Milestone Pharmaceuticals.
Recent Updates
- Achieved Required Number of PSVT Events Treated with Double Blind Study Medication to Initiate Preparation for the Primary Efficacy Analysis for RAPID Trial; Company Remains on Track to Report RAPID Topline Data in Mid-Second Half 2022. In July 2022, the RAPID trial, in which patients are randomized 1:1 to receive either etripamil or placebo, reached the pre-specified target of 180 confirmed PSVT events, adjudicated by a blinded, independent expert committee, required for the primary efficacy analysis. Data from RAPID is now in the process of being cleaned, verified, and analyzed, and the Company continues to expect to unblind RAPID results and report topline data in the middle of the second half of 2022. The primary efficacy analysis for the RAPID trial and the post hoc analysis of the NODE-301 trial will be time to conversion of supraventricular tachycardia (SVT) over the first 30 minutes following initial study drug administration. The RAPID and NODE-301 trials could potentially serve to fulfill the efficacy requirement for a future New Drug Application submission to the United States Food and Drug Administration for etripamil in patients with PSVT.
- Milestone's Partner, Ji Xing Pharmaceuticals Limited, Enrolled First Patient in Phase 3 Study of Etripamil in China. In July 2022, Milestone's partner, Ji Xing Pharmaceuticals Limited (Ji Xing), announced that it enrolled its first patient in its Phase 3 study of etripamil for the treatment of PSVT in China. The study is designed to evaluate the efficacy and safety of self-administered etripamil nasal spray as a treatment for PSVT with the eventual goal of generating clinical data potentially supportive of a new drug application in China. In May 2021, Milestone and Ji Xing entered into an exclusive license agreement to develop and commercialize etripamil for PSVT in Greater China.
- Data from Phase 3 NODE-302 Open-Label Extension Study of Etripamil for the Treatment of PSVT Presented at Heart Rhythm 2022. In April 2022, data from NODE-302, Milestone's Phase 3 open-label extension of the NODE-301 study evaluating a single, 70 mg dose of self-administered, intranasal etripamil in patients with PSVT, was presented at the Heart Rhythm Society's Heart Rhythm 2022 conference. The data demonstrated the potential for patients to self-treat recurrent SVT episodes with etripamil. Of 188 positively-adjudicated episodes observed in the trial, the PSVT conversion rate at 30 minutes following etripamil administration was 60.2%, and the need for emergency department (ED) intervention to terminate a PSVT episode was low (13% of patients and 8.5% of positively adjudicated PSVT episodes). Etripamil was generally well-tolerated, with adverse events (AEs) consistent with those observed in previous trials and largely confined to local and brief nasal AEs at the administration site. A copy of the presentation is available on request from Milestone Pharmaceuticals.
- Hosted Virtual KOL Event on Etripamil for the Treatment of PSVT. In April 2022, Milestone hosted a virtual Key Opinion Leader (KOL) event focused on etripamil for the possible treatment of PSVT. Members of management were joined by Bruce Stambler, M.D., FHRS, Director of Cardiac Arrhythmia Research and Education, Piedmont Heart Institute, Atlanta, GA, and Sean Pokorney, M.D., MBA, Director of the Arrhythmia Core Laboratory, Duke Clinical Research Institute, Assistant Professor of Medicine, Duke University School of Medicine, Durham, NC. The event featured an overview of PSVT, including disease prevalence, the current treatment landscape, patient and healthcare system burdens and a discussion of the potential commercial opportunity. A recording of the event is currently available under the News & Events of Milestone's website at www.milestonepharma.com.
- New Clinical Analysis Evaluating the Drug Characteristics and Safety of Etripamil Presented at the American College of Cardiology (ACC) 71st Annual Scientific Session and Expo. In April 2022, new analyses on the safety, tolerability, pharmacokinetics, and pharmacodynamics of etripamil in healthy Japanese and non-Japanese adults was presented at the ACC 71st Annual Scientific Session and Expo. The data demonstrate a comparable safety and tolerability profile in both Japanese and non-Japanese male and female adults, indicating no ethnic differences, and treatment-related AEs consistent with the safety and tolerability profile of etripamil seen to date. A copy of the presentation is available in the Publications section of the Milestone Pharmaceuticals website.
Second Quarter 2022 Financial Results
- As of June 30, 2022, Milestone had cash, cash equivalents, and short-term investments of $86.2 million and 29.9 million common shares and 12.3 million common shares issuable upon exercise of pre-funded warrants outstanding.
- Research and development (R&D) expense for the second quarter of 2022 was $10.7 million, compared with $9.4 million for the prior year period. The difference is primarily the result of an increase in clinical personnel related costs, clinical consulting fees and contract research organization (CRO) costs due to advancing the RAPID Phase 3 efficacy and safety trial in etripamil for the treatment of PSVT. For the six months ended June 30, 2022, R&D expense was $19.4 million compared with $18.0 million for the prior year period. The $1.4 million increase in R&D expense in the six months ended June 30, 2022 is the result of clinical personnel related costs, clinical consulting fees and CRO costs due to advancing the RAPID Phase 3 efficacy and safety trial in etripamil for the treatment of PSVT. These increases were offset by lower drug formulation and manufacturing costs. Additionally, regulatory costs increased primarily due to personnel-related costs.
- General and administrative (G&A) expense for the second quarter of 2022 was $3.9 million, compared with $3.0 million for the prior year period. The difference is primarily the result of an increase in personnel-related costs and consulting fees for general and administrative expenses. For the six months ended June 30, 2022, G&A expense was $7.6 million compared with $5.7 million for the prior year period. The $1.9 million increase in G&A expense in the six months ended June 30, 2022 is primarily the result of personnel-related costs and consulting fees for general and administrative expenses.
- Commercial expense for the second quarter of 2022 was $2.2 million, compared with $1.8 million for the prior year period. The difference is primarily the result of an increase in consulting and marketing analytics. For the six months ended June 30, 2022, commercial expense was $3.9 million compared with $3.2 million for the prior year period. The $0.7 million increase in commercial expense in the six months ended June 30, 2022 is the result of personnel-related costs.
- For the second quarter of 2022, operating loss was $16.8 million, compared to operating income of $0.7 million for the prior year period. For the six months ended June 30, 2022, Milestone's operating loss was $30.9 million, compared to $11.9 million in the prior year period. Included in the operating income for the second quarter of 2021 and operating loss for the six months ended June 30, 2021 was primarily the one-time upfront payment of $15.0 million, recognized as revenue, generated from Milestone's License Agreement with Ji Xing.
About Paroxysmal Supraventricular Tachycardia
Paroxysmal supraventricular tachycardia (PSVT) is a condition characterized by intermittent episodes of a rapid heartbeat that starts and stops suddenly that affects approximately two million Americans. Episodes of supraventricular tachycardia (SVT) are often associated with symptoms including palpitations, sweating, chest pressure or pain, shortness of breath, sudden onset of fatigue, lightheadedness or dizziness, fainting, and anxiety. Certain intravenous medications, including adenosine, beta-blockers and calcium channel blockers, have long been used for the acute treatment of PSVT. However, these medications must be administered under medical supervision, usually in an emergency department or other acute care setting.
About Atrial Fibrillation with Rapid Ventricular Rate
Atrial fibrillation (AFib) is a common arrhythmia marked by an irregular and often rapid heartbeat. AFib is estimated to affect five million patients in the United States, a prevalence projected by the Centers for Disease Control to increase to twelve million patients within the next 10 years. Atrial fibrillation with rapid ventricular rate (AFib-RVR) is a condition that some patients with AFib experience and includes episodes of abnormally high heart rate, often with symptoms such as palpitations, shortness of breath, dizziness and weakness. Oral calcium channel blockers and/or beta blockers are commonly used to reduce the heart rate in this condition. When AFib-RVR occurs, symptoms often cause patients to seek acute care in the emergency department, where standard-of-care procedures include intravenous administration of calcium channel blockers or beta blockers under medical supervision. Milestone's market research indicates that 30-40% of patients with AFib experience one or more symptomatic episodes of RVR per year that require treatment, suggesting a target addressable market of approximately three to four million patients in 2030 for etripamil in patients with AFib.
About Etripamil
Etripamil, a new chemical identity being Milestone's lead investigational product, is a novel calcium channel blocker designed to be a rapid-response therapy for episodic cardiovascular conditions. As a nasal spray that is self-administered by the patient, etripamil has the potential to shift the current treatment experience for many patients from the emergency department to a medically-unsupervised setting. Milestone is conducting a comprehensive development program for etripamil, with Phase 3 trials ongoing in paroxysmal supraventricular tachycardia (PSVT) and a Phase 2 proof-of-concept trial underway in patients with atrial fibrillation with rapid ventricular rate (AFib-RVR).
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone's lead product candidate etripamil is currently in a Phase 3 clinical-stage program for the treatment of paroxysmal supraventricular tachycardia (PSVT) and in a Phase 2 proof-of-concept trial for the treatment of patients with atrial fibrillation with rapid ventricular rate (AFib-RVR). Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow Milestone on Twitter at @MilestonePharma.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "will," "expect," "continue," "estimate," "potential," "progress" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on Milestone's expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from these forward-looking statements. Forward-looking statements contained in this press release include statements regarding the potential of etripamil to serve as a promising therapy for PSVT patients, the design, progress, timing, scope and results of the RAPID and ReVeRA trials; Milestone's ability to execute on the remainder of the PSVT program; the timing of release of unblind RAPID results and topline data with respect to the Company's RAPID trial; Milestone's ongoing plans to study etripamil in atrial fibrillation patients, the sufficiency of Milestone's current cash resources to support its operations, and estimates about the addressable market and commercial potential for treatments of atrial fibrillation with rapid ventricular rate. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, the risks inherent in biopharmaceutical product development and clinical trials, including the lengthy and uncertain regulatory approval process; uncertainties related to the timing of initiation, enrollment, completion and evaluation of clinical trials; risks and uncertainty related to the complexity inherent in cleaning, verifying and analyzing trial data; and whether the clinical trials will validate the safety and efficacy of etripamil for PSVT or other indications, among others, as well as risks related to pandemics and public health emergencies, including those related to the ongoing COVID-19 pandemic, and risks related the sufficiency of Milestone's capital resources and its ability to raise additional capital. These and other risks are set forth in Milestone's filings with the U.S. Securities and Exchange Commission, including in its annual report on Form 10-K for the year ended December 31, 2021, under the caption "Risk Factors," as such discussion may be updated from time to time by subsequent filings we may make with the U.S. Securities & Exchange Commission. Except as required by law, Milestone assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.
Contact:
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com
View original content to download multimedia:
SOURCE Milestone Pharmaceuticals, Inc. | https://www.kmvt.com/prnewswire/2022/08/10/milestone-pharmaceuticals-reports-second-quarter-2022-financial-results-provides-clinical-corporate-update/ | 2022-08-10T21:13:45Z | https://www.kmvt.com/prnewswire/2022/08/10/milestone-pharmaceuticals-reports-second-quarter-2022-financial-results-provides-clinical-corporate-update/ | false |
SALT LAKE CITY, Aug. 10, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter ended June 30, 2022.
Recent Highlights:
- Executed on Sera's strategy of pursuing healthcare systems where administrative and clinical leadership are aligned on incorporating PreTRM testing efficiently as an add-on to comprehensive services provided to pregnant women.
- Contracted with several new self-insured employer plans to incorporate PreTRM testing as an advanced pregnancy benefit.
- Demonstrated improved performance of the PreTRM test over an expanded time window for collecting blood, now from 18-20 weeks, allowing physicians to more easily schedule patients for preterm risk evaluation.
- Showed a sensitivity of nearly 90% for spontaneous preterm delivery risk prediction and a very high negative predictive value of 99% in a patient whose PreTRM test is interpreted to be "Lower Risk".
- Streamlined operations to meet our commercial plans, expand adoption of the PreTRM® Test and enable the Company to extend its operations into 2026 without the need for additional financing.
"We see a sizeable opportunity to increase awareness of our PreTRM® Test and build adoption within a variety of health systems," said Gregory C. Critchfield, MD, MS, Chairman and CEO of Sera Prognostics. "As example of many such systems, we are making demonstrable progress in contracting with self-insured employers who become adopters because they see the immediate value in managing escalating healthcare costs and offering important benefits to attract and retain talented employees. We anticipate additional clinical and health economic publications that further illustrate the clinical utility and benefit of PreTRM® technology, supporting the achievement of our vision to improve the well-being of mothers and newborns and decreasing healthcare costs."
Second Quarter 2022 Financial Results
Second quarter 2022 revenue of $78,000 compared to $20,000 for the same period of 2021.
Total operating expenses were $11.8 million, up from $7.4 million for the second quarter of 2021.
Research and development expenses for the second quarter of 2022 were $3.3 million compared to $2.8 million for the second quarter of 2021 due primarily to increased laboratory operations and clinical study costs.
Selling, general and administrative expenses for the second quarter of 2022 were $8.5 million, up from $4.6 million for the year-ago period due primarily to increased headcount as the company has scaled its commercial operations and general corporate infrastructure, as well as increased costs related to operating as a public company since our initial public offering in July 2021. Selling and marketing expenses decreased in the second quarter of 2022 compared to the first quarter of 2022 as we took steps to streamline our sales force and focus our commercial strategy in response to market dynamics.
Net loss for the second quarter of 2022 was $11.5 million compared to $6.3 million for the same quarter a year ago.
As of June 30, 2022, the Company had cash, cash equivalents, and available-for-sale securities of approximately $121 million.
Conference Call Information
Sera Prognostics will host a corresponding conference call and live webcast today to discuss second quarter 2022 operational highlights, financial results and key topics at 5:00 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing the following:
US domestic callers: (866) 218-2405
International callers: (412) 902-6607
Webcast Registration Link: https://app.webinar.net/JMrRmxrD9Qj
Live audio of the webcast will be available online from the Investors page of the Company's website at www.seraprognostics.com. The webcast will be archived on the Investors page and will be available for one year.
About Sera Prognostics, Inc.
Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to deliver early, pivotal information in pregnancy to physicians, enabling them to improve the health of their patients, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera's precision medicine PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is located in Salt Lake City, Utah.
About Preterm Birth
Preterm birth is defined as any birth before 37 weeks' gestation and is the leading cause of illness and death in newborns. The 2021 March of Dimes Report Card shows that more than one in ten infants is born prematurely. Prematurity is associated with a significantly increased risk of major long-term medical complications, including learning disabilities, cerebral palsy, chronic respiratory illness, intellectual disability, seizures, and vision and hearing loss, and can generate significant costs throughout the lives of affected children. The annual health care costs to manage short- and long-term complications of prematurity in the United States were estimated to be approximately $25 billion for 2016.
About the PreTRM® Test
The PreTRM® test is the only broadly validated, commercially available blood-based biomarker test that provides an early, accurate and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies. The PreTRM® test measures and analyzes proteins in the blood that are highly predictive of preterm birth. The PreTRM® test permits physicians to identify, during the 19th or 20th week of pregnancy, which women are at increased risk for preterm birth, enabling more informed, personalized clinical decisions based on each woman's individual risk. The PreTRM® test is ordered by a medical professional.
Sera Prognostics, the Sera Prognostics logo, The Pregnancy Company, and PreTRM are trademarks or registered trademarks of Sera Prognostics, Inc. in the United States and/or other countries.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to healthcare systems aligning on incorporating PreTRM testing as an add-on to comprehensive services provided to pregnant women; expanded adoption of the PreTRM® Test; the Company extending its operations into 2026 without the need for additional financing; demonstrable progress in contracting with self-insured employers; additional clinical and health economic publications that further illustrate the clinical utility and benefit of PreTRM® technology; the Company's strategy, future operations, prospects, plans, objectives of management; the Company's planned conference call and live webcast to discuss the quarter's operational highlights, financial results and key topics; availability of audio of the webcast online from the Investors page of the Company's website; and the company's strategic directives under the caption "About Sera Prognostics, Inc." These "forward-looking statements" are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: net losses, cash generation, and the potential need to raise more capital; revenues from the PreTRM test representing substantially all Company revenues to date; the need for broad scientific and market acceptance of the PreTRM test; a concentrated number of material customers; our ability to introduce new products; potential competition; our proprietary biobank; critical suppliers; the ongoing COVID-19 pandemic and its impact on our operations, as well as the business or operations of third parties with whom we conduct business; estimates of total addressable market opportunity and forecasts of market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests and market position; and other factors discussed under the heading "Risk Factors" contained in our Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, or Current Reports on Form 8-K filed with the SEC from time to time. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.
View original content to download multimedia:
SOURCE Sera Prognostics, Inc. | https://www.kmvt.com/prnewswire/2022/08/10/sera-prognostics-reports-second-quarter-2022-financial-results/ | 2022-08-10T21:15:46Z | https://www.kmvt.com/prnewswire/2022/08/10/sera-prognostics-reports-second-quarter-2022-financial-results/ | true |
PORTSMOUTH, Va. — A Virginia city is honoring hometown hero Missy Elliott by naming a boulevard in a new entertainment district after her.
The award-winning rapper, singer, songwriter and producer, born Melissa Arnette Elliott, graduated from Woodrow Wilson High School, now Manor High. In 2019, she gave the school $25,000.
Elliott thanked the council in a tweet saying she’s been through ups and downs and times when she wanted to give up “but Gods plan was different! & all I can do is say Thank you.”
Portsmouth resident and fan Erin Carter made the name change request to honor the artist she says had the courage to take on the world stage.
“It’s time for her hometown to honor her accomplishments as a music icon,” Carter said. “It will be a testament (of) our city greatness that Portsmouth was the place that launched her career.”
Such requests aren’t common, so it’s not clear when the change will be made, Planning Director Robert Baldwin said. | https://www.washingtonpost.com/local/portsmouth-to-name-street-for-hometown-hero-missy-elliott/2022/08/10/bc686518-18ec-11ed-b998-b2ab68f58468_story.html | 2022-08-10T21:18:17Z | https://www.washingtonpost.com/local/portsmouth-to-name-street-for-hometown-hero-missy-elliott/2022/08/10/bc686518-18ec-11ed-b998-b2ab68f58468_story.html | true |
This month’s supermoon will be the last of 2022. When is the Sturgeon supermoon and what is the best time to see it?
The last month of winter is here in the southern hemisphere and with it brings another lunar event: the Sturgeon supermoon.
This fishy Moon will be the last in a series of supermoons that Australia has seen over the past four months.
In fact, Friday's Sturgeon Moon marks the last time Australians will see a supermoon until 2023.
When can I see the Sturgeon supermoon in Australia?
The month's supermoon will be visible from Thursday evening and at its peak on Friday, August 12, at 11:35am AEST.
Its peak is when the moon will be at its fullest, but don't be put off by its mid-morning debut: The supermoon will still be shining as the sun sets on Australia.
When is the best time to see it?
Moonrise is when you'll be able to get the clearest view of the sturgeon moon, so — for those living on Australia's east coast — keep your eyes to the eastern horizon any time after 4:20pm AEST on Thursday, August 11, or after 5:30pm AEST on Friday, August 12.
Why is it called a Sturgeon supermoon?
It all comes back to the The Old Farmer's Almanac, and a bunch of fish.
First published in 1792, the reference book was the first to refer to the Moon as "sturgeon", because of the large number of sturgeon fish that were found in the North American Great Lakes around that time of year.
However, there are many different names for what is colloquially known as the Sturgeon Moon: Various Native American tribes refer to it as the Corn Moon (Algonquin, Ojibwe), Harvest Moon (Dakota), and Ricing Moon (Anishinaabe) as it signifies a time of harvesting and crop abundance.
There are a few interesting names given to supermoons. Here's what they are, by the month:
- January: Wolf Moon
- February: Snow Moon
- March: Worm Moon
- April: Pink Moon
- May: Flower Moon
- June: Strawberry Moon
- July: Buck Moon
- August: Sturgeon Moon
- September: Harvest Moon
- October: Hunter's Moon
- November: Beaver Moon
- December: Cold Moon
What makes a supermoon super?
A supermoon is defined by its close proximity to the Earth, or perigee.
As the Moon's orbit is not perfectly circular, the perigee is the name for the point of closest approach.
The closer the Moon, the brighter and bigger it will appear in the sky.
First coined by astrologer Richard Nolle in 1979, some say a supermoon is any full or new moon that occurs within 24 hours of it making its closest approach to Earth for that month.
Others say it is when the full moon comes within 360,000 kilometres of Earth.
This Sturgeon Moon will be the most marginal of the 2022 supermoons, but it still falls within the 360,000km benchmark.
What other supermoons have we seen in 2022?
Since May we've experienced a supermoon event every month — the Buck Moon in July, the Strawberry Moon in June and the Flower moon in May.
The Flower Moon in May coincided with a total lunar eclipse — which was seen best in the northern hemisphere — that turned the Moon partially red for 90 minutes, earning it the name "Super Flower Blood Moon".
Africa, Europe and the Americas got the best view, with Australian's experiencing a penumbral lunar eclipse, where the edge of the Earth's shadow fell over the moon.
Australians will get their next Blood Moon on November 8, this year, when a total lunar eclipse will be visible from Australia, Asia, North America and most of South America.
Look out for the Perseid meteor shower straight after
Once you've marvelled at the Sturgeon supermoon, keep an eye out on August 13 for the Perseid meteor shower — the peak of meteor shower season, which can see as many as a hundred shooting stars per hour skimming across the night sky.
While the recent full Moon will make the meteors a little less visible, you can see if you can spot some from 5am on Saturday morning.
Pro tip: Face north for the highest chance of seeing a shooting star. | https://www.abc.net.au/news/2022-08-11/sturgeon-supermoon-last-of-2022-how-to-see-it/101312128 | 2022-08-10T21:19:06Z | https://www.abc.net.au/news/2022-08-11/sturgeon-supermoon-last-of-2022-how-to-see-it/101312128 | false |
SCOTTSDALE, Ariz., Aug. 10, 2022 /PRNewswire/ -- Axon (NASDAQ: AXON), the global leader in connected public safety technologies, today announced that it has named Brittany Bagley as its new Chief Financial Officer and the newly created position of Chief Business Officer, effective September 26, 2022. Ms. Bagley replaces Jim Zito, who has been serving as interim Chief Financial Officer since May 4, 2022. Zito will resume his prior role as Senior Vice President of Accounting.
"Brittany's broad experience as a public company CFO, Board member and investor position her well to lead Axon's finance organization through our next phase of growth," says Axon founder and CEO Rick Smith. "We believe Brittany will be a valuable thought partner as we continue to execute against our mission and deliver for our customers and shareholders."
Josh Isner, Axon COO, adds, "Brittany brings to our bench 17 years of financial industry experience and we look forward to leveraging her analytical rigor, expertise in investing for strategic growth and keen ability to lead finance organizations in highly dynamic industries. Brittany will be a fundamental contributor across Axon's entire business and I am thrilled she chose to join our team in this extremely competitive market for top tier talent."
Ms. Bagley joins Axon from Sonos (NASDAQ:SONO), where she served as Chief Financial Officer, with oversight of financial, accounting, corporate development, investor relations, real estate, facilities organizations and the CIO and data organizations. Ms. Bagley joined Sonos in 2019 after having served as an investor and board member. Previously, she spent 12 years at KKR & Co., most recently serving as Managing Director, TMT Private Equity, where she was immersed in wide-ranging technology businesses, including semiconductors, consumer electronics and software. Ms. Bagley began her career at Goldman Sachs and holds a B.A. from Brown University.
Ms. Bagley is a current member of the Board of Directors of self-driving technology company Aurora (NASDAQ: AUR), where she also serves as Audit Committee Chair.
"I am excited and humbled to join Axon and play a role in the company's inspiring mission to protect life," says Ms. Bagley. "With a model of rapid software growth and annual recurring revenue, the company is uniquely positioned to deliver strong growth, build scale and drive long-term profitability. I look forward to partnering with this great team and building upon their outstanding track record of execution and delivering shareholder value."
About Axon
Axon is a network of devices, apps and people that helps public safety personnel become smarter and safer. With a mission of protecting life, our technologies give customers the confidence, focus and time they need to keep their communities safe. Our products impact every aspect of a public safety officer's day-to-day experience with the goal of helping everyone get home safe.
We work hard for those who put themselves in harm's way for all of us. To date, more than 270,000 lives and countless dollars have been saved with the Axon Network of devices, apps and people. Learn more at www.axon.com or by calling (800) 978-2737. Axon is a global company with headquarters in Scottsdale, Ariz. and global software engineering hub in Seattle, Wash., as well as additional offices in Australia, Canada, Finland, Vietnam, the UK and the Netherlands.
Brown University is a trademark of Brown University; Facebook is a trademark of Facebook, Inc.; Goldman Sachs is a trademark of Goldman Sachs & Co. LLC; Sonos is a trademark of Sonos, Inc. and Twitter is a trademark of Twitter, Inc. Axon, Axon Network, Protect Life and the Delta Logo are trademarks of Axon Enterprise, Inc., some of which are registered in the US and other countries. For more information, visit www.axon.com/legal. All rights reserved.
Follow Axon here:
- Axon on Twitter: https://twitter.com/axon
- Axon on Facebook: https://www.facebook.com/Axon.ProtectLife/
Note to Investors
Please visit http://investor.axon.com, https://www.axon.com/press, www.twitter.com/axon_us and https://www.facebook.com/Axon.ProtectLife/ where Axon discloses information about the company, its financial information and its business.
MEDIA CONTACT:
Corinne Clark
Public Relations Manager
Press@axon.com
View original content to download multimedia:
SOURCE Axon | https://www.wymt.com/prnewswire/2022/08/10/axon-names-brittany-bagley-new-chief-financial-officer-chief-business-officer/ | 2022-08-10T21:20:00Z | https://www.wymt.com/prnewswire/2022/08/10/axon-names-brittany-bagley-new-chief-financial-officer-chief-business-officer/ | true |
A 40-year-old cold case in California was finally solved after law enforcement authorities arrested a 75-year-old Hawaii man for the murder of a 15-year-old girl in 1982.
The Santa Clara District Attorney’s Office announced on Tuesday they charged Gary Ramirez for fatally stabbing 15-year-old Karen Stitt in 1982.
"Behind every old murder file in every major police department, there is a person, heartbreak, and a mystery,” District Attorney Jeff Rosen said. “The mystery of Karen Stitt’s death has been solved thanks to advances in forensic science and a detective that would never, ever give up.”
Prosecutors said Stitt was last seen by her then-boyfriend, who walked with her at night toward a bus stop in Sunnyvale.
According to the press release, Stitt's naked body was found concealed behind a blood-stained cinderblock wall the following day.
Prosecutors said the Palo Alto native had been sexually assaulted and stabbed 59 times.
ABC News reported that her then-boyfriend, long considered a suspect, was cleared in 2000 after his DNA did not match the DNA left at the crime scene.
ABC News reported that years went by without a significant lead until investigators turned to genetic genealogy.
In 2019, a tip led Sunnyvale Police Detective Matt Hutchison to determine that Stitt’s killer was possibly one of four brothers from Fresno, prosecutors said.
According to the press release, Ramirez was identified as the possible suspect in late April.
Last week, the district attorney's crime lab confirmed Ramirez's DNA matched the DNA found at the murder scene, prosecutors said.
Prosecutors said once Ramirez is extradited, he will be arraigned on murder, kidnapping, and rape charges. | https://www.ksby.com/news/national/40-year-old-cold-case-solved-hawaii-man-charged-for-1982-murder-of-15-year-old-in-california | 2022-08-10T21:23:08Z | https://www.ksby.com/news/national/40-year-old-cold-case-solved-hawaii-man-charged-for-1982-murder-of-15-year-old-in-california | true |
C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945
TORONTO, Aug. 10, 2022 /PRNewswire/ - Today, Manulife announced its second quarter of 2022 ("2Q22") results. Key highlights include:
- Net income attributed to shareholders of $1.1 billion in 2Q22, down $1.6 billion from the second quarter of 2021 ("2Q21")
- Core earnings1 of $1.6 billion in 2Q22, down 9% on a constant exchange rate basis from 2Q212
- LICAT ratio3 of 137%
- Core ROE4 of 12.1% and ROE of 8.3% in 2Q22
- NBV5 of $511 million in 2Q22, down 9%5 from 2Q21
- APE sales5 of $1.4 billion in 2Q22, down 1% from 2Q21
- Global Wealth and Asset Management ("Global WAM") net inflows5 of $1.7 billion in 2Q22, compared with net inflows of $8.6 billion in 2Q21
- Expense efficiency ratio4 of 49.2%, compared with our target of less than 50%, and general expenses decreased 3%6
"We delivered solid results, including core earnings of $1.6 billion, despite challenges posed by the macro environment, including the impact of market headwinds in Global WAM and extended COVID-19 restrictions in Asia," said Manulife President & Chief Executive Officer Roy Gori. "Our global franchise is strong and resilient, as evidenced by double-digit NBV growth in the U.S. and Canada on a combined basis, and core earnings growth in our Canada and U.S. Insurance businesses7, which reduced the impact of market and pandemic related headwinds elsewhere."
"While our net income for the second quarter was negatively impacted by market volatilities, on a year-to-date basis, we delivered net income attributed to shareholders of $4.1 billion, which was $0.6 billion higher than our year-to-date 2021 net income and $0.9 billion higher than our year-to-date 2022 core earnings. The 2022 results are reflective of positive investment-related experience that more than offset the negative direct impact of markets, as well as the one-time gain8 from our U.S. variable annuity reinsurance transaction that closed in the first quarter," Mr. Gori concluded.
"Expense efficiency continues to be an important strategic priority and we maintained an expense efficiency ratio of less than 50% during the quarter despite topline pressures. This, combined with our in-force business, which grew 7% over the prior year quarter9, and comprises approximately three-quarters of our insurance core earnings, has provided for earnings stability against a backdrop of an uncertain macro environment," said Phil Witherington, Chief Financial Officer.
"We are committed to delivering value to shareholders, and have repurchased approximately 2% of our common shares so far this year10," Mr. Witherington continued.
BUSINESS HIGHLIGHTS:
Manulife ranked among Corporate Knights' 2022 Best 50 Corporate Citizens, which recognizes the rising standard and ambition for corporate sustainability leadership in Canada. In Asia, we became the first life insurer in Vietnam to offer healthcare solutions via the MoMo e-wallet, providing the app's 31 million users with access to our award-winning Max-Health insurance product. MoMo users can now easily purchase Manulife Vietnam's Max-Health product in less than one minute through a simple three-step process. In our U.S. segment, we reported the highest ever quarterly sales in our international business. We signed new distributors in the Latin America region and launched a whole life product to support continued sales growth and diversify the business across geographies. In Global WAM, we published our 2022 Manulife Investment Management Stewardship report, detailing our commitment to sustainability as a global investment manager and outlining actions we are taking to address material sustainability risks and opportunities, build more resilient portfolios, and pursue long-term value creation.
In addition, we continued to make progress on our digital journey in 2Q22. In Asia, we enabled our distribution force with an advanced suite of digital tools, with the proportion of new policies sold being digitally submitted reaching 85.5%, an increase of 10 percentage points compared with 2Q21. In Canada, we continued to advance our digital solutions with enhancements to Manulife.ca that included enabling artificial intelligence and natural-language processing capabilities to make searching for product information quick, accurate and intuitive. In the U.S., we enhanced our digital capabilities by launching eDelivery notification of client correspondence to improve preferred producer experience and response to customers. In Global WAM, we launched a new mobile app feature in Canada Retirement that enables members to make additional contributions to their Registered Retirement Savings Plans, providing them with greater control over their financial future.
FINANCIAL HIGHLIGHTS:
PROFITABILITY:
Reported net income attributed to shareholders of $1.1 billion in 2Q22, down $1.6 billion from 2Q21
The decrease in net income attributed to shareholders was primarily driven by charges from the direct impact of markets (compared with net gains in 2Q21), smaller gains from investment-related experience, and lower core earnings. The charge from the direct impact of markets in 2Q22 was primarily driven by the impact of unfavourable equity market performance and interest rate hedge ineffectiveness due to significant interest rate movements across several markets of differing magnitudes and shape changes. In addition, foreign exchange movements, losses from the sale of available-for-sale ("AFS") bonds, and losses from non-parallel movements in swap spreads also contributed. Investment-related experience in 2Q22 reflected higher-than-expected returns (including fair value changes) on alternative long-duration assets primarily driven by fair value gains on private equity investments, the favourable impact of fixed income reinvestment activities, and favourable credit experience.
Delivered core earnings of $1.6 billion in 2Q22, a decrease of 9% compared with 2Q21
The decrease in core earnings was driven by the unfavourable impact of markets on seed money investments in new segregated and mutual funds (compared with gains in 2Q21) in Corporate and Other and on net fee income in Global WAM. In addition, core earnings were also impacted by lower new business gains across our insurance segments, lower in-force earnings in U.S. Annuities due to the variable annuity reinsurance transaction that closed in 1Q22, and lower fee spread in Global WAM. These items were partially offset by in-force business growth in Asia, U.S. Insurance and Canada, higher yields on fixed income investments and gains on AFS equities in Corporate and Other, and improved policyholder experience in the U.S.
ANNUAL REVIEW OF ACTUARIAL METHODS AND ASSUMPTIONS IN THE THIRD QUARTER OF 2022 ("3Q22")1:
In 3Q22, we will complete our annual review of actuarial methods and assumptions. The review includes a comprehensive study of our U.S. long-term care ("LTC") experience and, although work is still ongoing, preliminary indications suggest that the net impact to net income attributed to shareholders in 3Q22 will be approximately neutral in total and for LTC; however, there could be variability in this outcome. The LTC review includes all aspects of assumptions on claims and future premium rate increases. Other assumptions being reviewed this year include mortality and certain lapse assumptions for Canada life insurance, as well as lapse and mortality assumptions for certain Asia markets.
BUSINESS PERFORMANCE:
New business value ("NBV") of $511 million in 2Q22, a decrease of 9% compared with 2Q21
In Asia, NBV decreased 17% reflecting lower sales in Hong Kong, Japan corporate owned life insurance ("COLI") and Asia Other2, as well as unfavourable product mix in Asia Other, partially offset by higher individual protection and other wealth sales in Japan. In Canada, NBV increased 8% from 2Q21, driven by higher volumes in large-case group insurance, partially offset by less favourable business mix in Insurance. In the U.S., NBV increased 18% from 2Q21, driven by improved margins due to product actions, higher international sales volumes, and higher interest rates.
Annualized premium equivalent ("APE") sales of $1.4 billion in 2Q22, a decrease of 1% compared with 2Q21
In Asia, APE sales decreased 12%, reflecting continued adverse impacts from COVID-19 in Hong Kong, lower COLI product sales in Japan, and lower sales in Asia Other. In Hong Kong, APE sales decreased 32% driven by the continued effect of COVID-19 in Hong Kong and tighter containment measures in Macau during the quarter. In Japan, APE sales decreased 15% as a result of lower COLI product sales, partially offset by higher individual protection and other wealth sales. Asia Other APE sales decreased 3%, reflecting lower agency sales in Vietnam, mainland China and Indonesia, partially offset by higher bancassurance sales in Singapore, Vietnam and mainland China. In Canada, APE sales increased 32%, primarily driven by higher large-case group insurance and individual insurance par sales, partially offset by lower segregated fund sales. In the U.S., APE sales increased 6%, primarily due to strong international sales, which are reported as part of the U.S. segment results. This increase was partially offset by lower sales of domestic protection-oriented insurance products, as the impact of higher inflation on household discretionary spending reduced demand. APE sales of products with the John Hancock Vitality PLUS feature increased 13% compared with the prior year quarter, reflecting greater consumer interest in improving baseline health due to the impact of COVID-19, making our Vitality feature a desirable solution in the current environment.
Reported Global Wealth and Asset Management net inflows of $1.7 billion in 2Q22, compared with 2Q21 net inflows of $8.6 billion
Net inflows in Retirement were $1.0 billion in 2Q22 compared with net outflows of $0.6 billion in 2Q21, driven by growth in member contributions and lower plan redemptions. Net outflows in Retail were $1.9 billion in 2Q22 compared with net inflows of $7.3 billion in 2Q21, reflecting higher mutual fund redemption rates and lower gross flows due to decreased investor demand amid equity market declines and higher interest rates. Net inflows in Institutional Asset Management were $2.5 billion in 2Q22 compared with net inflows of $1.9 billion in 2Q21, driven by a $1.9 billion sale of an equity mandate, partially offset by the non-recurrence of a $1.0 billion sale to an existing client in the prior year.
QUARTERLY EARNINGS RESULTS CONFERENCE CALL
Manulife Financial Corporation will host a Second Quarter 2022 Earnings Results Conference Call at 8:00 a.m. ET on August 11, 2022. For local and international locations, please call 416-340-2217 or toll free, North America 1-800-806-5484 (Passcode: 5329622#). Please call in 15 minutes before the call starts. You will be required to provide your name and organization to the operator. A replay of this call will be available by 11:00 a.m. ET on August 11, 2022 through November 3, 2022 by calling 905-694-9451 or 1-800-408-3053 (Passcode: 1177427#).
The conference call will also be webcast through Manulife's website at 8:00 a.m. ET on August 11, 2022. You may access the webcast at: manulife.com/en/investors/results-and-reports. An archived version of the webcast will be available on the website following the call at the same URL as above.
The Second Quarter 2022 Statistical Information Package is also available on the Manulife website at: www.manulife.com/en/investors/results-and-reports.
Any information contained in, or otherwise accessible through, websites mentioned in this news release does not form a part of this document unless it is expressly incorporated by reference.
EARNINGS:
The following table presents net income attributed to shareholders, consisting of core earnings and details of the items excluded from core earnings:
NON-GAAP AND OTHER FINANCIAL MEASURES:
The Company prepares its Consolidated Financial Statements in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board. We use a number of non-GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. This section includes information required by National Instrument 52-112 – Non-GAAP and Other Financial Measures Disclosure in respect of "specified financial measures" (as defined therein).
Non-GAAP financial measures include core earnings (loss); pre-tax core earnings; core earnings available to common shareholders; core general expenses; and assets under management and administration ("AUMA").
Non-GAAP ratios include core return on common shareholders' equity ("core ROE"); diluted core earnings per common share ("core EPS"); expense efficiency ratio; and percentage growth/decline on a constant exchange rate basis in any of the above non-GAAP financial measures.
Other specified financial measures include assets under administration; NBV; APE sales; gross flows; net flows; and percentage growth/decline in such other financial measures.
Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP. For more information on non-GAAP financial measures, including those referred to above, see the section "Non-GAAP and other financial measures" in our 2Q22 MD&A, which is incorporated by reference.
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Core earnings available to common shareholders
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Core ROE
($ millions, unless otherwise stated)
Core EPS
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Global WAM AUMA reconciliation
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Expense efficiency ratio
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
From time to time, Manulife makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995.
The forward-looking statements in this document include, but are not limited to, statements with respect to the estimated impact of our annual review of actuarial methods and assumptions and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "suspect", "outlook", "expect", "intend", "estimate", "anticipate", "believe", "plan", "forecast", "objective", "seek", "aim", "continue", "goal", "restore", "embark" and "endeavour" (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts' expectations in any way.
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.
Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the ongoing prevalence of COVID-19, including any variants, as well as actions that have been, or may be taken by governmental authorities in response to COVID-19, including the impacts of any variants; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified as available-for-sale; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our non-North American operations; geopolitical uncertainty, including international conflicts; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company's or public infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found under "Risk Management and Risk Factors" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent annual report, under "Risk Management and Risk Factors Update" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent interim report, in the "Risk Management" note to the consolidated financial statements in our most recent annual and interim reports as well as elsewhere in our filings with Canadian and U.S. securities regulators.
The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.
View original content to download multimedia:
SOURCE Manulife Financial Corporation | https://www.wymt.com/prnewswire/2022/08/10/manulife-reports-2q22-net-income-11-billion-core-earnings-16-billion-ape-sales-14-billion-global-wealth-asset-management-net-inflows-17-billion/ | 2022-08-10T21:24:03Z | https://www.wymt.com/prnewswire/2022/08/10/manulife-reports-2q22-net-income-11-billion-core-earnings-16-billion-ape-sales-14-billion-global-wealth-asset-management-net-inflows-17-billion/ | false |
LINCOLN, Neb., Aug. 10, 2022 /PRNewswire/ -- PaymentSpring, a division of Nelnet, Inc. (NYSE: NNI) and a leader in secure payment technology for education and non-profits across the United States, has announced it has changed its name to Nelnet Payment Services.
Nelnet Payment Services currently serves as the payment engine for products and services across multiple Nelnet business units. This name change will further unify the business with the Nelnet brand to create opportunities to expand into new markets and facilitate additional partnerships.
Throughout its history, Nelnet Payment Services has created product and service offerings designed to simplify and secure the payment experience. Over the years, the company has expanded into a variety of industries and has added proven processing partners, powerful integrations, and leading services.
"As Nelnet Payment Services, we will continue to provide innovative and affordable payment solutions to our existing partners," said Becky Pollock, president of Nelnet Payment Services. "We'll also focus on enhancing our product set to provide unique, competitive advantages in support of new opportunities available through existing Nelnet business lines and beyond."
Nelnet Payment Services is a premier payment gateway, enabling software partners to offer secure, reliable payment solutions to their customers and members. From small businesses needing an easy gateway to add to their new business site to independent sales organizations in search of a processor that offers a better payment experience for their portfolio, Nelnet Payment Services delivers. For more information, visit nelnetpaymentservices.com.
View original content:
SOURCE Nelnet Payment Services | https://www.wymt.com/prnewswire/2022/08/10/paymentspring-announces-name-change-nelnet-payment-services/ | 2022-08-10T21:25:12Z | https://www.wymt.com/prnewswire/2022/08/10/paymentspring-announces-name-change-nelnet-payment-services/ | false |
WFO SAN ANGELO Warnings, Watches and Advisories for Wednesday, August 10, 2022
_____
SPECIAL WEATHER STATEMENT
Special Weather Statement
National Weather Service San Angelo TX
314 PM CDT Wed Aug 10 2022
...A strong thunderstorm will impact portions of southwestern Brown,
southeastern Coleman, northeastern McCulloch and northwestern San
Saba Counties through 400 PM CDT...
At 314 PM CDT, Doppler radar was tracking a strong thunderstorm near
Winchell, moving southeast at 10 mph.
HAZARD...Winds in excess of 40 mph and pea size hail.
SOURCE...Radar indicated.
IMPACT...Gusty winds could knock down tree limbs and blow around
unsecured objects. Minor damage to outdoor objects is
possible.
Locations impacted include...
Elm Grove, Winchell, Mercury, Brookesmith, Rockwood, Milburn, Fife,
Whon, Indian Creek and Us-283 Near The Mcculloch-
Coleman County Line.
PRECAUTIONARY/PREPAREDNESS ACTIONS...
If outdoors, consider seeking shelter inside a building.
LAT...LON 3133 9938 3151 9941 3160 9900 3150 9897
3147 9900 3145 9897 3144 9896 3144 9895
3136 9893
TIME...MOT...LOC 2014Z 327DEG 10KT 3151 9920
MAX HAIL SIZE...0.25 IN
MAX WIND GUST...40 MPH
_____
Copyright 2022 AccuWeather | https://www.registercitizen.com/weather/article/TX-WFO-SAN-ANGELO-Warnings-Watches-and-17365126.php | 2022-08-10T21:25:18Z | https://www.registercitizen.com/weather/article/TX-WFO-SAN-ANGELO-Warnings-Watches-and-17365126.php | true |
Español
Italiano
Français
My Account
My Account
Notifications
Log In
QQQ
–
–%
DIA
–
–%
SPY
–
–%
TLT
–
–%
GLD
–
–%
BTC/USD
–
–%
Data & APIs
Events
Marketfy
Premarket
Contribute
Español
Italiano
Français
Sign in
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Cryptocurrency
Penny Stocks
Digital Securities
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Fintech
News
Podcast
Personal Finance
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
Watch
YouTube
Podcasts
Trading School
Personal Finance
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
Watch
YouTube
Podcasts
Trading School
My Stocks
Tools
Calendars
Analyst Ratings Calendar
Dividend Calendar
Conference Call Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Retail Sales Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
100x Options Profit Calculator
Premium
QQQ
–
–%
DIA
–
–%
SPY
–
–%
TLT
–
–%
GLD
–
–%
BTC/USD
–
–%
COMPUTER PROGRAMS & SYSTEMS INC Quarterly Report (Form10)
Accepted:
Form Type:
10-Q
Accession Number:
0001169445-22-000010 | https://www.benzinga.com/secfilings/22/08/28404933/computer-programs-systems-inc-quarterly-report-form10 | 2022-08-10T21:25:58Z | https://www.benzinga.com/secfilings/22/08/28404933/computer-programs-systems-inc-quarterly-report-form10 | false |
DALLAS, Aug. 10, 2022 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) today announced the pricing of two series of senior unsecured notes for an aggregate principal amount of $700 million. The notes consist of the following:
- $400 million of 3.650% senior unsecured notes due August 16, 2032; and
- $300 million of 4.100% senior unsecured notes due August 16, 2052.
TI expects to use the net proceeds of this offering for general corporate purposes. The offering is expected to close on August 16, 2022.
BofA Securities, Inc.; Citigroup Global Markets Inc.; and U.S. Bancorp Investments, Inc. are serving as joint book-running managers for the offering.
The offering of the notes is made only by means of a prospectus and a related prospectus supplement, copies of which may be obtained for free by visiting EDGAR on the Securities and Exchange Commission website at www.sec.gov or, in the alternative, from BofA Securities, Inc., Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, North Carolina 28255, or by email at dg.prospectus_requests@bofa.com, or by calling (800) 294-1322; Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at prospectus@citi.com, or by calling (800) 831-9146; or U.S. Bancorp Investments, Inc., 214 N. Tryon Street, 26th Floor, Charlotte, North Carolina 28202, or by calling (877) 558-2607.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the notes or any other securities, nor will there be any sale of the notes or any other securities in any state or jurisdiction in which such an offer, solicitation or sale is not permitted.
About Texas Instruments
Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures, tests and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, communications equipment and enterprise systems. Our passion to create a better world by making electronics more affordable through semiconductors is alive today, as each generation of innovation builds upon the last to make our technology smaller, more efficient, more reliable and more affordable – making it possible for semiconductors to go into electronics everywhere. We think of this as Engineering Progress. It's what we do and have been doing for decades.
TXN-G
View original content to download multimedia:
SOURCE Texas Instruments Incorporated | https://www.wymt.com/prnewswire/2022/08/10/texas-instruments-prices-700-million-investment-grade-notes/ | 2022-08-10T21:27:40Z | https://www.wymt.com/prnewswire/2022/08/10/texas-instruments-prices-700-million-investment-grade-notes/ | false |
ISS Reinforces Ceragon's Concerns Regarding Valuation and Certainty
ISS States: "[Aviat's] offer lacks the certainty seen in typical M&A proxy contests."
Ceragon Urges Shareholders to Vote "AGAINST" All Proposals on the WHITE Proxy Card
ROSH HA'AIN, Israel, Aug. 10, 2022 /PRNewswire/ -- Ceragon Networks Ltd. (NASDAQ: CRNT) (the "Company", "Ceragon", "we", "us", or "our"), issued the following statement with reference to a report issued by Institutional Shareholder Services Inc. ("ISS") in connection with Extraordinary General Meeting (EGM) scheduled to be held on August 23, 2022.
We are pleased that ISS recommends that shareholders vote AGAINST all of Aviat's nominees and echoes Ceragon's concerns regarding valuation and certainty. As stated in its report1:
ISS highlighted a number of significant concerns regarding Aviat's low-ball indication of interest, and the uncertainties around Aviat's ability to finance the transaction:
ISS concludes that: "...a vote AGAINST all the dissident nominees is warranted."
We agree with ISS' recommendation to vote AGAINST all of Aviat's nominees. We believe that Aviat's nominees would leave Ceragon with a weak, inexperienced Board that will not be able to effectively oversee the Company's strategy or negotiate on behalf of Ceragon shareholders.
Our Board is comprised of leaders with substantial telecom and public company board experience. Our directors have served as executives and directors of many companies that have created meaningful shareholder value and have a robust track record of supporting M&A that deliver fair value to shareholders. Our Board continues to refresh itself, including the addition of three new independent directors at last year's AGM. Moreover, we continue to work on refreshing our Board with input from our shareholders.
As we have repeatedly stated, our Board remains open to exploring a transaction with Aviat or anyone else, but only if such combination delivers full, fair and certain value.
As ISS states: "It is in shareholders' best interests to encourage a hostile acquirer to submit an offer that is subject to as little conditionality as possible and is at an initial value sufficient to "earn" a seat at the negotiating table."
We are also pleased to have the support from our research analysts and many of our shareholders, including our largest shareholder, who believe that Aviat's indication of interest significantly undervalues Ceragon and support our Board.
The Ceragon Board and leadership team are focused on doing what is right for Ceragon, our shareholders and our customers. We are confident that we have the right strategy and the right leadership team to continue positioning our company for success. Ceragon urges shareholders to vote "AGAINST" all proposals on the WHITE proxy card to prevent Aviat's attempt to take control of the Ceragon Board.
Ceragon reminds shareholders that every vote is important. Shareholders are urged to discard any GOLD proxy materials and only to vote AGAINST using the WHITE proxy card.
If you have any questions or require any assistance with voting your shares, please contact the Company's proxy solicitor, Morrow Sodali LLC at 800-662-5200 (toll-free in North America) or +1 203-658-9400 or email at CRNT@info.morrowsodali.com.
Evercore is serving as financial advisor and Shibolet and Latham & Watkins LLP are serving as legal advisors to Ceragon.
About Ceragon Networks
Ceragon Networks Ltd. (NASDAQ: CRNT) is the global innovator and leading solutions provider of 5G wireless transport. We help operators and other service providers worldwide increase operational efficiency and enhance end customers' quality of experience with innovative wireless backhaul and fronthaul solutions. Our customers include service providers, public safety organizations, government agencies and utility companies, which use our solutions to deliver 5G & 4G broadband wireless connectivity, mission-critical multimedia services, stabilized communications, and other applications at high reliability and speed.
Ceragon's unique multicore technology and disaggregated approach to wireless transport provides highly reliable, fast to deploy, high-capacity wireless transport for 5G and 4G networks with minimal use of spectrum, power, real estate, and labor resources. It enables increased productivity, as well as simple and quick network modernization, positioning Ceragon as a leading solutions provider for the 5G era. We deliver a complete portfolio of turnkey end-to-end AI-based managed and professional services that ensure efficient network rollout and optimization to achieve the highest value for our customers. Our solutions are deployed by more than 400 service providers, as well as more than 800 private network owners, in more than 150 countries. For more information please visit: www.ceragon.com
Ceragon Networks® and FibeAir® are registered trademarks of Ceragon Networks Ltd. in the United States and other countries. CERAGON ® is a trademark of Ceragon Networks Ltd., registered in various countries. Other names mentioned are owned by their respective holders.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This document contains statements that constitute "forward-looking statements" within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended, and the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the current beliefs, expectations and assumptions of Ceragon's management about Ceragon's business, financial condition, results of operations, micro and macro market trends and other issues addressed or reflected therein. Examples of forward-looking statements include, but are not limited to, statements regarding: projections of demand, revenues, net income, gross margin, capital expenditures and liquidity, competitive pressures, order timing, supply chain and shipping, components availability, growth prospects, product development, financial resources, cost savings and other financial and market matters. You may identify these and other forward-looking statements by the use of words such as "may", "plans", "anticipates", "believes", "estimates", "targets", "expects", "intends", "potential" or the negative of such terms, or other comparable terminology, although not all forward-looking statements contain these identifying words.
Although we believe that the projections reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations therefrom will not be material. Such forward-looking statements involve known and unknown risks and uncertainties that may cause Ceragon's future results or performance to differ materially from those anticipated, expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, any ongoing actions taken and future actions that may be taken by Aviat Networks Inc. or other stockholders or others; the continuing impact of the components shortage due to the global shortage in semiconductors, chipsets, components and other commodities, on our supply chain, manufacturing capacity and ability to timely deliver our products, which have caused, and could continue to cause delays in deliveries of our products and in the deployment of projects by our customers, risk of penalties and orders cancellation created thereby, as well as profit erosion due to constant price increase, payment of expedite fees and costs of inventory pre-ordering and procurement acceleration of such inventory, and the risk of becoming a deadstock if not consumed; the continued effect of the global increase in shipping costs and decrease in shipping slots availability on us, our supply chain and customers, which have resulted, and may continue to result in, price erosion, late deliveries and the risk of penalties and orders cancellation due to late deliveries; the impact of the transition to 5G technologies on our revenues if such transition is developed differently than we anticipated; the risks relating to the concentration of a major portion of our business on large mobile operators around the world from which we derive a significant portion of our ordering, that due to their relative effect on the overall ordering coupled with inconsistent ordering pattern and volume of business directed to us, creates high volatility with respect to our financial results and results of operations; the effect of the competition from other wireless transport equipment providers and from other communication solutions that compete with our high-capacity point-to-point wireless products; the continued effect of the COVID-19 pandemic on the global economy and markets and on us and on the markets in which we operate and our and our customers, providers, business partners and contractors business and operations; the risks relating to increased breaches of network or information technology security along with increase in cyber-attack activities, growing cyber-crime threats, and changes in privacy and data protection laws, that could have an adverse effect on our business; risks associated with any failure to meet our product development timetable, including delay in the commercialization of our new chipset; imposition of additional sanctions and global trade limitations in connection with Russia's invasion to Ukraine, the effects of general economic conditions and trends on the global and local markets in which we operate and such other risks, uncertainties and other factors that could affect our results, as further detailed in Ceragon's most recent Annual Report on Form 20-F and in Ceragon's other filings with the Securities and Exchange Commission.
Such forward-looking statements, including the risks, uncertainties and other factors that could affect our results, represent our views only as of the date they are made and should not be relied upon as representing our views as of any subsequent date. Such forward-looking statements do not purport to be predictions of future events or results and there can be no assurance that it will prove to be accurate. Ceragon may elect to update these forward-looking statements at some point in the future but the company specifically disclaims any obligation to do so except as may be required by law.
Ceragon's public filings are available on the Securities and Exchange Commission's website at www.sec.gov and may also be obtained from Ceragon's website at www.ceragon.com.
ADDITIONAL INFORMATION
Ceragon has filed a definitive proxy statement and WHITE proxy card with the U.S. Securities and Exchange Commission (the "SEC") in connection with its solicitation of proxies for the 2022 Extraordinary General Meeting of Ceragon Shareholders (the "2022 Extraordinary General Meeting"). CERAGON SHAREHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY STATEMENT (AND ANY AMENDMENTS AND SUPPLEMENTS THERETO) AND ACCOMPANYING WHITE PROXY CARD AS THEY CONTAIN IMPORTANT INFORMATION. Shareholders may obtain the proxy statement, any amendments or supplements to the proxy statement and other documents as and when filed by Ceragon with the SEC without charge from the SEC's website at www.sec.gov.
Ceragon Investor & Media Contact:
Maya Lustig
Ceragon Networks
Tel. +972-54-677-8100
mayal@ceragon.com
1 Permission to Use Quotes Neither Sought Nor Obtained. Emphasis added.
View original content:
SOURCE Ceragon Networks Ltd. | https://www.wcjb.com/prnewswire/2022/08/10/leading-independent-proxy-advisor-iss-recommends-vote-against-all-aviat-director-nominees/ | 2022-08-10T21:27:57Z | https://www.wcjb.com/prnewswire/2022/08/10/leading-independent-proxy-advisor-iss-recommends-vote-against-all-aviat-director-nominees/ | true |
IGT PlaySports™ grows leadership in Washington State with Olympia's premier casino
LONDON, Aug. 10, 2022 /PRNewswire/ -- International Game Technology PLC ("IGT") (NYSE: IGT) announced today that it is expanding its sports betting leadership in Washington State via a multi-year contract with Nisqually Red Wind Casino. Under the terms of the agreement, Nisqually Red Wind Casino in Olympia, Wash. will leverage the award-winning IGT PlaySports platform, deploy IGT PlaySports betting kiosks and partner with the IGT trading advisory team.
"Nisqually Red Wind Casino is excited to offer our guests additional gaming entertainment and elevated fan engagement by introducing an IGT PlaySports-powered sportsbook," said Conrad Granito, Nisqually Red Wind Casino, General Manager. "Given IGT PlaySports' leadership across Washington State and the turnkey nature of their solution, we are confident that we've found the ideal sports betting growth partner."
"In adding a sportsbook to its already impressive casino, Nisqually Red Wind Casino can leverage sports betting as a powerful player acquisition tool and a driver of extended property visitation," said Joe Asher, IGT President of Sports Betting. "IGT PlaySports has significant experience powering sportsbooks at tribal casinos throughout the U.S. and we look forward to helping Nisqually Red Wind Casino create a must-visit destination for sports fans in Olympia and the surrounding areas."
IGT PlaySports is powering sports betting at 70+ gaming venues across the U.S. and Canada. Nisqually Red Wind Casino will be the eighth casino in Washington State to deliver world-class sports betting using IGT PlaySports technology. To learn more visit igt.com/playsports or follow us on LinkedIn.
About IGT
IGT (NYSE:IGT) is a global leader in gaming. We deliver entertaining and responsible gaming experiences for players across all channels and regulated segments, from Lotteries and Gaming Machines to Sports Betting and Digital. Leveraging a wealth of compelling content, substantial investment in innovation, player insights, operational expertise, and leading-edge technology, our solutions deliver unrivaled gaming experiences that engage players and drive growth. We have a well-established local presence and relationships with governments and regulators in more than 100 countries around the world, and create value by adhering to the highest standards of service, integrity, and responsibility. IGT has approximately 10,500 employees. For more information, please visit www.igt.com.
Cautionary Statement Regarding Forward-Looking Statements
This news release may contain forward-looking statements (including within the meaning of the Private Securities Litigation Reform Act of 1995) concerning International Game Technology PLC and its consolidated subsidiaries (the "Company") and other matters. These statements may discuss goals, intentions, and expectations as to future plans, trends, events, dividends, results of operations, or financial condition, or otherwise, based on current beliefs of the management of the Company as well as assumptions made by, and information currently available to, such management. Forward-looking statements may be accompanied by words such as "aim," "anticipate," "believe," "plan," "could," "would," "should," "shall", "continue," "estimate," "expect," "forecast," "future," "guidance," "intend," "may," "will," "possible," "potential," "predict," "project" or the negative or other variations of them. These forward-looking statements speak only as of the date on which such statements are made and are subject to various risks and uncertainties, many of which are outside the Company's control. Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may differ materially from those predicted in the forward-looking statements and from past results, performance, or achievements. Therefore, you should not place undue reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include (but are not limited to) the factors and risks described in the Company's annual report on Form 20-F for the financial year ended December 31, 2021 and other documents filed from time to time with the SEC, which are available on the SEC's website at www.sec.gov and on the investor relations section of the Company's website at www.IGT.com. Except as required under applicable law, the Company does not assume any obligation to update these forward-looking statements. You should carefully consider these factors and other risks and uncertainties that affect the Company's business. All forward-looking statements contained in this news release are qualified in their entirety by this cautionary statement. All subsequent written or oral forward-looking statements attributable to International Game Technology PLC, or persons acting on its behalf, are expressly qualified in their entirety by this cautionary statement.
Contact:
Phil O'Shaughnessy, Global Communications, toll free in U.S./Canada +1 (844) IGT-7452; outside U.S./Canada +1 (401) 392-7452
Francesco Luti, +39 06 5189 9184; for Italian media inquiries
James Hurley, Investor Relations, +1 (401) 392-7190
© 2022 IGT
The trademarks and/or service marks used herein are either trademarks or registered trademarks of IGT, its affiliates or its licensors.
View original content to download multimedia:
SOURCE International Game Technology PLC | https://www.wsaz.com/prnewswire/2022/08/10/igt-nisqually-red-wind-casino-team-up-multi-year-sports-betting-agreement/ | 2022-08-10T21:29:28Z | https://www.wsaz.com/prnewswire/2022/08/10/igt-nisqually-red-wind-casino-team-up-multi-year-sports-betting-agreement/ | false |
SOUTHFIELD, Mich., Aug. 10, 2022 /PRNewswire/ -- Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, today announced that its Board of Directors has declared a quarterly cash dividend of $0.77 per share on the Company's common stock. The dividend is payable on September 20, 2022, to shareholders of record at the close of business on September 1, 2022.
Lear, a global automotive technology leader in Seating and E-Systems, enables superior in-vehicle experiences for consumers around the world. Lear's diverse team of talented employees in 38 countries is driven by a commitment to innovation, operational excellence, and sustainability. Lear is Making every drive better™ by providing the technology for safer, smarter, and more comfortable journeys. Lear, headquartered in Southfield, Michigan, serves every major automaker in the world and ranks 186 on the Fortune 500. Further information about Lear is available at lear.com or on Twitter @LearCorporation.
View original content to download multimedia:
SOURCE Lear Corporation | https://www.wsaz.com/prnewswire/2022/08/10/lear-declares-quarterly-cash-dividend/ | 2022-08-10T21:30:02Z | https://www.wsaz.com/prnewswire/2022/08/10/lear-declares-quarterly-cash-dividend/ | true |
BOGOTA, Colombia (AP) _ Geopark Ltd. (GPRK) on Wednesday reported second-quarter net income of $67.9 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Bogota, Colombia-based company said it had net income of $1.12.
The oil and gas company posted revenue of $311.2 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GPRK at https://www.zacks.com/ap/GPRK | https://www.mrt.com/business/article/Geopark-Q2-Earnings-Snapshot-17365255.php | 2022-08-10T21:30:37Z | https://www.mrt.com/business/article/Geopark-Q2-Earnings-Snapshot-17365255.php | true |
The Justice Department has charged a suspected Iranian operative for allegedly plotting to assassinate former Trump national security adviser John Bolton.
Shahram Poursafi offered to pay contacts in the U.S. up to $300,000 to murder Bolton, according to court papers unsealed Wednesday. The Justice Department says the plot was likely in retaliation for the U.S. killing of top Iranian commander Qassem Soleimani in January 2020.
Bolton, an Iran-hawk who served as former President Donald Trump's national security adviser from 2018 to 2019, thanked the Justice Department and FBI for uncovering and foiling the alleged plot.
"While much cannot be said publicly right now, one point is indisputable: Iran's rulers are liars, terrorists, and enemies of the United States," he said. "Their radical anti-American objectives are unchanged; the commitments are worthless; and their global threat is growing."
Poursafi, who is 45 and believed to be in Iran, was charged by criminal complaint with two counts: use of interstate commerce in the commission of murder for hire; and providing material support to a transnational murder plot.
The court papers provide a wealth of details into Poursafi's alleged efforts to arrange the assassination from afar.
In October 2021 he first contacted a person only identified as Individual A over social media and asked them to take photographs of Bolton for a book Poursafi was writing, according to prosecutors.
That person put Poursafi in touch with a second individual, identified as a government confidential human source, or CHS, who could take the pictures.
A few weeks later, Poursafi asked the CHS on an encrypted messaging app if they could hire someone for $200,000 to "eliminate someone." He then provided Bolton's name and made clear that he was the target.
Court papers say that Poursafi and the CHS negotiated potential payments, and the price tag eventually rose to $300,000 to compensate the CHS as well as the person the CHS was hiring to carry out the murder.
Poursafi allegedly instructed the CHS to open a cryptocurrency account for eventual payment, but he stressed that "his group" would only pay for completed work.
Court papers say Poursafi then provided the CHS with Bolton's office address in Washington, D.C., including the name and contact details for someone in the office.
In mid-November, the CHS told Poursafi that arrangements had been made with an individual who would carry out the murder.
A few days later, the CHS traveled from Texas to Washington, went to Bolton's office, and sent Poursafi two photos of the building. Poursafi said the facility's parking garage would be a good place to carry out the hit.
On Dec. 2, the CHS said the person hired to kill Bolton was at Bolton's home taking pictures.
Poursafi appeared to be growing concerned that the plot might not come to fruition, and told the CHS that if one took too much time planning something, the window of opportunity could pass.
"The CHS thanked Poursafi for his advice and said he/she had no experience in the spy world or any training in killing people," court papers said.
By mid-January, the CHS told Poursafi that they'd acquired three vans as well as weapons, silencers and ammunition. But later that month said there was a problem and security concerns. Poursafi pushed for the CHS to "finish the job," and dangled more work in the future.
The two sides stayed in touch through April, although no action was ultimately taken against Bolton.
"The Justice Department has the solemn duty to defend our citizens from hostile governments who seek to hurt or kill them," said Assistant Attorney General Matthew G. Olsen, who leads the Justice Department's National Security Division. "This is not the first time we have uncovered Iranian plots to exact revenge against individuals on U.S. soil and we will work tirelessly to expose and disrupt every one of these efforts."
Copyright 2022 NPR. To see more, visit https://www.npr.org. | https://www.wunc.org/2022-08-10/iranian-charged-in-alleged-plot-to-kill-former-national-security-adviser-john-bolton | 2022-08-10T21:31:47Z | https://www.wunc.org/2022-08-10/iranian-charged-in-alleged-plot-to-kill-former-national-security-adviser-john-bolton | true |
WEATHER ALERT
Severe Thunderstorm Warning
Full Story
WATCH LIVE: Caswell County Arrest
Watch Now
WATCH
LIVE
Raleigh
Durham
Fayetteville
Surrounding Area
EDIT
Log In
Watch
Apps
Local News
Raleigh
Durham
Fayetteville
Surrounding Area
Categories
Weather
Traffic
U.S. & World
North Carolina
I-Team
Troubleshooter
Entertainment
Weather
LOCALISH
Sports
Politics
Health and Coronavirus
Science Club
Sweepstakes
Station Info
About ABC11
Contact Us
Send us your photos & videos
ABC11 Together
Events Calendar
TV Listings
Jobs
shows
ABC11 Live Newscasts
ABC11 Perspectives
Raleigh Equity Report
Durham Equity Report
Follow Us:
Welcome,
Your Account
Log Out
SPONSORED CONTENT
everyday heroes
Submit photos to have your everyday hero recognized on ABC11
1 hour ago
Here's a look back at previous heroes.
Report a correction or typo
Copyright © 2022 WTVD-TV. All Rights Reserved.
Related Topics
Education
NC
high school
teacher
college
abc11 together
teachers
everyday heroes
Everyday Heroes
SPONSORED: Weather Master and ABC 11 Everyday Hero Contest
Cary police officer and athletic trainer honored for saving man's life
SPONSORED: Share Your ABC11 Sheroes!
SPONSORED: Weather Master and ABC 11 Everyday Hero Contest | https://abc11.com/abc11-everyday-heroes-share-your-form-submission/12112666/ | 2022-08-10T21:32:03Z | https://abc11.com/abc11-everyday-heroes-share-your-form-submission/12112666/ | true |
Russian authorities detained a former state TV journalist who quit after making an on-air protest against Moscow’s war in Ukraine and charged her Wednesday with spreading false information about Russia’s armed forces, according to her lawyer.
Marina Ovsyannikova was charged over a protest she staged last month, holding a banner that said “(Russian President Vladimir) Putin is a killer, his soldiers are fascists. 352 children have been killed (in Ukraine). How many more children should die for you to stop?”
If tried and convicted, Ovsyannikova faces up to 10 years in prison under a new law that penalizes statements against the military and that was enacted shortly after Russian troops moved into Ukraine, her lawyer, Dmitry Zakhvatov, said in a Telegram post.
Ovsyannikova’s home was raided Wednesday and she was taken for questioning. Zakhvatov said the former producer for Russian state-funded Channel One would spend the night in a holding cell at Moscow police headquarters.
Ovsyannikova made international headlines on March 14, when she appeared behind the anchor of an evening news broadcast holding a poster that said “Stop the war, don’t believe the propaganda, they are lying to you here.” She was charged with disparaging the Russian military and fined 30,000 rubles ($270 at the time).
After quitting her job, Ovsyannikova became somewhat of an activist, staging antiwar pickets and speaking out publicly against the conflict.
She was fined two more times in recent weeks for disparaging the military in a critical Facebook post and comments she made at a court where opposition figure Ilya Yashin was remanded in custody pending trial for spreading false information about the military.
According to Net Freedoms, a legal aid group focusing on free speech cases, as of Wednesday there were 79 criminal cases on charges of spreading false information about the military and up to 4,000 administrative cases on charges of disparaging the armed forces.
Independent journalists in Russia have come under particular Kremlin scrutiny. A Moscow court on Wednesday fined the independent Russian newspaper Novaya Gazeta 350,000 rubles ($5,700) for “abusing the freedom of mass information.” It was unclear what the newspaper allegedly did wrong.
Since Putin came into power more than two decades ago, nearly two dozen journalists have been killed, including at least four who had worked for Novaya Gazeta. The newspaper shut down in March.
Its editor-in-chief, Dmitry Muratov, won the Nobel Peace Prize last year. In June, he auctioned off his prize to raise money for Ukrainian child refugees. The gold medal sold for $103.5 million. | https://www.wivb.com/news/world/russia-targets-reporter-with-raid-probe-over-war-criticism/ | 2022-08-10T21:34:13Z | https://www.wivb.com/news/world/russia-targets-reporter-with-raid-probe-over-war-criticism/ | false |
(NEXSTAR) – In November 2020, McDonald’s announced plans to begin testing the McPlant, a “delicious plant-based burger crafted for McDonald’s, by McDonald’s, and with the kind of craveable McDonald’s flavor our customers love.”
But nearly two years later — during which time several fast-food chains have debuted their own plant-based offerings — the McPlant is still seemingly no closer to obtaining a spot on the national menu.
So what happened?
In late 2021, McDonald’s began testing the McPlant at only eight U.S. locations after previously testing the burger in select European countries. In Feb. 2021, the McPlant tests expanded to around 600 restaurants in the San Francisco Bay and Dallas-Fort Worth areas, with McDonald’s aiming to better understand “customer demand” — and that was the last they’ve mentioned of the sandwich on their corporate website.
In late July, McDonald’s quietly confirmed to CNBC these tests concluded as planned, but a representative for the restaurant made no mention of any future initiatives to offer the McPlant at U.S. locations when contacted by Nexstar.
A representative for Beyond Meat, which partnered with McDonald’s to create the McPlant patty, directed Nexstar back to McDonald’s when asked about any future plans for the burger.
It’s possible McDonald’s could be keeping mum on its plant-based plans, though analysts indicate it’s more likely that the item failed to meet sales expectations, and likely won’t be coming back.
In a note from financial services firm BTIG, obtained by MarketWatch in March and cited by Eat This this week, analysts with the firm found evidence that the McPlant failed to gain the same momentum that it demonstrated in the eight initial test restaurants, each of which had sold around 70 units per day.
Upon the rollout to San Francisco Bay and Dallas-Fort Worth, restaurants were only selling around 20 per day, with some in more rural Texas only selling between three and five, BTIG’s analysts found.
Some of the franchisees had even claimed that, since the McPlant wasn’t selling, it was being cooked to order whenever a customer requested one — which created longer wait times for customers ordering the McPlant and those waiting behind them in the drive-thru.
In their note, BTIG analysts said a nationwide launch “seems a ways off” as of March 2022.
Still, McDonald’s hasn’t completely killed the McPlant. It’s still among the vegetarian-friendly offerings in the U.K., and customers in Australia can find it on their local menus too.
Here in the U.S., however, customers looking for the McPlant may have to keep on waiting — or simply settle for an Impossible Whopper. | https://www.kark.com/news/business/is-mcdonalds-ditching-plans-for-the-mcplant-its-long-awaited-plant-based-burger/ | 2022-08-10T21:34:43Z | https://www.kark.com/news/business/is-mcdonalds-ditching-plans-for-the-mcplant-its-long-awaited-plant-based-burger/ | false |
SOUTH BEND, Ind. (AP) — Notre Dame athletic director Jack Swarbrick says the coming Big Ten television contract with NBC is a “perfect” way for the network to complement its deal with the Fighting Irish.
Swarbrick held a live online chat for Notre Dame's alumni association Wednesday, during which he addressed recent developments with the Big Ten and how they could impact the school's ability to remain a football independent.
The Big Ten's new media rights deals are not yet finalized, but the conference is moving toward contracts with Fox, NBC and CBS. The league has also said it is having discussions with streaming services to televise its games.
NBC has had exclusive rights to broadcast Notre Dame home games since 1991. The latest iteration of that deal runs through 2025.
Swarbrick called the Big Ten's strategy brilliant and said he expected the value of the deals will be “pretty amazing” for the conference.
“But it's also perfect for Notre Dame,” Swarbrick said. “We need NBC to have more college football to more effectively promote our games and to talk about our games and to have NBC be seen in that light. So that was great for us that (NBC) got a big piece of this.”
Swarbrick said the recent expansions of the Big Ten (adding Southern California and UCLA in 2024) and the Southeastern Conference (adding Texas and Oklahoma in 20225) have only helped strengthen Notre Dame's position as a college football independent.
Notre Dame is a member of the Atlantic Coast Conference for most of its sports and has an agreement to play five football games per season against ACC schools. Plus, a clause in Notre Dame's deal with the ACC would require it to join that league if it decides to give up football independence. That deal runs through 2036.
Swarbrick said the three factors Notre Dame would weigh if it considered joining a conference for football would be a television partner to broadcast all home games, access to the College Football Playoff and how it would impact Olympic sports.
“When I started this job ... all the commentary was were we relevant anymore? This year, no one is asking that question,” Swarbrick said. “A lot of this dynamic has just reinforced the decisions made over a lot of years that have placed Notre Dame in a very good position. That’s my biggest takeaway.”
___
More AP college sports: https://apnews.com/hub/college-sports and https://twitter.com/AP_Top25 | https://www.mrt.com/sports/article/Notre-Dame-AD-Big-Ten-deal-with-NBC-perfect-17365069.php | 2022-08-10T21:35:45Z | https://www.mrt.com/sports/article/Notre-Dame-AD-Big-Ten-deal-with-NBC-perfect-17365069.php | true |
Blast from the past: Bafana Bafana sparkle against Black Stars
Today in SA sports history: August 11
1960 — SA’s 400m hurdles world record-holder Gert Potgieter is seriously injured in a motor accident at Edencoven in West Germany, ruling him out of the Olympic Games in Rome. He was a passenger in a car driven by track and field teammate, sprinter Edward Jefferys, who suffered a cut above an eye and was able to return to training a week later. Potgieter, however, underwent surgery and lost the sight in his left eye. Defending champion Glenn Davis of America rated Potgieter as his only real challenge. “I regarded Gert as the only man I had to beat. He is a wonderful runner and I would say he had a very strong chance of beating me,” said Davis, who went on to retain his crown. The accident ended Potgieter’s career as a world-class athlete and underlined his run of poor luck. At the 1956 Olympics he was second in the 400m hurdles final when he fell going over the final hurdle and finished last. In 1957 he broke his neck playing rugby. ..
Support the Sunday Times by buying a subscription.
You’ve always trusted us to help you navigate the world. Support the Sunday Times by becoming a premium member for only R80 (digital access) and keep the conversation going. You can cancel anytime.
Already subscribed? Sign in below.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting. | https://www.timeslive.co.za/sunday-times-daily/sport/2022-08-10-blast-from-the-past-bafana-bafana-sparkle-against-black-stars/ | 2022-08-10T21:37:05Z | https://www.timeslive.co.za/sunday-times-daily/sport/2022-08-10-blast-from-the-past-bafana-bafana-sparkle-against-black-stars/ | true |
FBI Director Wray declines to comment on Mar-a-Lago search
In Nebraska to discuss cyberattacks on a rural community, he spoke about attacks on law enforcement.
OMAHA, Neb. (WOWT) - FBI Director Christopher Wray, in Nebraska on Wednesday to talk about attempted cyberattacks in David City, wouldn’t answer questions about the agency’s recent search at Mar-a-Lago, but did comment on attacks on law enforcement, calling them “deplorable and dangerous.”
He was also asked for his response to former President Trump’s criticism of the search, specifically his comments about the conduct of agents executing the search.
“I’m sure you can appreciate that’s not something I can talk about, so I would refer you to the department,” Wray said about the search FBI agents executed Monday at former President Trump’s estate and subsequent statements Trump has made.
Wray said he’s spoken frequently with law enforcement officials — in Iowa and Illinois on Tuesday and in Nebraska on Wednesday — about the matter.
“As to the issue of threats, I will say I’m always concerned about violence and the threat of violence against law enforcement... Any threat made against law enforcement — including the men and women of the FBI as with any law enforcement agency — are deplorable or dangerous.”
6 News asked Wray whether he was concerned the raid would incentivize — or even embolden — some of the same “bad actors” from the Jan. 6, 2021, riot at the Capitol to attempt any sort of similar attack.
“Violence against law enforcement is not the answer, no matter what anyone is upset about or who they are upset with,” Wray said. “I think we have in this country had, over the last few years, an alarming rise of violence against law enforcement. Last year, there were 73 law enforcement officers around this country who were killed in the line of duty —- as in murdered in the line of duty. It’s the highest number since 9/11.”
It’s important to recognize and appreciate the sacrifices law enforcement are willing to make in the line of duty, Wray said.
“The men and women of law enforcement, including the men and women in the FBI, make heroic sacrifices for everyone in this country,” he said. “And it takes an incredibly special person to be willing to get up every day and give his or her life, sacrifice his or her life for a total stranger. And so it’s important that we view the men and women of law enforcement as a resource to cherish.”
—
Managing Editor Kevin Westhues contributed to this report.
Copyright 2022 WOWT. All rights reserved. | https://www.1011now.com/2022/08/10/fbi-director-wray-declines-comment-mar-a-lago-search/ | 2022-08-10T21:37:32Z | https://www.1011now.com/2022/08/10/fbi-director-wray-declines-comment-mar-a-lago-search/ | true |
ATLANTA, Aug. 10, 2022 /PRNewswire/ -- The Aaron's Company, Inc. (NYSE: AAN), a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.1125 per share and declared such dividend payable October 4, 2022, to shareholders of record as of the close of business on September 15, 2022.
Headquartered in Atlanta, The Aaron's Company, Inc. is a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions of appliances, electronics, furniture, and other home goods across its brands, Aaron's, BrandsMart U.S.A., BrandsMart Leasing, and Woodhaven. Aaron's offers a direct-to-consumer lease-to-own solution through its approximately 1,300 company-operated and franchised stores in 47 states and Canada, as well as its e-commerce platform. BrandsMart U.S.A. is one of the leading appliance and consumer electronics retailers in the southeast United States and one of the largest appliance retailers in the country with ten retail stores in Florida and Georgia. BrandsMart Leasing offers lease-to-own solutions to customers of BrandsMart U.S.A. Woodhaven is our furniture manufacturing division.
For more information, visit investor.aarons.com.
View original content to download multimedia:
SOURCE The Aaron's Company, Inc. | https://www.valleynewslive.com/prnewswire/2022/08/10/aarons-directors-declare-cash-dividend/ | 2022-08-10T21:37:53Z | https://www.valleynewslive.com/prnewswire/2022/08/10/aarons-directors-declare-cash-dividend/ | true |
Denham Springs couple continues to battle flooding
DENHAM SPRINGS, La. (WAFB) - Scott and Lori Browning say their home in Denham Springs keeps flooding even after a thunderstorm. The couple lives on Pin Oak Street.
“Then the drainage had backed up and it then took on about maybe a couple of inches of water in here, and it did severe damage,” explains Scott.
A flash flood in 2019 and a heavy rainstorm last week have the couple thinking their dream house is now becoming a money pit.
“I like panic, I mean we worry, it’s going to get water in the house again, not knowing what tomorrow is going to be like. If we are going to have to worry about losing stuff again or furniture because we just replaced everything in here. All of this is new, new furniture and everything,” adds Scott.
Around eight inches of water filled the Brownings’ house during the flash flood in 2019. They replaced the damaged floors and walls.
Just last week, heavy rains sent water into their kitchen, den, and one bedroom, causing the floors to buckle once again. It has made it hard for Lori to get around the house, even with the use of her crutch.
“It affects us emotionally and stressfully because my wife being with her disability. It’s hard for her to get in and out. We have to get help to get her in, and it’s very concerning,” says Scott.
Besides the house taking in water, the Brownings say their carport regularly floods, along with their street. They suspect the street drains or the canal behind their neighborhood is to blame.
“I would like to see some help, I mean being like I said with my wife having a disability. We are living here as concerned citizens, and we are working hard to put our home together. We would like to see some help, I mean something finally getting done around here,” says Scott.
WAFB did reach out to the Denham Springs Mayor’s Office. They say this is one of the spots in the city that continues to flood. Right now, they do not have a clear solution to stop the flooding, but they are aware of the issue and trying to figure out the next step.
Click here to report a typo.
Copyright 2022 WAFB. All rights reserved. | https://www.wafb.com/2022/08/10/denham-springs-couple-continues-battle-flooding/ | 2022-08-10T21:39:50Z | https://www.wafb.com/2022/08/10/denham-springs-couple-continues-battle-flooding/ | true |
NASHVILLE, Tenn., Aug. 10, 2022 /PRNewswire/ -- AllianceBernstein L.P. ("AB") and AllianceBernstein Holding L.P. ("AB Holding") (NYSE: AB) today announced that preliminary assets under management increased to $689 billion during July 2022 from $647 billion at the end of June. The 6.5% increase was driven by market appreciation and the July 1 acquisition of CarVal Investors, partially offset by firm-wide net outflows. By channel, net inflows to Private Wealth were offset by net outflows from Retail and Institutions. July month-end AUM reflected $1.7 billion of outflows resulting from AXA S.A's ongoing redemption of certain low-fee fixed income mandates, of which approximately $2.3 billion remains outstanding and is expected to be redeemed by year-end. Excluding these AXA outflows, Institutional net flows were positive for the month of July.
Cautions Regarding Forward-Looking Statements
Certain statements provided by management in this news release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. The most significant of these factors include, but are not limited to, the following: the performance of financial markets, the investment performance of sponsored investment products and separately-managed accounts, general economic conditions, industry trends, future acquisitions, integration of acquired companies, competitive conditions, and government regulations, including changes in tax regulations and rates and the manner in which the earnings of publicly-traded partnerships are taxed. AB cautions readers to carefully consider such factors. Further, such forward-looking statements speak only as of the date on which such statements are made; AB undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. For further information regarding these forward-looking statements and the factors that could cause actual results to differ, see "Risk Factors" and "Cautions Regarding Forward-Looking Statements" in AB's Form 10-K for the year ended December 31, 2021 or form 10-Q for the quarter ended June 30, 2022. Any or all of the forward-looking statements made in this news release, Form 10-K, Form 10-Q, other documents AB files with or furnishes to the SEC and any other public statements issued by AB, may turn out to be wrong. It is important to remember that other factors besides those listed in "Risk Factors" and "Cautions Regarding Forward-Looking Statements", and those listed above, could also adversely affect AB's financial condition, results of operations and business prospects.
About AllianceBernstein
AllianceBernstein is a leading global investment management firm that offers high-quality research and diversified investment services to institutional investors, individuals and private wealth clients in major world markets.
As of June 30, 2022, including both the general partnership and limited partnership interests in AllianceBernstein, AllianceBernstein Holding owned approximately 35.7% of AllianceBernstein and Equitable Holdings, Inc. ("EQH"), directly and through various subsidiaries, owned an approximate 65.0% economic interest in AllianceBernstein.
Additional information about AB may be found on our website, www.alliancebernstein.com.
View original content:
SOURCE AllianceBernstein | https://www.wistv.com/prnewswire/2022/08/10/ab-announces-july-31-2022-assets-under-management/ | 2022-08-10T21:39:58Z | https://www.wistv.com/prnewswire/2022/08/10/ab-announces-july-31-2022-assets-under-management/ | true |
In this Golf Central Podcast presented by Callaway Golf, Ryan Lavner and Rex Hoggard, who was in the courtroom Tuesday in San Jose, react to the PGA Tour’s first legal victory against LIV, discuss the ramifications and more. They then weigh in on Cameron Smith’s reported move to LIV Golf after the playoffs. | https://www.golfchannel.com/news/golf-central-podcast-pga-tour-scores-first-win-against-liv-whats-next | 2022-08-10T21:40:00Z | https://www.golfchannel.com/news/golf-central-podcast-pga-tour-scores-first-win-against-liv-whats-next | false |
DOJ Official Declares Mar-a-Lago Raid 'A Spectacular Backfire': Report
In the aftermath of the FBI raid at former President Donald Trump’s Mar-a-Lago home, a Justice Department official said that the operation has backfired after garnering furious responses from many on the right and that it was not the FBI’s intention to make a political fiasco.
On Monday, FBI agents arrived at Trump’s home in Florida with a search warrant to obtain any government documents that the former president may have had in his possession, Newsweek reported.
According to the 1978 Presidential Records Act, once out of office a former president is required to hand over government documents to the Archives.
The raid was based on information that the FBI received from a confidential source who reported that Trump was hiding classified documents, two officials told Newsweek.
According to these two sources Newsweek spoke with, the FBI was trying to keep the raid quiet.
It was deliberately timed to happen while Trump was not at Mar-a-Lago.
One Justice Department official, who was also with the FBI for 30 years, told Newsweek that FBI officials wanted to deny Trump the publicity of a raid.
However, the attempt to keep the raid quiet failed.
“What a spectacular backfire,” the anonymous DOJ official said, according to Newsweek.
“I know that there is much speculation out there that this is political persecution, but it is really the best and the worst of the bureaucracy in action,” the official said.
“They wanted to punctuate the fact that this was a routine law enforcement action, stripped of any political overtones, and yet [they] got exactly the opposite,” they added.
Both of Newsweek’s government sources also said that the FBI raid did not have political intentions.
Allegedly, the bureau simply wanted to recover sensitive, classified documents that were supposedly illegally taken from the White House.
The officials said that the FBI had been preparing for the operation at Mar-a-Lago for several weeks.
Meanwhile, the FBI Miami Field Office and headquarters were planning around Trump’s scheduled return to Florida from his New York and New Jersey homes.
“They were seeking to avoid any media circus,” Newsweek’s second source said.
This source is a senior intelligence official and was briefed on the investigation and operation concerning the recovery of the classified documents.
“So even though everything made sense bureaucratically and the FBI feared that the documents might be destroyed, they also created the very firestorm they sought to avoid, in ignoring the fallout,” they added.
“It really is a case of the Bureau misreading the impact,” the official added.
The raid sparked the ire of many Republican officials and Trump supporters.
Kevin McCarthy, the House minority leader, has even threatened to investigate the DOJ, if the GOP is able to regain control of the House in the upcoming election, The Guardian reported.
“I’ve seen enough,” McCarthy said in a statement. “The Department of Justice has reached an intolerable state of weaponized politicization.”
Truth and Accuracy
We are committed to truth and accuracy in all of our journalism. Read our editorial standards. | https://www.westernjournal.com/doj-official-declares-mar-lago-raid-spectacular-backfire-report/?utm_source=facebook&utm_medium=conservativeupdate&utm_campaign=cuwjpost&utm_content=2022-08-10 | 2022-08-10T21:40:14Z | https://www.westernjournal.com/doj-official-declares-mar-lago-raid-spectacular-backfire-report/?utm_source=facebook&utm_medium=conservativeupdate&utm_campaign=cuwjpost&utm_content=2022-08-10 | false |
Watch: Even Blue Cities Have Had Enough of Fauci, Gets Booed While Throwing First Pitch at Game
If you’re tired of hearing about Dr. Anthony Fauci, you are not alone.
On Tuesday, the White House’s chief medical adviser was invited to throw out the first pitch at T-Mobile Park in Seattle, where the Mariners were taking on the New York Yankees.
When Fauci was introduced over the loudspeaker, many fans booed.
#Anthonyfauci gets mixed reception when introduced to throw out the first pitch at @Mariners vs @Yankees game in #seattle pic.twitter.com/V9Wom7f0rI
— Matt Markovich (@mattmarkovich) August 10, 2022
Another video showed the mixed reception from another angle, with one fan shouting that Fauci would “miss this [pitch] like you missed the pandemic, loser!”
Fauci mercilessly BOOED in liberal Seattle while throwing out the first pitch at the Mariners game
“You’re going to miss this like you missed the pandemic, loser!”
Video @thehoffatherpic.twitter.com/7TMRCEb4uL
— Mia Cathell (@MiaCathell) August 10, 2022
Fauci’s appearance even led to a gathering of Trump supporters outside the ballpark.
How you know Fauci is at the @Mariners game pic.twitter.com/kMrLqZstov
— Ari Hoffman (@thehoffather) August 10, 2022
Since Seattle is one of the bluest cities in the country, it was a bit surprising to Fauci receive such a cold reception. But given his record as the nation’s coronavirus expert, these fans should not be blamed for their lack of excitement about seeing him at a sporting event.
For one thing, the director of the National Institute of Allergy and Infectious Diseases spent the better part of the last two years trying to prevent sporting events from taking place.
In September 2021, after fans had returned to many stadiums across the country without any evidence of games becoming “superspreader” events, Fauci attempted to fearmonger about attending them.
According to a CNN transcript, co-anchor Jim Sciutto asked him whether it was acceptable to attend sporting events.
“No, I don’t think it’s smart,” Fauci responded. “I think when you’re dealing particularly — you know, outdoors is always better than indoors, but even when you have such a congregant setting of people close together, first, you should be vaccinated. And when you do have congregant settings, particularly indoors, you should be wearing a mask.”
A little less than a year later, he appears to be fine with attending games — at least when it gives him an opportunity to receive his favorite thing: public recognition.
According to MLB.com, Fauci was presented the Hutch Award before the game. The award was created in 1965 to honor Fred Hutchinson, a former MLB pitcher and manager who died from lung cancer in 1964.
It is supposed to be given each year to an MLB player who “best exemplifies the fighting spirit and competitive desire” Hutchinson embodied.
Instead, the 2022 award was given to Fauci, making him just the second non-player to win the award, joining former President Jimmy Carter, according to MLB.com
As for the first pitch itself, it left no question that Fauci is not, in fact, an MLB player.
Dr. Fauci’s first pitch. Servais caught it and then had Fauci sign his mask after. pic.twitter.com/SjOf4alLtE
— Lookout Landing (@LookoutLanding) August 10, 2022
To his credit, he at least got the ball to the catcher, which is more than he could say for his previous first pitch at a Washington Nationals game two years ago.
Dr. Anthony Fauci threw out the first pitch before the Nationals-Yankees game. pic.twitter.com/04Tbkh7Voa
— ESPN (@espn) July 23, 2020
If Facui’s trip to Seattle told us anything, it is that many Americans are sick and tired of him.
Truth and Accuracy
We are committed to truth and accuracy in all of our journalism. Read our editorial standards. | https://www.westernjournal.com/watch-even-blue-cities-enough-fauci-gets-booed-throwing-first-pitch-game/?utm_source=facebook&utm_medium=conservativeupdate&utm_campaign=cuwjpost&utm_content=2022-08-10 | 2022-08-10T21:40:21Z | https://www.westernjournal.com/watch-even-blue-cities-enough-fauci-gets-booed-throwing-first-pitch-game/?utm_source=facebook&utm_medium=conservativeupdate&utm_campaign=cuwjpost&utm_content=2022-08-10 | true |
WFO NORMAN Warnings, Watches and Advisories for Wednesday, August 10, 2022
_____
SPECIAL WEATHER STATEMENT
Special Weather Statement
National Weather Service Norman OK
421 PM CDT Wed Aug 10 2022
...A strong thunderstorm will impact portions of southwestern Clay
and southeastern Archer Counties through 445 PM CDT...
At 421 PM CDT, Doppler radar was tracking a strong thunderstorm 5
miles southeast of Windthorst, moving south at 5 mph.
HAZARD...Wind gusts up to 50 mph.
SOURCE...Radar indicated.
IMPACT...Gusty winds could knock down tree limbs and blow around
unsecured objects.
Locations impacted include...
Windthorst and Shannon.
PRECAUTIONARY/PREPAREDNESS ACTIONS...
If outdoors, consider seeking shelter inside a building.
LAT...LON 3357 9849 3358 9827 3347 9823 3347 9842
3340 9842 3340 9851
TIME...MOT...LOC 2121Z 355DEG 6KT 3351 9838
MAX HAIL SIZE...0.00 IN
MAX WIND GUST...50 MPH
_____
Copyright 2022 AccuWeather | https://www.greenwichtime.com/weather/article/TX-WFO-NORMAN-Warnings-Watches-and-Advisories-17365337.php | 2022-08-10T21:40:38Z | https://www.greenwichtime.com/weather/article/TX-WFO-NORMAN-Warnings-Watches-and-Advisories-17365337.php | false |
ALBANY, N.Y. (NEWS10)—One year ago, Governor Andrew Cuomo held a press conference just days after a report from the New York Attorney General was released. The report concluded he sexually harassed 11 women. Cuomo said the allegations were false.
“Don’t get me wrong,” Cuomo stated at the August 10th, 2021 press conference. “This is not to say that there are not 11 women who I truly offended. There are. And for that I deeply, deeply apologize.”
After multiple calls for him to resign and the possibility of impeachment, Cuomo announced he would be stepping down and that Lieutenant Governor Kathy Hochul would be taking over as governor.
“She can come up to speed quickly,” said Cuomo. “And my resignation would be effective in 14 days.”
Hochul became the first woman Governor of New York State. To this day, Cuomo maintains his innocence.
“It certainly was a political earthquake in Albany and changed the direction of the state,” explained Blair Horner, NYPIRG Executive Director. “Certainly Governor Hochul is not completely dissimilar policy wise to her predecessor, but it is a clear break with the Hochul Administration now in office.”
Capitol Correspondent Jamie DeLine asked Horner if he felt as though things have changed in Albany since Governor Hochul took the position.
“Much of Albany’s DNA continues to operate. So decisions made in secret. That’s that same. Negotiations between the governor and leaders and a lot of issues that the public doesn’t even know about getting hammered out in secret. That continues.” Horner went on to say, “It’s obviously quite clear to anyone that deals with the Hochul Administration that you get treated differently than you did by the members of the Cuomo Administration.”
Now, Governor Hochul is running for governor in her own right. She is trying to become the first woman elected to the position in New York State. | https://www.binghamtonhomepage.com/news/one-year-since-former-gov-cuomo-announced-resignation/ | 2022-08-10T21:41:25Z | https://www.binghamtonhomepage.com/news/one-year-since-former-gov-cuomo-announced-resignation/ | true |
Kindergartner removed from academy over same-sex parents accepted into new school
LAKE CHARLES, La. (KPLC/Gray News) - A child removed from a Louisiana private school after being adopted by her aunts will be starting kindergarten at another Christian school, her mother announced on Facebook.
Zoey’s parents, Emily and Jennifer Parker, spoke earlier this week after Bible Baptist Academy in Dequincy refused to enroll her for kindergarten. They adopted her after her father was killed in an industrial accident.
Zoey attended pre-K at Bible Baptist, but the private school refused to enroll her again, stating the Parkers’ same-sex marriage conflicted with its Christian values.
“This should not be interpreted that we have any hatred or malice toward them,” the school said in a statement. “We are just as committed to loving all people as we are to holding to Bible principles that people may not agree with or may not understand.”
The family’s story was shared internationally, and Emily Parker said they have been approached by multiple news outlets, writers and talk shows.
“We feel so blessed to have an army at our side,” she wrote.
Emily Parker announced in a Facebook post on Wednesday that Zoey will attend kindergarten at Hamilton Christian School in Lake Charles, another private school closer to their home.
“My little girl will never find herself alone or without love. She is loved farther than comprehension could explain,” Parker wrote. “I am so excited for her new journey I just hate how it came about.”
Copyright 2022 KPLC via Gray Media Group, Inc. All rights reserved. | https://www.kold.com/2022/08/10/kindergartner-removed-academy-over-same-sex-parents-accepted-into-new-school/ | 2022-08-10T21:42:05Z | https://www.kold.com/2022/08/10/kindergartner-removed-academy-over-same-sex-parents-accepted-into-new-school/ | false |
Español
Italiano
Français
My Account
My Account
Notifications
Log In
QQQ
–
–%
DIA
–
–%
SPY
–
–%
TLT
–
–%
GLD
–
–%
BTC/USD
–
–%
Data & APIs
Events
Marketfy
Premarket
Contribute
Español
Italiano
Français
Sign in
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Cryptocurrency
Penny Stocks
Digital Securities
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Fintech
News
Podcast
Personal Finance
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
Watch
YouTube
Podcasts
Trading School
Personal Finance
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
Watch
YouTube
Podcasts
Trading School
My Stocks
Tools
Calendars
Analyst Ratings Calendar
Dividend Calendar
Conference Call Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Retail Sales Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
100x Options Profit Calculator
Premium
QQQ
–
–%
DIA
–
–%
SPY
–
–%
TLT
–
–%
GLD
–
–%
BTC/USD
–
–%
Atara Biotherapeutics, Inc. Quarterly Report (Form10)
Accepted:
Form Type:
10-Q
Accession Number:
0000950170-22-015536 | https://www.benzinga.com/secfilings/22/08/28405287/atara-biotherapeutics-inc-quarterly-report-form10 | 2022-08-10T21:42:11Z | https://www.benzinga.com/secfilings/22/08/28405287/atara-biotherapeutics-inc-quarterly-report-form10 | true |
ATLANTA, Aug. 10, 2022 /PRNewswire/ -- The Aaron's Company, Inc. (NYSE: AAN), a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.1125 per share and declared such dividend payable October 4, 2022, to shareholders of record as of the close of business on September 15, 2022.
Headquartered in Atlanta, The Aaron's Company, Inc. is a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions of appliances, electronics, furniture, and other home goods across its brands, Aaron's, BrandsMart U.S.A., BrandsMart Leasing, and Woodhaven. Aaron's offers a direct-to-consumer lease-to-own solution through its approximately 1,300 company-operated and franchised stores in 47 states and Canada, as well as its e-commerce platform. BrandsMart U.S.A. is one of the leading appliance and consumer electronics retailers in the southeast United States and one of the largest appliance retailers in the country with ten retail stores in Florida and Georgia. BrandsMart Leasing offers lease-to-own solutions to customers of BrandsMart U.S.A. Woodhaven is our furniture manufacturing division.
For more information, visit investor.aarons.com.
View original content to download multimedia:
SOURCE The Aaron's Company, Inc. | https://www.kold.com/prnewswire/2022/08/10/aarons-directors-declare-cash-dividend/ | 2022-08-10T21:42:24Z | https://www.kold.com/prnewswire/2022/08/10/aarons-directors-declare-cash-dividend/ | false |
WFO AUSTIN/SAN ANTONIO Warnings, Watches and Advisories for Wednesday, August 10, 2022
_____
LOCAL AREA EMERGENCY
...DO NOT DRINK WATER ADVISORY...
The following message is transmitted at the request of FrioCo.
...A DO NOT DRINK WATER ADIVSORY is being issued for residents
using the DERBY WATER SYSTEM until further notice....
...DO NOT DRINK the WATER
Use Bottled Water for:
- Drinking and Cooking
- Brushing Teeth
- Washing Fruits and Vegetables
- Preparing Food
- Mixing Baby Formula
- Making Ice
- Giving Water to Pets...
-Drinking and Cooking
-Brushing Teeth
-Washing Fruits and Vegetables
-Preparing Food
-Mixing Baby Formula
-Making Ice
-Giving Water to Pets...
_____
Copyright 2022 AccuWeather | https://www.milfordmirror.com/weather/article/TX-WFO-AUSTIN-SAN-ANTONIO-Warnings-Watches-and-17365342.php | 2022-08-10T21:42:43Z | https://www.milfordmirror.com/weather/article/TX-WFO-AUSTIN-SAN-ANTONIO-Warnings-Watches-and-17365342.php | true |
SALT LAKE CITY, Aug. 10, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter ended June 30, 2022.
Recent Highlights:
- Executed on Sera's strategy of pursuing healthcare systems where administrative and clinical leadership are aligned on incorporating PreTRM testing efficiently as an add-on to comprehensive services provided to pregnant women.
- Contracted with several new self-insured employer plans to incorporate PreTRM testing as an advanced pregnancy benefit.
- Demonstrated improved performance of the PreTRM test over an expanded time window for collecting blood, now from 18-20 weeks, allowing physicians to more easily schedule patients for preterm risk evaluation.
- Showed a sensitivity of nearly 90% for spontaneous preterm delivery risk prediction and a very high negative predictive value of 99% in a patient whose PreTRM test is interpreted to be "Lower Risk".
- Streamlined operations to meet our commercial plans, expand adoption of the PreTRM® Test and enable the Company to extend its operations into 2026 without the need for additional financing.
"We see a sizeable opportunity to increase awareness of our PreTRM® Test and build adoption within a variety of health systems," said Gregory C. Critchfield, MD, MS, Chairman and CEO of Sera Prognostics. "As example of many such systems, we are making demonstrable progress in contracting with self-insured employers who become adopters because they see the immediate value in managing escalating healthcare costs and offering important benefits to attract and retain talented employees. We anticipate additional clinical and health economic publications that further illustrate the clinical utility and benefit of PreTRM® technology, supporting the achievement of our vision to improve the well-being of mothers and newborns and decreasing healthcare costs."
Second Quarter 2022 Financial Results
Second quarter 2022 revenue of $78,000 compared to $20,000 for the same period of 2021.
Total operating expenses were $11.8 million, up from $7.4 million for the second quarter of 2021.
Research and development expenses for the second quarter of 2022 were $3.3 million compared to $2.8 million for the second quarter of 2021 due primarily to increased laboratory operations and clinical study costs.
Selling, general and administrative expenses for the second quarter of 2022 were $8.5 million, up from $4.6 million for the year-ago period due primarily to increased headcount as the company has scaled its commercial operations and general corporate infrastructure, as well as increased costs related to operating as a public company since our initial public offering in July 2021. Selling and marketing expenses decreased in the second quarter of 2022 compared to the first quarter of 2022 as we took steps to streamline our sales force and focus our commercial strategy in response to market dynamics.
Net loss for the second quarter of 2022 was $11.5 million compared to $6.3 million for the same quarter a year ago.
As of June 30, 2022, the Company had cash, cash equivalents, and available-for-sale securities of approximately $121 million.
Conference Call Information
Sera Prognostics will host a corresponding conference call and live webcast today to discuss second quarter 2022 operational highlights, financial results and key topics at 5:00 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing the following:
US domestic callers: (866) 218-2405
International callers: (412) 902-6607
Webcast Registration Link: https://app.webinar.net/JMrRmxrD9Qj
Live audio of the webcast will be available online from the Investors page of the Company's website at www.seraprognostics.com. The webcast will be archived on the Investors page and will be available for one year.
About Sera Prognostics, Inc.
Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to deliver early, pivotal information in pregnancy to physicians, enabling them to improve the health of their patients, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera's precision medicine PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is located in Salt Lake City, Utah.
About Preterm Birth
Preterm birth is defined as any birth before 37 weeks' gestation and is the leading cause of illness and death in newborns. The 2021 March of Dimes Report Card shows that more than one in ten infants is born prematurely. Prematurity is associated with a significantly increased risk of major long-term medical complications, including learning disabilities, cerebral palsy, chronic respiratory illness, intellectual disability, seizures, and vision and hearing loss, and can generate significant costs throughout the lives of affected children. The annual health care costs to manage short- and long-term complications of prematurity in the United States were estimated to be approximately $25 billion for 2016.
About the PreTRM® Test
The PreTRM® test is the only broadly validated, commercially available blood-based biomarker test that provides an early, accurate and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies. The PreTRM® test measures and analyzes proteins in the blood that are highly predictive of preterm birth. The PreTRM® test permits physicians to identify, during the 19th or 20th week of pregnancy, which women are at increased risk for preterm birth, enabling more informed, personalized clinical decisions based on each woman's individual risk. The PreTRM® test is ordered by a medical professional.
Sera Prognostics, the Sera Prognostics logo, The Pregnancy Company, and PreTRM are trademarks or registered trademarks of Sera Prognostics, Inc. in the United States and/or other countries.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to healthcare systems aligning on incorporating PreTRM testing as an add-on to comprehensive services provided to pregnant women; expanded adoption of the PreTRM® Test; the Company extending its operations into 2026 without the need for additional financing; demonstrable progress in contracting with self-insured employers; additional clinical and health economic publications that further illustrate the clinical utility and benefit of PreTRM® technology; the Company's strategy, future operations, prospects, plans, objectives of management; the Company's planned conference call and live webcast to discuss the quarter's operational highlights, financial results and key topics; availability of audio of the webcast online from the Investors page of the Company's website; and the company's strategic directives under the caption "About Sera Prognostics, Inc." These "forward-looking statements" are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: net losses, cash generation, and the potential need to raise more capital; revenues from the PreTRM test representing substantially all Company revenues to date; the need for broad scientific and market acceptance of the PreTRM test; a concentrated number of material customers; our ability to introduce new products; potential competition; our proprietary biobank; critical suppliers; the ongoing COVID-19 pandemic and its impact on our operations, as well as the business or operations of third parties with whom we conduct business; estimates of total addressable market opportunity and forecasts of market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests and market position; and other factors discussed under the heading "Risk Factors" contained in our Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, or Current Reports on Form 8-K filed with the SEC from time to time. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.
View original content to download multimedia:
SOURCE Sera Prognostics, Inc. | https://www.ktre.com/prnewswire/2022/08/10/sera-prognostics-reports-second-quarter-2022-financial-results/ | 2022-08-10T21:43:11Z | https://www.ktre.com/prnewswire/2022/08/10/sera-prognostics-reports-second-quarter-2022-financial-results/ | true |
Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET
Corporate Highlights
- Celebrated 10th anniversary as a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies
- Added to Russell 3000® Index, Russell 2000® Index and Russell Microcap® Index
- During the second quarter of 2022, $2.6 million was funded to existing borrowers
- Subsequent to quarter end, closed a new transaction, deploying $5.0 million
- SWK well positioned for current capital markets environment with cash and unfunded credit facility availability totaling $77.1 million as of June 30, 2022
Finance Receivables Segment Update
- For the three months ended June 30, 2022, GAAP net income was $0.6 million, or $0.04 per diluted share, a 96.0% decrease from June 30, 2021
- As of June 30, 2022, non-GAAP tangible finance book value per share was $18.48, a 7.2% increase from June 30, 2021
- Second quarter 2022 finance portfolio effective yield was 14.2%, a 2.0% increase compared with 13.9% for the second quarter 2021
- Second quarter 2022 finance portfolio realized yield was 15.0%, a 790 bps year-over-year decrease
- Second quarter 2022 core finance receivables business adjusted non-GAAP net income was $4.6 million, a 50.3% decrease from the second quarter of 2021
- As of June 30, 2022, total investment assets were $181.4 million, a 14.8% decrease from June 30, 2021
- During the second quarter of 2022, $17.2 million of principal payments and royalty paydowns were received, bringing total loan and royalty repayments to $78.7 million over the last twelve months
- For the trailing twelve months ended June 30, 2022, SWK's core finance receivables segment generated a 12.1% adjusted return on tangible book value
DALLAS, Aug. 10, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided a business update and announced its financial and operating results for the second quarter ended June 30, 2022.
"Over the past several quarters, SWK has had several successful payoffs in the portfolio, which we believe provide a strong endorsement of the innovation we support through our investments. While this, combined with our disciplined underwriting philosophy, led to a material decline in the size of our aggregate portfolio and a corresponding decrease in revenues year over year, we believe our focused stewardship of our shareholders' capital has provided an important benefit going forward – well positioning our balance sheet for the current environment," stated Winston Black, Chairman and CEO of SWK. "During the second quarter, SWK evaluated numerous life science financing opportunities with a focus on high quality assets that, we believe, are positioned to weather the current market volatility and challenging capital market environment. We believe these efforts will lead to additional closed financings in the second half of 2022."
Mr. Black continued, "Our capital position is strong with $55.1 million in cash and an untapped $22.0 million credit facility as of June 30, 2022. Our current liquidity and anticipated debt capital raise efforts will give us greater capacity to execute on new investment opportunities where our creative, non-dilutive financing can accelerate the growth of small and mid-sized life sciences companies and fuel the development and commercialization of lifesaving and life-enhancing technologies. The stock repurchase program SWK re-instituted during the quarter also reflects the Board of Director's confidence in our strategy and financial position and illustrates our ongoing commitment to accretive capital deployment."
Mr. Black concluded, "At the close of the second quarter, SWK was added to the Russell 2000, 3000 and Microcap Indexes, a catalyst that should expand awareness of our company within the investment community, increase liquidity of our stock, and broaden our shareholder base. Further, we recently celebrated our 10th anniversary under our current business strategy. Reflecting on the past 10 years, I am pleased to note that since the fourth quarter of 2012 we have produced consistent returns on our investments and to our shareholders with our book value per share increasing at a 10% compound annual growth rate. Looking ahead, our strategy will continue to focus on identifying companies, technologies and intellectual property to which our investment vehicles are well-suited and where strong risk-adjusted returns are likeliest to be achieved, while working with the team at Enteris BioPharma to unlock additional opportunities for growth."
Second Quarter 2022 Financial Results
During the last twelve month period, there were $78.7 million of loan repayments and royalty paydowns, which were partially offset by $45.0 million of new investments. As a result, income-producing assets (defined as finance receivables and corporate debt securities) totaled $175.0 million as of June 30, 2022. This is a 13.9% decrease compared with income-producing assets of $203.2 million as of June 30, 2021. Total investment assets, which include income-producing assets plus equity-linked securities, totaled $181.4 million as of June 30, 2022, compared to the June 30, 2021 total investment assets of $213.0 million.
For the second quarter 2022, SWK reported total revenue of $6.9 million, a 68.8% decrease compared to $22.3 million for the second quarter 2021. The $15.4 million decrease in revenue consisted of a $10.3 million decrease in Pharmaceutical Development segment revenue, which included $10.0 million of milestone revenue related to Enteris' License Agreement with Cara Therapeutics, Inc. received during the three months ended June 30, 2021, which did not recur during the three months ended June 30, 2022. Finance Receivables segment revenue decreased $5.0 million year-over-year to $6.8 million, with the decrease consisting of a $3.1 million decrease in interest and fees earned on finance receivables that were either paid off or paid down since the second quarter of 2021 and a $4.0 million decrease in net royalty income primarily due to the achievement of return premiums that caused a step down in royalty rates. The decrease in revenue was partially offset by a $2.1 million increase in interest and fees earned due to funding new and existing loans.
Income before taxes for the quarter was $0.7 million compared to $17.5 million for the same period the previous year, a decrease of 96%. The year-over-year decrease is due to a $10.3 million decrease in income from our Pharmaceutical Development segment and a $5.0 million decrease in income from our Finance Receivables segment. The decrease in income before income taxes was also due to a $1.0 million net loss on the change in fair value of our warrant assets and marketable investments. The decrease was partially offset by a $0.5 million decrease in expenses.
GAAP net income for the quarter ended June 30, 2022, decreased 96% to $0.6 million, or $0.04 per diluted share, from $14.0 million, or $1.09 per diluted share for the second quarter 2021.
For the second quarter 2022, non-GAAP adjusted net income was $2.2 million, a decrease from $17.2 million for the second quarter 2021. Non-GAAP adjusted net income for the Finance Receivables segment was $4.6 million, a decrease from $9.3 million for the second quarter 2021.
Book value per share was $21.15 as of June 30, 2022, compared to $20.18 as of June 30, 2021. Tangible financing book value per share totaled $18.48 as of June 30, 2022, a 7.2% increase from $17.23 as of June 30, 2021. Management views tangible financing book value per share as a relevant metric to value the Company's core finance receivable business. Tangible book value per share removes the value of the deferred tax asset from the book value.
Tables detailing SWK's financial performance for the second quarter 2022 are below.
Portfolio Status
At the end of the second quarter 2022, the weighted average projected effective yield of 14.2% for the finance receivables portfolio, including non-accrual positions, increased from 13.9% for the same period of the previous year. The projected effective yield is the rate at which income is expected to be recognized pursuant to the Company's revenue recognition policies, if all payments are received pursuant to the terms of the finance receivables and excludes non-interest earning assets such as warrants and equity investments.
For the second quarter 2022, the realized yield of the finance receivables portfolio was 15.0%, versus 22.9% for the same period the previous year. The realized yield is inclusive of all fees, including all realized unamortized fees, amendment fees, and prepayment fees, and is calculated based on the simple average of finance receivables at the beginning and end of the period. The realized yield is greater than the effective yield due to actual cash collections being greater than modeled.
Non-accrual loans totaled $9.8 million, while non-accrual royalty purchases, net of credit loss allowances, totaled $3.1 million. The $9.8 million loan to Flowonix Medical Inc. remains on non-accrual, and SWK continues to work with the company to achieve a resolution.
Subsequent to quarter end, SWK deployed $5.0 million in a structured debt transaction to Exeevo, Inc., while SWK royalties Beleodaq® and Trio were fully satisfied by achieving their respective multiple of invested capital caps. As of August 9, 2022, SWK had $3.9 million of unfunded commitments.
Total portfolio investment activity for the three months ended June 30, 2022, and 2021 was as follows (in thousands):
Adjusted Non-GAAP Net Income
The following table provides a reconciliation of SWK's reported (GAAP) consolidated net income to SWK's adjusted consolidated net income (Non-GAAP) for the three-month period ended June 30, 2022 and 2021. The table eliminates provisions for income taxes, non-cash mark-to-market changes on warrant assets and equity securities, amortization of Enteris intangible assets and any non-cash impact on the remeasurement of contingent consideration.
In the table above, management has deducted the following non-cash items: (i) change in the fair-market value of equities and warrants, as mark-to-market changes are non-cash, (ii) income taxes, as the Company has substantial net operating losses to offset against future income, (iii) amortization expense associated with Enteris intangible assets, and (iv) (gain) loss on remeasurement of contingent consideration.
Finance Receivables Adjusted Non-GAAP Net Income
The following table provides a reconciliation of SWK's consolidated adjusted income before provision for income taxes, listed in the table above, to the non-GAAP adjusted net income for the Finance Receivable segment for the three-month period ended June 30, 2022 and 2021. The table eliminates Enteris operating (income) loss. The adjusted income before income taxes is derived in the table above and eliminates income tax expense, non-cash mark-to-market changes on warrant assets and equity securities.
Conference Call Information
SWK Holdings will host a conference call and live audio webcast on Thursday, August 11, 2022, at 10:00 a.m. ET, to discuss its corporate and financial results for the second quarter 2022. Interested participants and investors may access the conference call by dialing either:
(844) 378-6488 (U.S.)
(412) 317-1079 (International)
Passcode: 10166330
An audio webcast will be accessible via the Investors Events & Presentations section of the SWK Holdings' website: https://swkhold.investorroom.com/events. An archive of the webcast will remain available for 90 days beginning at approximately 11:30 a.m. ET, on August 11, 2022.
Non-GAAP Financial Measures
This release includes non-GAAP adjusted net income and non-GAAP finance receivable segment net income, which are metrics that are not compliant with generally accepted accounting principles in the United States (GAAP).
Non-GAAP adjusted net income is adjusted for certain items (including (i) changes in the fair-market value of public equity-related assets and SWK's warrant assets as mark-to-market changes are non-cash, (ii) income taxes as the Company has substantial net operating losses to offset against future income, (iii) changes in the fair-market value of contingent consideration associated with the Enteris acquisition as these changes are non-cash, and (iv) depreciation and amortization expenses, primarily associated with the Enteris acquisition.
In addition to the adjustments noted above, non-GAAP finance receivable segment net income also excludes Enteris operating losses.
Tangible financing book value per share excludes the deferred tax asset, intangible assets, goodwill, Enteris PP&E, and contingent consideration associated with the Enteris transaction. Adjusted return on tangible financing book value is calculated by dividing finance receivables segment adjusted non-GAAP net income by tangible financing book value.
These non-GAAP measures may not be directly comparable to similar measures used by other companies in our industry, as other companies may define such measures differently. Management believes that these measures are useful to investors and management in understanding our ongoing operations and in analysis of ongoing operating trends and provides useful additional information relating to our operations and financial condition. These metrics should be considered in addition to, and not as a replacement for, the most comparable GAAP measure.
About SWK Holdings Corporation
SWK Holdings Corporation is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK's business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. SWK also owns Enteris BioPharma, whose Peptelligence® and ProPerma® drug delivery technologies create oral formulations of peptide-based and BCS class II, III, and IV small molecules. With Enteris, SWK has the opportunity to grow its finance business by actively building a wholly-owned portfolio of milestones and royalties through licensing activities. Additional information on the life science finance market is available on the Company's website at www.swkhold.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
View original content:
SOURCE SWK Holdings Corporation | https://www.ktre.com/prnewswire/2022/08/10/swk-holdings-corporation-announces-financial-results-second-quarter-2022/ | 2022-08-10T21:43:54Z | https://www.ktre.com/prnewswire/2022/08/10/swk-holdings-corporation-announces-financial-results-second-quarter-2022/ | false |
All figures in USD unless stated otherwise
TORONTO, Aug. 10, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN) today announced that its Budega Hollywood Dispensary, the Company's first superstore, passed its Los Angeles Department of Cannabis Regulation (the "DCR") inspection and is expected to open in 2022. Given the larger square footage, the Company anticipates, after a ramp-up period, Budega Hollywood to be the Company's top grossing retail store with up to $15 million in annual sales per year.
CEO and Director Katie Field commented, "This is a significant milestone towards our third planned Budega opening in the Los Angeles market. It will be the first superstore format for Budega as well. As we complete the build-out of this flagship location, we plan to simultaneously prepare the groundwork for opening, including hiring, training, and back-end infrastructure. We are extremely pleased with the location and design for our flagship dispensary and look forward to welcoming Hollywood locals and tourists alike."
On Thursday, August 4, 2022, Budega Hollywood successfully passed the DCR's final site inspection and has been approved to proceed with the agency's final administrative review. Budega Hollywood has already obtained its state license. Once opened, the store will mark the Company's third Los Angeles dispensary.
The flagship Hollywood location is located at Franklin and Argyle, next to the 101 freeway, near the iconic Hollywood sign, and across Franklin from the famed Hollywood Tower. With ample parking, the site is strategically located, boasting high foot and car traffic accessible by locals and tourists alike. Additionally, the location features an iconic floral themed mural by Oakland artist Jet Martinez known for creating vibrant works of art that put a contemporary spin on folk art motifs.
Budega Hollywood will offer a leading, curated product assortment, including many top-tier California brands such as STIIIZY, Jungle Boys, Jeeter, 710 Labs, Alien Labs, Connected, Cookies, and Kiva, as well as highlight Budega's line of branded products, which remain the top-selling SKU's at the existing Budega locations. In addition, the store will also stock Halo's Hush™ branded cartridges, gummies, and pre-rolls. The store plans to operate Monday through Sunday from 7 a.m. to 10 p.m. Visit https://budega.com/ for more information or to place an order online.
California is the highest-grossing state for cannabis retail sales in the United States, with legal retail sales of $5.2 billion in 2021, up 17% from 2020. California is projected to gross $7 billion in cannabis retail sales by 2025.1
Halo is focused on the United States West Coast, where it has vertically integrated operations covering the entire value chain from seed to sale. Halo cultivates, extracts, manufactures, and distributes quality cannabis flower, pre-rolls, vape carts, edibles, and concentrates. Halo sells these products under a portfolio of brands, including Hush™, Winberry Farms™, Williams Wonder Farms, its retail brand Budega™, and license agreements with Papa's Herb®, DNA Genetics, and FlowerShop*. In addition, Halo has opened two dispensaries in Los Angeles under the Budega™ brand in North Hollywood and Hollywood, with plans to open one more in Hollywood in the third quarter of 2022.
In the non-THC sector, Halo is expanding into health and wellness categories, including CBD and functional supplements such as nootropic nutraceuticals and non-psychotropic mushrooms. Halo, through a series of acquisitions, has product offerings in the form of beverages (H2C Beverages), dissolvable strips (Dissolve Medical), capsules (Hushrooms™), and topical supplements (Hatshe) with proposed national distribution via a strategic agreement with SWAY Energy Corporation.
Halo has successfully acquired and integrated a variety of companies which were subsequently reorganized to create Akanda Corp. (NASDAQ:AKAN), an international medical cannabis and wellness company, of which Halo currently owns 12,674,957 common shares worth approximately US$15.8 million as of August 9, 2022. Halo has also acquired a range of software development assets, including CannPOS, Cannalift, CannaFeels, and a discrete sublingual dosing technology, Accudab. Halo intends to reorganize these entities (including their intellectual property and patent applications) into a subsidiary called Halo Tek Inc. and to complete the distribution of the shares of Halo Tek Inc. to shareholders on record at a date to be determined.
For further information regarding Halo, see Halo's disclosure documents on SEDAR at www.sedar.com.
_________________________
1 According to year-end data released Feb. 23 by the state's Department of Tax and Fee Administration (CDTFA).
Connect with Halo Collective: Email | Website | LinkedIn | Twitter | Instagram
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Halo's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Halo's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". Forward-looking information may relate to anticipated events or results including, but not limited to the planned commencement of operation at Budega Hollywood and management's plans regarding its portfolio of cannabis businesses.
By identifying such information and statements in this manner, Halo is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Halo has made certain assumptions. Although Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Among others, the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: inability of management to successfully integrate the operations of acquired businesses, changes in the consumer market for cannabis products, changes in the expected outcomes of the proposed changes to Halo's operations, delays in obtaining required licenses or approvals necessary for the build-out of the Company's cannabis operations, dispensaries or Canadian operations, the proposed spin-out with Halo Tek Inc., delays or unforeseen costs incurred in connection with construction, delays or unforeseen difficulties in connection with the cultivation and harvest of Halo's raw material, changes in general economic, business and political conditions, including changes in the financial markets; and the other risks disclosed in the Company's annual information form dated March 31, 2022 and other disclosure documents available on the Company's profile at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Halo does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Halo or persons acting on its behalf is expressly qualified in its entirety by this notice.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
View original content to download multimedia:
SOURCE Halo Collective Inc. | https://www.kold.com/prnewswire/2022/08/10/halo-collective-receives-all-regulatory-approvals-its-third-budega-dispensary-hollywood-halos-first-superstore/ | 2022-08-10T21:45:16Z | https://www.kold.com/prnewswire/2022/08/10/halo-collective-receives-all-regulatory-approvals-its-third-budega-dispensary-hollywood-halos-first-superstore/ | true |
Takes over responsibility from Scott Minder, who is leaving to pursue other opportunities
DALLAS, Aug. 10, 2022 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announced today that Tom Wright will assume interim responsibility for investor relations in addition to his current role as vice president, financial planning and analysis. Wright, who joined ATI earlier this year to lead corporate financial planning and analysis, will continue to report to Don Newman, executive vice president and chief financial officer.
Wright takes over responsibility from Scott Minder, who is leaving ATI to become chief financial officer with a leading public company. "Scott has been instrumental in connecting the investment community to our strategy of becoming an aerospace and defense leader and helping to improve ATI's capital structure, a key component of positioning ATI for growth," said Newman. "We appreciate his contributions and wish him much success in his new role."
ATI is working to identify a permanent investor relations leader.
ATI (NYSE: ATI) is a $3 billion global producer of high performance materials and solutions for the global aerospace and defense markets, and critical applications in electronics, medical and specialty energy. We're solving the world's most difficult challenges through materials science. We partner with our customers to deliver extraordinary materials that enable their greatest achievements: their products fly higher and faster, burn hotter, dive deeper, stand stronger and last longer. Our proprietary process technologies, unique customer partnerships and commitment to innovation deliver materials and solutions for today and the evermore challenging environments of tomorrow. We are proven to perform anywhere. Learn more at ATImaterials.com.
View original content to download multimedia:
SOURCE ATI | https://www.wistv.com/prnewswire/2022/08/10/tom-wright-named-interim-head-investor-relations/ | 2022-08-10T21:48:04Z | https://www.wistv.com/prnewswire/2022/08/10/tom-wright-named-interim-head-investor-relations/ | false |
How one California family helped win new benefits for sickened vets
Jennifer Kepner seemed like one of the healthiest people you could meet. She ran, she did CrossFit and she worked at the local hospital in Cathedral City.
Then her back started to hurt.
Doctors found a mass on her pancreas. But they couldn’t figure out why someone so healthy would’ve come down with pancreatic cancer, which is extremely rare in young people, at age 37. Eventually, an oncologist pointed to the one red flag in Jennifer’s otherwise pristine medical history: her proximity to a burn pit while she served as an Air Force medic at Balad Air Force Base in Iraq.
As Jennifer’s health failed, the Department of Veterans Affairs rejected request after request for benefits to support her treatment and her family, including her husband Ben and their two young children. The Department of Defense uses burn pits like the one at Jennifer’s base to dispose of chemicals, cans, tires, plastics, medical equipment and human waste. But the Kepners couldn’t convince the agency that Jennifer’s sickness was due to breathing in the burn pit’s toxic fumes.
Enraged by the VA’s reticence, Jennifer’s friends and coworkers reached out to local media and the couple’s member of Congress, Rep. Raul Ruiz (D-Palm Springs). In 2017, Ruiz met the Kepners at their kitchen table and vowed to ensure that their family, and families like them, receive the help they need.
Jennifer died Oct. 18, 2017, at the age of 37.
Shortly after Jennifer passed, the first check from the VA finally arrived at the Kepners home. “Her biggest fight was that she didn’t want other families to have to go through what we went through,” Ben Kepner told The Times. “It was a year-and-a-half battle while she was alive, dealing with her health, and then dealing with the VA as well. It was a year and a half of hell, with pretty much no help from the VA, which are the people that are supposed to take care of you. … That’s the last thing you want to deal with.”
After Jennifer’s death, Ben and Ruiz continued to work to ensure that other families don’t have to endure what she did.
On Wednesday, they celebrated a major victory as President Biden signed the $280-billion PACT Act into law at the White House. The measure directs the Veterans Affairs to presume that certain cancers and respiratory illnesses are related to burn pit exposure, allowing veterans to obtain disability payments without having to prove that their sickness is a result of their service, like the Kepners had to. One of the measures in the package, titled the Jennifer Kepner HOPE Act, will provide veterans exposed to burn pits eligibility for VA Healthcare.
“So many of you here today remind us that we have fought for this for so many years,” Biden said during the signing ceremony in the White House East Room. Biden’s elder son Beau died of cancer after deploying to Iraq. Beau “was lost to the same burn pits,” Biden said.
The new law removes the burden of proof that weighed down families like the Kepners, and was years in the making, Ruiz said. One of the primary hurdles he faced was a lack of definitive scientific proof to link illnesses with exposure to burn pits.
“There were hundreds of toxic chemicals, and there were known carcinogens, tested from the soils near the burn pits due to the smoke,” Ruiz said. “We do not have time for the 20-year double-cohort, longitudinal study to prove causality. … In this case, there was enough scientific suspicion and evidence in the literature and through the medical practice, that burn pits were causing a severe enough illness — people were dying, and still are — that we need to act on it.”
Six open-air burn pits remain in operation across Syria, Yemen, Iraq, Egypt and Chad, according to Ruiz’s office. Roughly 70% of disability claims related to burn pit exposure are denied by Veterans Affairs, which has cited a lack of evidence, scientific data and information from the Defense Department.
“Over 8 million veterans and families will be positively impacted,” Ruiz, who authored several of the burn pit provisions, said of the new law. “Their pain and suffering will be reduced because they will have access to healthcare, and their widows and families will be taken care of because they will receive their benefits.”
The legislation, which the Senate approved 86-11 earlier this month, is considered to be the largest expansion of veterans healthcare in decades. Hundreds of thousands of Vietnam War-era veterans and survivors will also benefit from the new law. It adds hypertension, or high blood pressure, as a presumptive disease associated with Agent Orange exposure.
Senators had approved the legislation in June, but had to vote again this month to approve a technical fix. Senate Republicans then blocked the bill from advancing, saying they wanted to change another part of the legislation. The delay outraged veterans groups and advocates, including comedian Jon Stewart, many of whom camped out at the Capitol in protest.
Ruiz and Kepner said that the bill is just one step toward greater justice. Both aim to see the Department of Defense cease its practice of using burn pits altogether. In the most recent National Defense Authorization Act, Ruiz secured language that directs the agency to seek alternatives to burn pits.
“My wife kind of started the phrase, that it’s this generation’s Agent Orange, and it truly is,” Kepner said. “This bill means the world to not just me, but everyone going through what we went through. … They served their country and were exposed to ridiculous, harmful carcinogens. It’s just unacceptable.”
Get Group Therapy
Life is stressful. Our weekly mental wellness newsletter can help.
You may occasionally receive promotional content from the Los Angeles Times. | https://www.latimes.com/politics/story/2022-08-10/california-family-va-benefits-burn-pits | 2022-08-10T21:49:30Z | https://www.latimes.com/politics/story/2022-08-10/california-family-va-benefits-burn-pits | true |
OKLAHOMA CITY, Aug. 10, 2022 /PRNewswire/ -- Riley Exploration Permian, Inc. (NYSE American: REPX) ("Riley Permian" or the "Company"), today reported financial and operating results for the fiscal third quarter ended June 30, 2022.
HIGHLIGHTS FOR THE FISCAL THIRD QUARTER ENDING JUNE 30, 2022
- Averaged oil production of 8.4 MBbls per day, which exceeds the high end of guidance and represents an increase of 24% as compared year-over-year to the fiscal third quarter 2021 and 12% as compared quarter-over-quarter to the fiscal second quarter 2022
- Reported net income of $39 million, which includes $13 million of non-cash gain on derivative contracts and income from operations of $63 million
- Generated $45 million of Adjusted EBITDAX(1) and $44 million of operating cash flow, representing an increase of 29% and 47%, respectively, over the prior quarter
- Incurred total accrual (activity-based) capital expenditures of $34 million and total cash capital expenditures of $37 million
- Paid dividends of $0.31 per share for a total of $6 million
- Reported proved reserves of 79 MMBoe (64% oil) with a standardized measure of future discounted cash flows of $1,046 million
- PV-10 value(1) of total proved reserves and total proved developed reserves of $1,098 million and $807 million, respectively, as of June 30, 2022 based on NYMEX strip pricing
"In the fiscal third quarter, we generated record oil production, revenue and operating cash flow," said Riley Permian Chairman and CEO, Bobby Riley. "Our cash flow benefited from a decreased impact of financial hedges this past quarter, and we see a continuation of that trend for the quarters and year ahead. We are experiencing increased costs like many other companies in our industry, but we are proud of our team's efforts to control costs where we can. Based on the strength of our fiscal third quarter production, and given modest increased activity plans, we are increasing previously released midpoint guidance for oil production for the fiscal fourth quarter by 6% and for the fiscal year by 4%. Related, we are increasing our midpoint guidance for fiscal year capital expenditures by approximately 5%, driven by increased activity and cost increases. We continue to return a substantial portion of our cash flow to shareholders in the form of dividends, and we see opportunity to pay down our debt in the coming quarters, further strengthening our balance sheet."
(1) Non-GAAP financial measure, which is defined and reconciled below.
OPERATIONS AND DEVELOPMENT ACTIVITY UPDATE
Riley Permian averaged oil production of 8.4 MBbls per day for the three months ended June 30, 2022, representing an increase of 24% as compared year-over-year to the fiscal third quarter 2021 and 12% as compared quarter-over-quarter to the fiscal second quarter 2022. The Company averaged total equivalent production of 10.2 MBoe per day for the three months ended June 30, 2022, an increase of 12% as compared to the same period in 2021 and 4% as compared to the prior quarter.
Oil production represented 82% of the total equivalent production for the fiscal third quarter of 2022, which compares to 77% of the total in the fiscal second quarter of 2022 and 74% in the fiscal third quarter of 2021. Such changes are not indicative of changing reservoir properties but rather reflect the impact of curtailed natural gas production. Beginning in February 2022 and continuing through the fiscal third quarter, the Company's primary midstream gas gathering and processing counterparty underwent a temporary curtailment and shutdown of their primary plant as part of an overall capacity expansion project. While the processing plant project was expected, the duration of the curtailment lasted longer than originally anticipated, which negatively impacted sales of natural gas and NGLs during this period and led to lower growth in natural gas and NGL sales volumes as compared to oil sales volumes.
The Company's development activity during the fiscal third quarter included drilling 5 gross (3.0 net) horizontal wells (scheduled for completion in fiscal fourth quarter 2022), turning to sales 5 gross (5.0 net) horizontal wells, drilling and completing 1 gross (1.0 net) saltwater disposal well and preparatory activity for 1 gross (1.0 net) horizontal well to be drilled and completed during the fiscal fourth quarter. This activity corresponds with previously provided guidance, with the exception that 1 gross (1.0 net) well previously planned for completion during the fiscal third quarter was officially completed and brought online during the fiscal fourth quarter, while capital expenditures were incurred for the well completion during the third quarter. Such activity corresponds with $30.8 million in accrual basis drilling, completions and facility capital expenditures, which also includes capitalized workovers, midstream infrastructure and minor additions to land and working interests.
The Company advanced its EOR pilot project in Yoakum County, Texas during the fiscal third quarter, completing an additional three of the remaining five injection wells. Such activity corresponded with $3.6 million of accrual basis capital expenditures for the quarter. Subsequent to quarter end, in July 2022, the Company completed the remaining two injection wells with water injection initiated on all six injection wells.
The Company incurred $34 million in total accrued capital expenditures for the three months ended June 30, 2022, which compares to the Company's previously released guidance of $28 million to $33 million. Overages on accrued capital expenditures compared to the Company's previously released guidance are primarily related to the accelerated timing of the saltwater disposal well drilled during the quarter, in addition to higher costs being realized. During the quarter, the average completed lateral length on the 5.0 horizontal wells turned to sales was approximately 7,100 feet, with drilling and completion costs of approximately $800 per completed lateral foot. The current costs per completed lateral length on similar wells has increased approximately 26% since the start of this fiscal year, with the largest increase being associated with completion costs. On a cash basis, the Company had total capital expenditures of $37 million for the three months ended June 30, 2022.
FINANCIAL RESULTS
For the three months ended June 30, 2022, the Company reported net income of $39 million and operating income of $63 million. The Company generated Adjusted EBITDAX(1) of $45 million, operating cash flow from continuing operations of $44 million and Free Cash Flow(1) of $7 million.
For the nine months ended June 30, 2022 (fiscal year to date), the Company reported net income of $53 million and operating income of $137 million. The Company generated Adjusted EBITDAX(1) of $106 million, operating cash flow from continuing operations of $97 million (inclusive of negative changes in working capital of $2 million) and Free Cash Flow(1) of $22 million. The pattern of the Company's development activity affects cash capital expenditures and may continue to cause fluctuations in Free Cash Flow(1) from quarter to quarter with longer periods more representative of Free Cash Flow(1) generation potential than an individual quarter.
(1) Non-GAAP financial measure, which is defined and reconciled below.
FINANCIAL RESULTS, Continued
Fiscal third quarter 2022 average realized prices, before derivative settlements were $108.41 per barrel of oil, $4.98 per Mcf of natural gas and $34.71 per barrel of natural gas liquids, resulting in a total equivalent price, before derivative settlements, of $94.80 per Boe. The Company benefited from a favorable $1.65 per barrel positive differential to the WTI index for the quarter. Adjusted for derivative settlements, total equivalent price was $66.97 per Boe, corresponding to realized derivative settlement losses of $27.83 per Boe or $25.8 million. The Company reported a $12.4 million loss on derivatives, which includes the $25.8 million loss on settlements and a $13.4 million non-cash gain due to changes in the fair value of derivatives. Total oil and natural gas sales revenue was $88 million for the fiscal third quarter 2022 with $62 million of oil and natural gas sales revenue net of derivative settlements, representing quarter-over-quarter increases of 32% and 28%, respectively, and year-over-year increases of 111% and 83%, respectively. For the quarter, oil revenue represented 94% of total revenue.
Riley Permian's total Cash Costs(1) for the fiscal third quarter of 2022 were $18.2 million, representing an increase of 25% compared to the fiscal second quarter of 2022. Lease operating expense ("LOE") was $8.1 million, corresponding to the low end of guidance and an 18% increase quarter-over-quarter. Workover activity was unusually high during the fiscal third quarter of 2022 with workover expense (a component of LOE) approximately $1.4 million higher than the average of the prior three quarters. Excluding workover expense, LOE was lower than the prior two quarters, despite materially increasing production. Cash G&A expense(1) was $3.9 million, which was at the low end of guidance. Interest expense was $0.7 million, essentially flat with interest expense for the fiscal second quarter of 2022. Production and ad valorem taxes increased 58% quarter-over-quarter as a result of higher commodity prices and an increase in our estimated property values, which increased our ad valorem tax estimate. Accordingly, increases in production and ad valorem taxes accounted for 55% of the total increase in Cash Costs quarter-over-quarter. Excluding production and ad valorem taxes, Cash Costs(1) increased 15% quarter-over-quarter, which is consistent with the 13% quarter-over-quarter increase in oil production.
Riley Permian increased margins significantly for the fiscal third quarter of 2022, as compared to prior periods. Higher production volumes and realized commodity prices more than offset the impacts from the natural gas curtailment, loss on settlements of derivatives and increased Cash Costs(1). Adjusted EBITDAX(1) increased 29% quarter-over-quarter while operating cash flow from continuing operations increased 47% quarter-over-quarter. Compared to the fiscal third quarter of 2021, Adjusted EBITDAX(1) increased by 98% and operating cash flow from continuing operations increased by 113%.
During the fiscal third quarter 2022, the Company paid common dividends of $0.31 per share or $6 million. Subsequent to the quarter end, the Company paid common dividends of $0.31 per share in August 2022.
The Company completed an amendment to its credit facility during the quarter which extended the maturity to April 2026 and increased the borrowing base to $200 million. As of August 8, 2022, we had $61 million drawn and $139 million, or approximately 70%, of availability on the credit facility.
(1) Non-GAAP financial measure, which is defined and reconciled below.
REVISED FISCAL FOURTH QUARTER 2022 OUTLOOK AND GUIDANCE
Based on current market conditions, the Company forecasts drilling 4 gross (3.2 net), completing 7 gross (4.2 net) and turning to production 7 gross (4.2 net) horizontal wells during the fiscal fourth quarter 2022. Additional scheduled activity includes capital workovers and midstream infrastructure. Management forecasts accrual basis capital expenditures related to such development activity of approximately $24 million to $28 million, which also includes estimates for anticipated non-operated drilling and completions, capital workovers, infrastructure, preparatory work for the fiscal 2023 development program and minor additions to land and existing working interests.
The Company forecasts fiscal fourth quarter 2022 oil production to average 8.2 MBbls per day to 8.6 MBbls per day, with the midpoint average representing 21% year-over-year growth. The midstream gas gathering and processing expansion project has been fully commissioned. Following completion of the expansion project in mid July, the Company has realized a larger volume of contractual, firm capacity, which has led to increased sales for natural gas and NGLs and reduced flaring. However, despite the physical and contractual increases in processing capacity, the Company is currently producing natural gas in excess of our contractual minimum processing capacity, which will lead to continued, partial curtailment. Based on estimates of available gas processing capacity, we forecast total equivalent production to average 11.1 MBoe per day to 11.6 MBoe per day for the fiscal fourth quarter.
The Company forecasts fiscal fourth quarter 2022 LOE of approximately $8.0 million to $10.0 million, with the low end corresponding to fiscal third quarter actual results and the high end accounting for costs associated with increased production volumes and inflationary pressures. We forecast Cash G&A expenses(1) for the fiscal fourth quarter of approximately $4.1 million to $4.7 million.
For its EOR pilot project, management forecasts spending approximately $4 million to $6 million of accrual basis capital expenditures in the fiscal fourth quarter related to completion of the remaining injection wells and the CO2 tap installation. Based on anticipated delivery timing of compressors needed for CO2 injection, the Company forecasts beginning CO2 injection during late 2022 (calendar fourth quarter 2022). Approximately $4 million of anticipated, accrual basis capital expenditures for our EOR program, previously estimated to be incurred during fiscal 2022, are now anticipated to be incurred in fiscal 2023.
In total, management forecasts total accrual basis capital expenditures of $28 million to $34 million for the fiscal fourth quarter 2022.
REVISED FISCAL YEAR 2022 OUTLOOK AND GUIDANCE
Incorporating actual, accrual basis capital expenditures to date for the fiscal year, and combined with revised fiscal fourth quarter guidance above, the Company forecasts full-year fiscal 2022 accrual basis capital expenditures to total approximately $109 million to $115 million, with modest upward revisions from previously provided estimates of $102 million to $111 million.
This total includes estimates of $93 million to $97 million for drilling and completions, which compares to previous guidance of $84 million to $89 million. We are forecasting an annual total of 19 gross (15.0 net) wells drilled, completed and brought online during fiscal year 2022. The forecasted capital expenditures include $16 million to $18 million for our EOR program, down from $18 million to $22 million forecasted previously.
We forecast full-year fiscal 2022 oil production to average 7.8 MBbls per day to 7.9 MBbls per day (corresponding to approximately 2.9 MMBbls), representing 22% to 24% growth from fiscal year 2021 average oil production and corresponding with upward revisions from previously provided growth estimates of 17% to 22% during the prior quarter. Further, we forecast that full-year fiscal 2022 total equivalent production could average 10.3 MBoe per day to 10.4 MBoe per day.
(1) Non-GAAP financial measure, which is defined above.
CONFERENCE CALL
Riley Permian management will host a conference call for investors and analysts on August 11, 2022 at 10:00 a.m. CT to discuss the Company's results. Interested parties are invited to participate by calling:
- U.S./Canada Toll Free, (888) 330-2214
- International, +1 (646) 960-0161
- Conference ID number 5405646
An updated company presentation, which will include certain items to be discussed on the call, will be posted prior to the call on the Company's website (www.rileypermian.com). A replay of the call will be available until August 25, 2022 by calling:
- (800) 770-2030 or (647) 362-9199
- Conference ID number 5405646
About Riley Exploration Permian, Inc.
Riley Permian is a growth-oriented, independent oil and natural gas company focused on the acquisition, exploration, development and production of oil, natural gas and natural gas liquids. For more information, please visit www.rileypermian.com.
Investor Contact:
Rick D'Angelo
405-438-0126
IR@rileypermian.com
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The statements contained in this release that are not historical facts are forward-looking statements that represent management's beliefs and assumptions based on currently available information. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, need for financing, competitive position and potential growth opportunities. Our forward-looking statements do not consider the effects of future legislation or regulations. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words "believes," "intends," "may," "should," "anticipates," "expects," "could," "plans," "estimates," "projects," "targets," "forecasts" or comparable terminology or by discussions of strategy or trends. You should not place undue reliance on these forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this release are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved or occur, and actual results could differ materially and adversely from those anticipated or implied by the forward-looking statements.
Among the factors that could cause actual future results to differ materially are the risks and uncertainties the Company is exposed to. While it is not possible to identify all factors, we continue to face many risks and uncertainties including, but not limited to: the volatility of oil, natural gas and NGL prices; the scope, duration, and reoccurrence of any epidemics or pandemics (including, specifically, the coronavirus disease 2019 ("COVID-19") pandemic and any related variants), including reactive or proactive measures taken by governments, regulatory agencies and businesses related to the pandemic, and the effects of COVID-19 on the oil and natural gas industry, pricing and demand for oil and natural gas and supply chain logistics; regional supply and demand factors, any delays, curtailment delays or interruptions of production, and any governmental order, rule or regulation that may impose production limits; cost and availability of gathering, pipeline, refining, transportation and other midstream and downstream activities; severe weather and other risks that lead to a lack of any available markets; our ability to successfully complete mergers, acquisitions and divestitures; the risk that the Company's EOR project may not perform as expected or produce the anticipated benefits; risks relating to our operations, including development drilling and testing results and performance of acquired properties and newly drilled wells; any reduction in our borrowing base on our revolving credit facility from time to time and our ability to repay any excess borrowings as a result of such reduction; the impact of our derivative strategy and the results of future settlement; our ability to comply with the financial covenants contained in our credit agreement; conditions in the capital, financial and credit markets and our ability to obtain capital needed for development and exploration operations on favorable terms or at all; the loss of certain tax deductions; risks associated with executing our business strategy, including any changes in our strategy; inability to prove up undeveloped acreage and maintain production on leases; risks associated with concentration of operations in one major geographic area; legislative or regulatory changes, including initiatives related to hydraulic fracturing, emissions, and disposal of produced water, which may be negatively impacted by regulation or legislation; the ability to receive drilling and other permits or approvals and rights-of-way in a timely manner (or at all), which may be restricted by governmental regulation and legislation; risks related to litigation; evolving geopolitical and military hostilities in other areas of the world; and cybersecurity threats, technology system failures and data security issues. Additional factors that could cause results to differ materially from those described above can be found in Riley Permian's Annual Report on Form 10-K for the year ended September 30, 2021 filed with the SEC and available from the Company's website at www.rileypermian.com under the "Investor" tab, and in other documents the Company files with the SEC.
The forward-looking statements in this press release are made as of the date hereof and are based on information available at that time. The Company does not undertake, and expressly disclaims, any duty to update or revise our forward-looking statements based on new information, future events or otherwise.
Cautionary Statement Regarding Guidance
The estimates and guidance presented in this release are based on assumptions of current and future capital expenditure levels, prices for oil, natural gas and NGLs, available liquidity, indications of supply and demand for oil, well results, and operating costs. The guidance provided in this release does not constitute any form of guarantee or assurance that the matters indicated will be achieved. While we believe these estimates and the assumptions on which they are based are reasonable as of the date on which they are made, they are inherently uncertain and are subject to, among other things, significant business, economic, operational, and regulatory risks, and uncertainties, some of which are not known as of the date of the statement. Guidance and estimates, and the assumptions on which they are based, are subject to material revision. Actual results may differ materially from estimates and guidance. Please read the "Cautionary Statement Regarding Forward-Looking Information" section above, as well as "Risk Factors" in our annual report on Form 10-K and our quarterly reports on Form 10-Q, which are incorporated herein.
Cautionary Statement Regarding Reserves
The reserves information as of June 30, 2022 in this press release, including standardized measure of future discounted cash flows and PV-10 value are preliminary estimates that have not been audited or reviewed by Netherland, Sewell & Associates, Inc. or BDO USA, LLP and are subject to material revision. These are estimates that should not be regarded as a representation. Investors should not place undue reliance on these estimates.
Source: Riley Exploration Permian, Inc.
OIL, NATURAL GAS AND NGL RESERVES
The Company prepared estimates of reserves using an average price equal to the unweighted arithmetic average of the first day of each month within the 12-month period ended June 30, 2022 of $85.82 per Bbl for oil and $4.13 per Mcf for gas in accordance with SEC guidelines. The Company also prepared estimates of proved reserves as of June 30, 2022 using NYMEX pricing. Netherland, Sewell & Associates, Inc. ("NSAI") is the Company's third-party reservoir engineer, which prepares estimates of the Company's proved reserves annually as of its fiscal year-end, in accordance with the rules and regulations of the SEC. NSAI has not reviewed our proved reserves at June 30, 2022 using SEC or NYMEX pricing. A summary of these internal estimates as of June 30, 2022 is presented below.
OIL, NATURAL GAS AND NGL RESERVES, Continued
Estimates of reserves were prepared using an average price equal to the unweighted arithmetic average of the first day of each month within the 12-month period ended September 30, 2021 of $57.64 per Bbl for oil and $2.94 per Mcf for gas in accordance with SEC guidelines. Additionally, the Company prepared estimates of proved reserves as of September 30, 2021 using NYMEX pricing. The table below presents a summary of our proved reserves as of September 30, 2021.
Reserve estimates above do not include any value for probable or possible reserves that may exist, nor do they include any value for undeveloped acreage. The reserve estimates represent our net revenue interest in our properties, all of which are located within the continental United States. NYMEX pricing does not comport with the reporting requirements of the SEC and should not be used as a substitute for or compared with estimates of proved reserves using SEC pricing.
DERIVATIVE CONTRACTS
The following table summarizes the open financial derivatives as of August 8, 2022, related to oil and natural gas production. Derivative positions in the table for calendar Q3 2022 are as of June 30, 2022(1).
NON-GAAP MEASURES
The Company presents certain non-GAAP financial measures to supplement its financial statements prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). The non-GAAP financial measures include Adjusted Net Income, Adjusted EBITDAX, Cash G&A, Cash Costs and Cash Margin per Boe, Free Cash Flow and PV-10. A reconciliation of each non-GAAP measure to the most directly comparable GAAP financial measure is presented below.
We believe that these non-GAAP measures presented, in conjunction with our financial and operating results prepared in accordance with GAAP, provide a more complete understanding of the Company's performance. We use these non-GAAP measures to compare our financial and operating performance with that of other companies in the oil and natural gas industry as well as our financial and operating performance for current and historical periods. These non-GAAP measures should not be considered in isolation or as a substitute for GAAP measures, such as net income (loss), operating income (loss), total costs and expenses, general and administrative expenses, net cash provided by operating activities or standardized measure of discounted future net cash flows or any other GAAP measure of financial position or results of operations.
As not all companies use the same calculation, our non-GAAP measures may not be comparable to similarly titled measures presented by other companies.
Adjusted Net Income: We define Adjusted Net Income as net income (loss) plus loss on discontinued operations, non-cash (gain) loss on derivatives, transaction costs and other, income tax expense related to our change in tax status and the changes in estimated income tax as a result of these adjustments. We believe that Adjusted Net Income is a widely followed measure of operating performance and is one of many metrics used by investors as well as our management team. For example, Adjusted Net Income can be used to assess our operating performance and return on capital in comparison to other independent exploration and production companies without regard to financial or capital structure and to assess the financial performance of our assets and our company without regard to capital structure or historical cost basis. The following table provides a reconciliation of Net Income (Loss) to Adjusted Net Income for the periods indicated:
Adjusted EBITDAX: We define Adjusted EBITDAX as net income (loss) adjusted for loss on discontinued operations, exploration costs, depletion, depreciation, amortization and accretion, equity-based compensation expense, interest expense, non-cash (gain) loss on derivatives, income taxes and transaction costs and other. We believe Adjusted EBITDAX is useful to investors because it provides an effective way to evaluate our operating performance and compare the results of our operations from period to period as well as to other companies in the oil and natural gas industry without regard to our financing methods or capital structure. The following table provides a reconciliation from the GAAP measure of Net Income (Loss) to Adjusted EBITDAX.
Cash G&A: Cash G&A is defined as general and administrative expense, excluding equity-based compensation, plus cost of contract services–related parties less contract services–related parties revenue. We believe Cash G&A is used by analysts and others in valuation, comparison and investment recommendations of companies in our industry to allow for analysis of Cash G&A spend without regard to equity-based compensation programs or amounts related to contract services. Administrative costs exclude equity-based compensation as those expenses are presented separately as components of general and administrative expense on our condensed consolidated statement of operations. The following table provides a calculation of Cash G&A for the periods indicated:
Cash Costs and Cash Margin per Boe: Cash Costs is a non-GAAP financial measure that we use as an indicator of our total cash-based cost of production and operations. We define Cash Costs as lease operating expenses plus production and ad valorem taxes, Cash G&A(1), and interest expense. Management believes that Cash Costs is an important financial measure for use in evaluating the Company's operating and financial performance and for comparison to other companies in the oil and natural gas industry. We also believe this is a useful measure for investors in evaluating our results against other oil and natural gas companies. Cash Costs should be considered in addition to, rather than as a substitute for, Total Costs and Expenses on our condensed consolidated statement of operations. The following table provides a calculation of Cash Costs and Cash Margin for the periods indicated:
Free Cash Flow: Free Cash Flow is a measure that we use as an indicator of our ability to fund our development activities and generate excess cash for other corporate purposes. We define Free Cash Flow as Net Cash Provided by Operating Activities, before changes in working capital and reduced by capital expenditures before acquisitions. Free Cash Flow should be considered in addition to, rather than as a substitute for, net cash provided by operating activities as a measure of our liquidity. The following table provides a reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow for the periods indicated:
PV-10: PV-10 is derived from the standardized measure of discounted future net cash flows ("Standardized Measure"), which is the most directly comparable financial measure under GAAP. PV-10 is a computation of the Standardized Measure on a pre-tax basis. PV-10 is equal to the Standardized Measure at the applicable date, before deducting future income taxes, discounted at an annual rate of 10%, determined in accordance with GAAP. We believe that the presentation of PV-10 is relevant and useful to investors because it presents the discounted future net cash flows attributable to our estimated net proved reserves prior to taking into account future corporate income taxes, and it is a useful measure for evaluating the relative monetary significance of our oil and natural gas properties. We believe that securities analysts and rating agencies use PV-10 in similar ways. Further, investors may utilize the measure as a basis for comparison of the relative size and value of our estimated reserves to other companies. We use this measure when assessing the potential return on investment related to our oil and natural gas properties. PV-10, however, is not a substitute for the Standardized Measure. Our PV-10 and the Standardized Measure do not purport to present the fair value of our estimated oil and natural gas reserves.
The following table provides a reconciliation of the Standardized Measure to PV-10 of the Company's estimated total proved reserves as of June 30, 2022 and September 30, 2021:
View original content to download multimedia:
SOURCE Riley Exploration Permian, Inc. | https://www.wflx.com/prnewswire/2022/08/10/riley-permian-reports-fiscal-third-quarter-2022-financial-operating-results/ | 2022-08-10T21:49:45Z | https://www.wflx.com/prnewswire/2022/08/10/riley-permian-reports-fiscal-third-quarter-2022-financial-operating-results/ | false |
Customer examples of the Mercedes-Benz AMG One hypercar are now in production at a dedicated facility in Coventry, U.K., five years after the car was first shown.
Just 275 will be built, and the first will be delivered to its owner in the second half of 2022. All build slots are gone, even with the starting price set at a lofty 2.275 million euros (approximately $2.3 million).
Given the close relationship between the One and Mercedes’ Formula 1 cars (the engine is common, after all), it shouldn’t be a surprise the hypercar is built in the U.K. Mercedes’ F1 team may race under a German license but the team is very much based in the U.K. The race cars are built in Brackley, northwest of London, while the power units are sourced from nearby Brixworth.
MercedesâBenz AMG High Performance Powertrains, which develops and builds the power units for the F1 cars, also builds the One’s powertrain. Interestingly, the Brixworth-based outfit has been involved in the One project right from the start. In fact, the project initially came to life in 2015 when former AMG chief Tobias Moers asked Andy Cowell, who until 2020 was responsible for the F1 team’s power units, whether the engine in the F1 cars could be used in a road car.
The engine is a turbocharged 1.6-liter V-6, specifically the design from Mercedes’ championship-winning race car from the 2015 F1 season. But the rest of the One’s powertrain is actually more sophisticated than in the F1 car. While in the race car there’s only the turbo V-6 and a motor-generator driving the rear wheels, plus a second motor-generator integrated with the turbocharger, the One has two additional motor-generators. These drive each of the front wheels and provide the One with all-wheel drive. Peak output is 1,049 hp, though the car is relatively heavy for a two-seater, weighing in at 3,737 lb, or close to the weight of a Ford Mustang GT.
As for the rest of the One’s production, AMG worked closely with Canada’s Multimatic, the same company that built the Ford GT, to source the carbon-fiber monocoque with a bonded-in roof, and establish the car’s production line. It takes around 50 people to build each of the cars, and that doesn’t include the powertrain. There are 16 key steps to each build, starting with the assembly of key components and ending with a wet weather test and final drive. After each step, there are multiple quality checks, the results of which are recorded in detail in documentation of the production process.
Once everything is complete, the cars are wrapped in protective material for transport and shipped via truck to AMG’s headquarters in Affalterbach, Germany, for delivery. Note that even though many build slots went to customers in the U.S., AMG wasn’t able to certify the car and its finicky engine for sale here without a substantial loss in performance. Fortunately there is some hope for U.S. customers looking to bring home their Ones in the form of the Show or Display rule. Under the rule, non-U.S. certified cars with historical or technological significance can be granted permission for private import, albeit with restrictions, such as annual mileage limited to 2,500 miles.
Performance estimates for the One include a 0-62 mph time in 2.9 seconds and a top speed capped at 219 mph, likely due to the aerodynamics. A production car lap record of the Nürburgring is also likely. The time to beat is the 6:43.61 set by AMG’s GT Black Series in 2020.
Related Articles
- Hennessey Venom F5 Roadster teased, debuts Aug. 19
- Baidu’s self-driving taxis deliver rides without safety driver in China
- More than 23,000 Ferraris recalled because of possible brake failure
- VW Group picks Innoviz for lidar and perception software
- McLaren F1 with one-off headlights is for sale | https://www.myarklamiss.com/automotive/internet-brands/1049-hp-mercedes-benz-amg-one-starts-production-in-uk/ | 2022-08-10T21:55:17Z | https://www.myarklamiss.com/automotive/internet-brands/1049-hp-mercedes-benz-amg-one-starts-production-in-uk/ | true |
BOISE, Idaho (AP) — U.S. officials won’t approve a natural gas pipeline from Idaho to Wyoming until additional environmental studies are completed.
A U.S. District Court on Wednesday approved an agreement between the U.S. Forest Service and two environmental groups that filed a lawsuit to stop the 50-mile (80-kilometer) Crow Creek Pipeline Project.
The Forest Service agreed to complete a supplemental environmental impact statement before authorizing the project that partially crosses Forest Service land. The timeline for completing the environmental study isn't clear.
Wyoming-based Lower Valley Energy wants to build the pipeline that would start near Montpelier, Idaho, and run to Afton, Wyoming. But the Alliance for the Wild Rockies and Yellowstone to Uintas Connection say it will harm protected grizzly bears and other wildlife.
"The ruling is a huge victory for the climate as well as free-roaming endangered species like grizzly bears, wolverines, and lynx,” said Mike Garrity, executive director of the Alliance for the Wild Rockies.
A lawsuit the groups filed in 2020 contended an 18-mile (29-kilometer) portion of the pipeline would cut a corridor through Caribou-Targhee National Forest and create a road through six roadless areas. The 2001 Roadless Rule prevents road construction and timber harvest in designated roadless areas, which are typically 5,000 acres (2,000 hectares) or larger.
The environmental groups argued the pipeline corridor would be a permanent motorized trail through the roadless areas.
"This unique area that links the Northern and Southern Rocky Mountains must be protected and managed as a wildlife corridor for our endangered wildlife species,” said Jason Christensen, director of Yellowstone to Uintas Connection.
Lower Valley Energy — which intervened in the case on the side of the Forest Service, as did the state of Wyoming — has previously said it has been trucking natural gas to Afton, but that delivery has been unreliable and the town has sometimes nearly run out.
Lower Valley Energy spokesman Brian Tanabe didn’t immediately return a call Wednesday from The Associated Press.
The Forest Service, before the lawsuit, approved building the pipeline through the forest with a temporary 50-foot (15-meter) wide right-of-way for construction and then a 20-foot (6-meter) utility corridor as a permanent right-of-way. In all, the construction phase would use about 110 acres (45 hectares) of forest land and the permanent right-of-way about 45 acres (18 hectares).
About 26 miles (40 kilometers) of the pipeline crosses private land and about 4 miles (6 kilometers) crosses state land. | https://www.ourmidland.com/news/article/Idaho-Wyoming-natural-gas-pipeline-needs-17365358.php | 2022-08-10T21:55:57Z | https://www.ourmidland.com/news/article/Idaho-Wyoming-natural-gas-pipeline-needs-17365358.php | true |
Decatur's evening forecast: Clear skies. Low 61F. Winds light and variable. Hot temperatures are predicted tomorrow. It looks to reach a warm 84 degrees. Expect a drastic drop in temperatures though, with a low reaching 58 degrees. Tomorrow's conditions are expected to be clear, so there shouldn't been too many clouds in the sky. Tomorrow's UV index is high. Be careful outside, especially during late morning through mid-afternoon. If your shadow is shorter than you, seek shade and wear protective clothing and generously apply sunscreen on exposed skin. The area will see gentle winds tomorrow, with winds only reaching 9 miles per hour, coming from the north. This report is created automatically with weather data provided by TownNews.com. For more daily forecast information, visit herald-review.com.
Aug. 10, 2022 evening weather update for Decatur and Macon County
Related to this story
Most Popular
Wind gusts to more than 60mph down trees and power lines.
National Weather Service has issued a thunderstorm watch through Wednesday evening and a flood watch until Thursday morning for portions of Central Illinois.
No damaging wind or hail, but heavy rain is once again expected in spots this morning thru the evening across Illinois. Isolated flooding is possible. Hour by hour timing and forecast rainfall here.
Watch now: Flooding possible again in southern Illinois Friday, isolated storms for central Illinois
Heavy rain in spots could cause additional flooding in southern Illinois this afternoon. Track the rain today and see what Saturday and Sunday are looking like across Illinois in our latest forecast.
Decatur folks should be prepared for high temperatures. It looks to reach a balmy 83 degrees. Today's forecasted low temperature is 70 degrees…
Decatur folks should be prepared for high temperatures. It looks to reach a warm 87 degrees. We'll see a low temperature of 72 degrees today. …
Decatur folks should be prepared for high temperatures. Temperatures are projected to be a steamy day today with temperatures reaching a high …
Decatur folks will see warm temperatures today. It looks like it will be a pleasant 79 degrees. We'll see a low temperature of 62 degrees toda…
The Biden administration cited heat waves and the warming climate as serious health threats. Here's what you should know about heat and health.
Decatur folks should be prepared for high temperatures. It looks like it will be a balmy 88 degrees. 66 degrees is today's low. Don't leave th… | https://herald-review.com/weather/aug-10-2022-evening-weather-update-for-decatur-and-macon-county/article_438491a7-d00e-5ccb-8e3e-6b6d4fe20ebd.html | 2022-08-10T21:57:25Z | https://herald-review.com/weather/aug-10-2022-evening-weather-update-for-decatur-and-macon-county/article_438491a7-d00e-5ccb-8e3e-6b6d4fe20ebd.html | true |
This is a carousel. Use Next and Previous buttons to navigate
CHARLOTTE, N.C. (AP) — Kurt Busch said Wednesday he pushed himself too hard trying to return to NASCAR competition and will miss his fourth consecutive Cup Series race because of concussion-like symptoms.
Busch has been out since crashing in qualifying on July 23 at Pocono Raceway. He had hoped to be back in the No. 45 Toyota for 23XI Racing on Sunday at Richmond Raceway.
“Brain injury recovery doesn't always take a linear path. I've been feeling well in my recovery, but this week I pushed to get my heart rate and body in a race simulation type environment, and it's clear I'm not ready to be back in the race car,” Busch wrote on Twitter.
“This was by far the hardest week emotionally because I do feel the progression of recovery, but racing requires an extreme physical and mental effort, and my body is not 100% able to sustain the intense race conditions.”
Ty Gibbs will again replace Busch in the car.
Gibbs, the 19-year-old grandson of Joe Gibbs, scored his first career top-10 Cup finish on Sunday when filling in for Busch at Michigan. He has finished 16th, 17th and 10th in his three races as a substitute.
Busch has a waiver to hold his spot in NASCAR’s playoff field should he qualify. He has a spot based on his May victory at Kansas, but he's dropped from 14th to 20th in the standings while sidelined.
Should there be two more first-time Cup winners this season over the next three races, Busch could find himself knocked from one of the 16 playoff spots.
___
More AP auto racing: https://apnews.com/hub/auto-racing and https://twitter.com/AP_Sports | https://www.ourmidland.com/sports/article/Busch-to-miss-4th-NASCAR-race-with-17365297.php | 2022-08-10T21:57:40Z | https://www.ourmidland.com/sports/article/Busch-to-miss-4th-NASCAR-race-with-17365297.php | true |
Though she’s written songs for as long as she can remember, Chrissy Metz, who played Kate Pearson on NBC’s Emmy-winning series “This is Us,” hadn’t ever pursued a career in music.
It was “something I always wanted to do, but didn’t know how in the world I would ever do it,” she said.
Then, during the 2019 Billboard Music Awards, Kelly Clarkson’s musical director Jason Halbert served as “the catalyst.” He approached “and said: ‘You don’t know me, and you probably think I’m crazy, but, literally, I heard a voice say: Help her with her music,’ ” Metz, 41, recalled.
Advertisement
Halbert “set me up in Nashville when I didn’t know anybody, and I’m just so grateful. The universe works in such incredible ways.”
So after six seasons of making viewers cry on “This is Us,” Metz is working on her debut country album, and she’s hitting the road for her debut concert tour. Ahead of her show at Boston’s City Wintery Aug. 14, she spoke to the Globe by phone from her home in Nashville.
Q. Singing was your first love, before acting.
A. Yeah, a lot of people don’t know that. I’ve been songwriting for, gosh, as long as I can remember, but extensively, probably, the past six years. I realized there was so much healing that needed to happen. I find that through music.
Q. How did you get into acting?
A. I went to an open-call at a Holiday Inn in Gainesville, Florida, where I’m from, because my sister heard an ad on the radio and was interested in modeling. They were looking for actors, comedians, models. I was maybe 19 or 20. My sister’s like “Please just take me,” so I’m like, “Fiiiine.”
Q. [laughs] Right.
A. The woman who was conducting the talent search said, “What are you doing?” I was teaching preschool at the time, but I was always doing impressions, wanting to tell stories; in high school I was the class clown. But I never thought I’d be an actor. [But] she wanted to sign me. [I] moved out to [LA] for pilot season. Then my talent agent needed an assistant. My manager said, “I really think you should take this job.” And I’m like: “Wait. What about acting?”
Advertisement
So for 9 years, I was an assistant, a junior agent, then a talent agent. I’m so grateful I had that experience, but it was a longer detour than I expected. [laughs]
Q. How did you get on “This is Us” from there?
A. A co-worker and I would watch out for each other, and she said, “I think this is a role you should audition for.” I said, “There’s no way I’m going to audition for a series-lead in a television show. I’ve never even tested for a TV show. No way.” Even talking to you about it, I’m like: What in the world?
Q. Have viewers told you the show changed their lives?
A. All the time. . They share stories about their adoption processes, their battle with weight, their self-esteem, relationships with their kids, how their parents are going through an illness — anything and everything. As an actor you just want to relate to people, connect to people. To be able to do it in such a beautiful, real way is such a gift.
Advertisement
Q. You also sang on the show.
A. I did! That wasn’t even planned. I remember getting this script and I was like wait, Kate’s gonna sing? And [creator/executive producer/writer] Dan [Fogelman] said: “Oh, if you don’t feel comfortable singing…” and I’m like, “No, no, no, I want to sing!”
Q. Did Mandy Moore give you any advice?
A. She’s always been so respectful and so complimentary, and said “Chrissy, you can do anything you want to do. You just have to do what makes you happy.” And we all know that, but we need, sometimes, another person to say that. And when it’s Mandy Moore, you really do listen.
Q. You also wrote a bestseller, “This Is Me: Loving the Person You Are Today,”
A. [When it was suggested] I said, “I don’t think I have anything to say,” and my agent was like, “I think you have a lot to say.” When I was going through my meditation and journaling I realized ... everybody deserves to tell their story. It was really about my life lessons, and what I’ve learned so far.
That’s the impetus for a lot of the songs on this tour — love, loss, healing through my feelings, and understanding that the only way to get on the other side of something is to go through it, and boy, that’s tough.
Q. Can you describe any struggles that prompted the book and songs?
Advertisement
A. So I had a pretty tumultuous childhood. My parents divorced when I was young, my mom remarried, and I love my stepfather very much but we did not get along for quite some time. He was very hard on me growing up and it really affected a lot of my self-confidence or lack of, and my self-esteem. And having to come out of the other side of that and realize that hurt people hurt people. So I wrote a song called “Broken Hearts Break Things.” It’s really about hurt people hurting people — it’s really not personal although it feels that way.
Q. Is there a song you feel closest to, or you feel encapsulates your story the most?
A. Oh boy. I wrote a song about [my boyfriend] Bradley [Collins] called “New Love.” New love doesn’t have to be a significant other — it could be your relationship with yourself. To really love yourself is an act of rebellion these days.
Q. You and Bradley met at the start of the pandemic.
A. We did, on Bumble. [laughs] It’s been almost two-and-a-half years, which is really great. He’s a very calm, cool, collected guy. So it’s a great match.
Q. Will you continue acting?
A. Oh yeah, music, acting are never going to stop. I just finished a psychological horror [film] over the summer. That was very different from Kate Pearson.
Interview has been edited and condensed.
At City Winery Boston, Aug. 14. 6 p.m. doors, 8 p.m. show. Tickets from $28, citywinery.com/boston.
Advertisement
Lauren Daley can be reached at ldaley33@gmail.com. Follow her on Twiiter @laurendaley1. | https://www.bostonglobe.com/2022/08/10/arts/chrissy-metz-this-is-us-brings-country-songs-city-winery-aug-14/ | 2022-08-10T21:59:38Z | https://www.bostonglobe.com/2022/08/10/arts/chrissy-metz-this-is-us-brings-country-songs-city-winery-aug-14/ | false |
Olivia Newton-John's husband John Easterling pays tribute to late 'Grease' star
Olivia Newton-John's husband John Easterling spoke about the love he and the 'Grease' star shared
Olivia Newton-John's husband John Easterling is speaking out about the late "Grease" star's death, releasing a statement on Newton-John's official social media accounts on Wednesday.
Easterling wrote about the love they shared and how it always came easy for them.
"Our love for each other transcends our understanding. Every day we expressed our gratitude for this love that could be so deep, so real, so natural. We never had to ‘work’ on it," Easterling wrote. "We were in awe of this great mystery and accepted the experience of our love as past, present and forever."
He shared with fans about the actress' caring nature and how she was able to lift people up through her music and how she was able to have "the spirit, the humor, and the will power to move things into the light" even in her hardest moments.
"At Olivia’s deepest essence she was a healer using her mediums of song, of words, of touch," he explained. "She was the most courageous woman I’ve ever known. Her bandwidth for genuinely caring for people, for nature and all creatures almost eclipses what is humanely possible."
OLIVIA NEWTON-JOHN'S DAUGHTER CHLOE LATTANZI HONORS LATE ‘GREASE’ STAR WITH EMOTIONAL TRIBUTE
Easterling concluded by thanking everyone for the outpouring of love and support they have shown since her passing.
Newton-John died at her ranch in Southern California on the morning of Aug. 8, after a 30-year public battle with breast cancer, after first being diagnosed in 1992. Throughout her long battle with the disease, she underwent a partial mastectomy, chemotherapy and breast reconstruction ultimately being diagnosed with stage 4 breast cancer in 2020.
Her husband announced her death on her social media accounts, calling her "a symbol of triumphs and hope" as she continuously shared her journey with the disease and even starting a foundation geared towards researching plant medicine and cancer called the Olivia Newton-John Foundation Fund.
Since her passing, celebrities and fans have flooded social media with tributes to the legend, including her daughter Chloe Lattanzi and her "Grease" co-star John Travolta.
Lattanzi posted a series of photos featuring her with her mother throughout her childhood and as an adult, choosing not to include a caption and letting the photos speak for themselves. A day later, Lattanzi posted a never-before-seen video of the two of them singing "Window in the Wall," a song they released together in 2021.
"You are my lighthouse mama. My safe place. My heart space," Lattanzi wrote. "It has been my honor and continues to be my honor to be your baby and best friend. You are an angel on earth and everyone touched by you has been blessed. I love you forever my life giver, my teacher, my mama."
CLICK HERE TO SIGN UP FOR THE ENTERTAINMENT NEWSLETTER
Travolta took to Instagram to honor his co-star and friend, saying she made his life so much better and made an incredible impact on the world. He went on to say he loved her from the second he first saw her.
"My dearest Olivia, you made all of our lives so much better. Your impact was incredible. I love you so much," Travolta wrote. "We will see you down the road and we will all be together again. Yours from the first moment I saw you and forever! Your Danny, your John!"
CLICK HERE TO GET THE FOX NEWS APP
Newton-John became a household name in the 1970s, after starring as Sandy Olsson in "Grease." She was able to show off her musical and acting talents in the film, and she instantly won the hearts of fans. | https://www.foxnews.com/entertainment/olivia-newton-john-husband-john-easterling-pays-tribute-late-grease-star | 2022-08-10T21:59:43Z | https://www.foxnews.com/entertainment/olivia-newton-john-husband-john-easterling-pays-tribute-late-grease-star | false |
DOWNERS GROVE, Ill., Aug. 10, 2022 /PRNewswire/ -- Inpro/Seal, part of Dover Precision Components and Dover (NYSE: DOV), today announced the launch of its new magnetic bearing isolator, VBMag™, which utilizes magnetic force to create a liquid-tight seal and protect against lubrication loss and contamination ingress in challenging applications, such as flooded, high oil splash or oil mist environments.
"The VBMag Bearing Isolator combines decades of knowledge and engineering expertise to deliver a reliable, long-lasting, leak-free seal for a variety of challenging applications," said Chris Solfelt, Product Manager at Inpro/Seal. "The addition of VBMag expands Inpro/Seal's product portfolio, allowing us to better support our customers with the best bearing protection solution for any application."
With VBMag, there is zero shaft wear, making it the superior choice for applications that historically used elastomeric lip seals, which can wear quickly at the point of contact and damage the shaft. Engineered with rare Earth magnets and precision-manufactured components, the VBMag allows maximum lubrication to reach the faces, extending sealing life and reducing the need for unscheduled downtime and maintenance costs.
Bearing failure impacts equipment reliability across all industries and is a leading cause of equipment downtime and lost production. VBMag rounds out Inpro/Seal's bearing protection product line to offer customers a complete set of solutions.
To learn more about VBMag Bearing Isolators, please visit https://www.inpro-seal.com/en/products/extend-bearing-life/bearing-isolators/vbmag.html.
About Inpro/Seal:
The inventor of the original Bearing Isolator, Inpro/Seal® has been delivering innovative sealing solutions and outstanding customer service for more than 40 years. Their unique technologies increase the reliability of rotating equipment and provide real cost savings by improving the mean time between repairs (MTBR). Inpro/Seal's superior customer service and streamlined production processes allow for same- or next-day shipments on most products, even new designs. Headquartered in Rock Island, Ill., USA, Inpro/Seal maintains a global sales and distribution network to provide responsive, localized support to customers worldwide and manufactures in North America, Asia and Europe. Inpro/Seal is part of Dover Precision Components, an integrated provider of performance-critical solutions for rotating and reciprocating machinery. Additional information is available at www.inpro-seal.com.
About Dover Precision Components:
Dover Precision Components delivers performance-critical solutions for rotating and reciprocating machinery across the oil & gas, power generation, marine, industrial, chemical and general processing markets. Comprising the Waukesha Bearings, Bearings Plus, Inpro/Seal and Cook Compression brands, our portfolio includes hydrodynamic bearings, active magnetic bearings, system and bearing protection, and reciprocating compressor valves, sealing technologies, pistons, rods and more. Each solution is custom-engineered to provide optimum efficiency, reliability and productivity, and backed by comprehensive aftermarket services. Dover Precision Components serves its global customer base through facilities in North America, Europe, Asia and the Middle East, as well as technical sales representatives around the world. Additional information is available at doverprecision.com.
About Dover:
Dover is a diversified global manufacturer and solutions provider with annual revenue of approximately $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 65 years, our team of over 25,000 employees takes an ownership mindset, collaborating with customers to redefine what's possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under "DOV." Additional information is available at dovercorporation.com.
Dover Precision Components Contact:
Robin Vodenlic
(281) 939-2450
rvodenlic@doverprecision.com
Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com
Dover Investor Contact:
Jack Dickens, Senior Director, Investor Relations
(630) 743-2566
jdickens@dovercorp.com
View original content to download multimedia:
SOURCE Dover | https://www.wbay.com/prnewswire/2022/08/10/inproseal-introduces-vbmag-bearing-isolator-address-growing-need-bearing-protection-flooded-mist-applications/ | 2022-08-10T22:03:48Z | https://www.wbay.com/prnewswire/2022/08/10/inproseal-introduces-vbmag-bearing-isolator-address-growing-need-bearing-protection-flooded-mist-applications/ | false |
C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945
TORONTO, Aug. 10, 2022 /PRNewswire/ - Today, Manulife announced its second quarter of 2022 ("2Q22") results. Key highlights include:
- Net income attributed to shareholders of $1.1 billion in 2Q22, down $1.6 billion from the second quarter of 2021 ("2Q21")
- Core earnings1 of $1.6 billion in 2Q22, down 9% on a constant exchange rate basis from 2Q212
- LICAT ratio3 of 137%
- Core ROE4 of 12.1% and ROE of 8.3% in 2Q22
- NBV5 of $511 million in 2Q22, down 9%5 from 2Q21
- APE sales5 of $1.4 billion in 2Q22, down 1% from 2Q21
- Global Wealth and Asset Management ("Global WAM") net inflows5 of $1.7 billion in 2Q22, compared with net inflows of $8.6 billion in 2Q21
- Expense efficiency ratio4 of 49.2%, compared with our target of less than 50%, and general expenses decreased 3%6
"We delivered solid results, including core earnings of $1.6 billion, despite challenges posed by the macro environment, including the impact of market headwinds in Global WAM and extended COVID-19 restrictions in Asia," said Manulife President & Chief Executive Officer Roy Gori. "Our global franchise is strong and resilient, as evidenced by double-digit NBV growth in the U.S. and Canada on a combined basis, and core earnings growth in our Canada and U.S. Insurance businesses7, which reduced the impact of market and pandemic related headwinds elsewhere."
"While our net income for the second quarter was negatively impacted by market volatilities, on a year-to-date basis, we delivered net income attributed to shareholders of $4.1 billion, which was $0.6 billion higher than our year-to-date 2021 net income and $0.9 billion higher than our year-to-date 2022 core earnings. The 2022 results are reflective of positive investment-related experience that more than offset the negative direct impact of markets, as well as the one-time gain8 from our U.S. variable annuity reinsurance transaction that closed in the first quarter," Mr. Gori concluded.
"Expense efficiency continues to be an important strategic priority and we maintained an expense efficiency ratio of less than 50% during the quarter despite topline pressures. This, combined with our in-force business, which grew 7% over the prior year quarter9, and comprises approximately three-quarters of our insurance core earnings, has provided for earnings stability against a backdrop of an uncertain macro environment," said Phil Witherington, Chief Financial Officer.
"We are committed to delivering value to shareholders, and have repurchased approximately 2% of our common shares so far this year10," Mr. Witherington continued.
BUSINESS HIGHLIGHTS:
Manulife ranked among Corporate Knights' 2022 Best 50 Corporate Citizens, which recognizes the rising standard and ambition for corporate sustainability leadership in Canada. In Asia, we became the first life insurer in Vietnam to offer healthcare solutions via the MoMo e-wallet, providing the app's 31 million users with access to our award-winning Max-Health insurance product. MoMo users can now easily purchase Manulife Vietnam's Max-Health product in less than one minute through a simple three-step process. In our U.S. segment, we reported the highest ever quarterly sales in our international business. We signed new distributors in the Latin America region and launched a whole life product to support continued sales growth and diversify the business across geographies. In Global WAM, we published our 2022 Manulife Investment Management Stewardship report, detailing our commitment to sustainability as a global investment manager and outlining actions we are taking to address material sustainability risks and opportunities, build more resilient portfolios, and pursue long-term value creation.
In addition, we continued to make progress on our digital journey in 2Q22. In Asia, we enabled our distribution force with an advanced suite of digital tools, with the proportion of new policies sold being digitally submitted reaching 85.5%, an increase of 10 percentage points compared with 2Q21. In Canada, we continued to advance our digital solutions with enhancements to Manulife.ca that included enabling artificial intelligence and natural-language processing capabilities to make searching for product information quick, accurate and intuitive. In the U.S., we enhanced our digital capabilities by launching eDelivery notification of client correspondence to improve preferred producer experience and response to customers. In Global WAM, we launched a new mobile app feature in Canada Retirement that enables members to make additional contributions to their Registered Retirement Savings Plans, providing them with greater control over their financial future.
FINANCIAL HIGHLIGHTS:
PROFITABILITY:
Reported net income attributed to shareholders of $1.1 billion in 2Q22, down $1.6 billion from 2Q21
The decrease in net income attributed to shareholders was primarily driven by charges from the direct impact of markets (compared with net gains in 2Q21), smaller gains from investment-related experience, and lower core earnings. The charge from the direct impact of markets in 2Q22 was primarily driven by the impact of unfavourable equity market performance and interest rate hedge ineffectiveness due to significant interest rate movements across several markets of differing magnitudes and shape changes. In addition, foreign exchange movements, losses from the sale of available-for-sale ("AFS") bonds, and losses from non-parallel movements in swap spreads also contributed. Investment-related experience in 2Q22 reflected higher-than-expected returns (including fair value changes) on alternative long-duration assets primarily driven by fair value gains on private equity investments, the favourable impact of fixed income reinvestment activities, and favourable credit experience.
Delivered core earnings of $1.6 billion in 2Q22, a decrease of 9% compared with 2Q21
The decrease in core earnings was driven by the unfavourable impact of markets on seed money investments in new segregated and mutual funds (compared with gains in 2Q21) in Corporate and Other and on net fee income in Global WAM. In addition, core earnings were also impacted by lower new business gains across our insurance segments, lower in-force earnings in U.S. Annuities due to the variable annuity reinsurance transaction that closed in 1Q22, and lower fee spread in Global WAM. These items were partially offset by in-force business growth in Asia, U.S. Insurance and Canada, higher yields on fixed income investments and gains on AFS equities in Corporate and Other, and improved policyholder experience in the U.S.
ANNUAL REVIEW OF ACTUARIAL METHODS AND ASSUMPTIONS IN THE THIRD QUARTER OF 2022 ("3Q22")1:
In 3Q22, we will complete our annual review of actuarial methods and assumptions. The review includes a comprehensive study of our U.S. long-term care ("LTC") experience and, although work is still ongoing, preliminary indications suggest that the net impact to net income attributed to shareholders in 3Q22 will be approximately neutral in total and for LTC; however, there could be variability in this outcome. The LTC review includes all aspects of assumptions on claims and future premium rate increases. Other assumptions being reviewed this year include mortality and certain lapse assumptions for Canada life insurance, as well as lapse and mortality assumptions for certain Asia markets.
BUSINESS PERFORMANCE:
New business value ("NBV") of $511 million in 2Q22, a decrease of 9% compared with 2Q21
In Asia, NBV decreased 17% reflecting lower sales in Hong Kong, Japan corporate owned life insurance ("COLI") and Asia Other2, as well as unfavourable product mix in Asia Other, partially offset by higher individual protection and other wealth sales in Japan. In Canada, NBV increased 8% from 2Q21, driven by higher volumes in large-case group insurance, partially offset by less favourable business mix in Insurance. In the U.S., NBV increased 18% from 2Q21, driven by improved margins due to product actions, higher international sales volumes, and higher interest rates.
Annualized premium equivalent ("APE") sales of $1.4 billion in 2Q22, a decrease of 1% compared with 2Q21
In Asia, APE sales decreased 12%, reflecting continued adverse impacts from COVID-19 in Hong Kong, lower COLI product sales in Japan, and lower sales in Asia Other. In Hong Kong, APE sales decreased 32% driven by the continued effect of COVID-19 in Hong Kong and tighter containment measures in Macau during the quarter. In Japan, APE sales decreased 15% as a result of lower COLI product sales, partially offset by higher individual protection and other wealth sales. Asia Other APE sales decreased 3%, reflecting lower agency sales in Vietnam, mainland China and Indonesia, partially offset by higher bancassurance sales in Singapore, Vietnam and mainland China. In Canada, APE sales increased 32%, primarily driven by higher large-case group insurance and individual insurance par sales, partially offset by lower segregated fund sales. In the U.S., APE sales increased 6%, primarily due to strong international sales, which are reported as part of the U.S. segment results. This increase was partially offset by lower sales of domestic protection-oriented insurance products, as the impact of higher inflation on household discretionary spending reduced demand. APE sales of products with the John Hancock Vitality PLUS feature increased 13% compared with the prior year quarter, reflecting greater consumer interest in improving baseline health due to the impact of COVID-19, making our Vitality feature a desirable solution in the current environment.
Reported Global Wealth and Asset Management net inflows of $1.7 billion in 2Q22, compared with 2Q21 net inflows of $8.6 billion
Net inflows in Retirement were $1.0 billion in 2Q22 compared with net outflows of $0.6 billion in 2Q21, driven by growth in member contributions and lower plan redemptions. Net outflows in Retail were $1.9 billion in 2Q22 compared with net inflows of $7.3 billion in 2Q21, reflecting higher mutual fund redemption rates and lower gross flows due to decreased investor demand amid equity market declines and higher interest rates. Net inflows in Institutional Asset Management were $2.5 billion in 2Q22 compared with net inflows of $1.9 billion in 2Q21, driven by a $1.9 billion sale of an equity mandate, partially offset by the non-recurrence of a $1.0 billion sale to an existing client in the prior year.
QUARTERLY EARNINGS RESULTS CONFERENCE CALL
Manulife Financial Corporation will host a Second Quarter 2022 Earnings Results Conference Call at 8:00 a.m. ET on August 11, 2022. For local and international locations, please call 416-340-2217 or toll free, North America 1-800-806-5484 (Passcode: 5329622#). Please call in 15 minutes before the call starts. You will be required to provide your name and organization to the operator. A replay of this call will be available by 11:00 a.m. ET on August 11, 2022 through November 3, 2022 by calling 905-694-9451 or 1-800-408-3053 (Passcode: 1177427#).
The conference call will also be webcast through Manulife's website at 8:00 a.m. ET on August 11, 2022. You may access the webcast at: manulife.com/en/investors/results-and-reports. An archived version of the webcast will be available on the website following the call at the same URL as above.
The Second Quarter 2022 Statistical Information Package is also available on the Manulife website at: www.manulife.com/en/investors/results-and-reports.
Any information contained in, or otherwise accessible through, websites mentioned in this news release does not form a part of this document unless it is expressly incorporated by reference.
EARNINGS:
The following table presents net income attributed to shareholders, consisting of core earnings and details of the items excluded from core earnings:
NON-GAAP AND OTHER FINANCIAL MEASURES:
The Company prepares its Consolidated Financial Statements in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board. We use a number of non-GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. This section includes information required by National Instrument 52-112 – Non-GAAP and Other Financial Measures Disclosure in respect of "specified financial measures" (as defined therein).
Non-GAAP financial measures include core earnings (loss); pre-tax core earnings; core earnings available to common shareholders; core general expenses; and assets under management and administration ("AUMA").
Non-GAAP ratios include core return on common shareholders' equity ("core ROE"); diluted core earnings per common share ("core EPS"); expense efficiency ratio; and percentage growth/decline on a constant exchange rate basis in any of the above non-GAAP financial measures.
Other specified financial measures include assets under administration; NBV; APE sales; gross flows; net flows; and percentage growth/decline in such other financial measures.
Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP. For more information on non-GAAP financial measures, including those referred to above, see the section "Non-GAAP and other financial measures" in our 2Q22 MD&A, which is incorporated by reference.
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Reconciliation of core earnings to net income attributed to shareholders
Core earnings, CER basis
Core earnings available to common shareholders
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Core ROE
($ millions, unless otherwise stated)
Core EPS
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Global WAM AUMA reconciliation
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Expense efficiency ratio
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
From time to time, Manulife makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995.
The forward-looking statements in this document include, but are not limited to, statements with respect to the estimated impact of our annual review of actuarial methods and assumptions and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "suspect", "outlook", "expect", "intend", "estimate", "anticipate", "believe", "plan", "forecast", "objective", "seek", "aim", "continue", "goal", "restore", "embark" and "endeavour" (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts' expectations in any way.
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.
Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the ongoing prevalence of COVID-19, including any variants, as well as actions that have been, or may be taken by governmental authorities in response to COVID-19, including the impacts of any variants; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified as available-for-sale; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our non-North American operations; geopolitical uncertainty, including international conflicts; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company's or public infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found under "Risk Management and Risk Factors" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent annual report, under "Risk Management and Risk Factors Update" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent interim report, in the "Risk Management" note to the consolidated financial statements in our most recent annual and interim reports as well as elsewhere in our filings with Canadian and U.S. securities regulators.
The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.
View original content to download multimedia:
SOURCE Manulife Financial Corporation | https://www.wbay.com/prnewswire/2022/08/10/manulife-reports-2q22-net-income-11-billion-core-earnings-16-billion-ape-sales-14-billion-global-wealth-asset-management-net-inflows-17-billion/ | 2022-08-10T22:04:29Z | https://www.wbay.com/prnewswire/2022/08/10/manulife-reports-2q22-net-income-11-billion-core-earnings-16-billion-ape-sales-14-billion-global-wealth-asset-management-net-inflows-17-billion/ | false |
PHOENIX (AP) — The moment was hilarious because it was so relatable.
Pittsburgh Pirates infielder Rodolfo Castro and third-base coach Mike Rabelo stood and stared, mortified, at a smartphone that had mistakenly made its way onto a Major League Baseball field on Tuesday night. Even third base umpire Adam Hamari had the perfect reaction, pointing at the phone that had come loose out of Castro’s back pocket during a slide, trying not to giggle at the absurdity of the situation.
Those around the sport cringed along with them.
“That’s obviously not something that should happen,” Yankees manager Aaron Boone said.
Yet it did. Just like it does to pretty much all of us. Who hasn’t had their ringer go off at a wedding, a funeral, school or church? Or been at the apex of a cannonball into the pool, only to realize their phone was still in their back pocket?
C’mon, be honest.
This faux pas just happened to be at a televised big league game, creating a video clip seen by millions.
“I just remember getting dressed, putting my pants on, getting something to eat, using the restroom,” Castro said through a translator Tuesday night after the Pirates lost 6-4 to Arizona. “Never did it ever cross my mind that I still had my cellphone on me.”
It’s far from the first time a phone has made a cameo on a pro sports field. One of the most famous examples came nearly 20 years ago when New Orleans Saints receiver Joe Horn pulled out a flip phone — Remember those? — that he had hidden in the padding around the goalpost and then acted like he was taking a call after scoring a touchdown.
Of course, there are legitimate reasons MLB doesn’t want phones on the field.
MLB has cracked down on technology use by players since the Houston Astros used live TV feeds to steal opposing teams’ signs during their run to the 2017 World Series championship and part of the subsequent season.
Astros general manager Jeff Luhnow and then-manager A.J. Hinch were suspended for the 2020 season. The Astros also were fined $5 million and forfeited their first- and second-round picks in 2020 and 2021.
That kind of discipline obviously isn’t warranted in this situation, but phones on the field are still a no-no. MLB hadn’t announced any sort of punishment for Castro as of Wednesday afternoon.
“I’m sure we’ll hear from the league, but I feel like everybody, including the umpires — which, again, they handled it great — it was a young kid who made a mistake and put his phone in his pocket,” Pirates manager Derek Shelton said. “There was no intent to use it or do anything with it.”
___
AP Sports Writer Tim Booth in Seattle contributed to this report.
___
More AP MLB: https://apnews.com/hub/mlb and https://twitter.com/AP_Sports | https://www.myarklamiss.com/sports/ap-sports/rodolfo-castros-on-field-phone-flub-a-relatable-moment/ | 2022-08-10T22:05:17Z | https://www.myarklamiss.com/sports/ap-sports/rodolfo-castros-on-field-phone-flub-a-relatable-moment/ | true |
It's peak blackberry season in Oregon. And residents' fingers are sticky with sweet juice. Even if you don't live there, the blackberries you eat are likely from the state's Willamette Valley.
Copyright 2022 NPR
It's peak blackberry season in Oregon. And residents' fingers are sticky with sweet juice. Even if you don't live there, the blackberries you eat are likely from the state's Willamette Valley.
Copyright 2022 NPR | https://www.iowapublicradio.org/2022-08-10/heres-why-oregonians-are-so-proud-of-their-blackberries | 2022-08-10T22:06:08Z | https://www.iowapublicradio.org/2022-08-10/heres-why-oregonians-are-so-proud-of-their-blackberries | true |
When Brad Jones was tapped as interim chief executive of the nonprofit that runs the state’s power grid following the deadly February 2021 winter storm that left most of Texas without power for days, he said he would help stabilize the grid and get it through the summer. Jones was clear he wasn’t interested in keeping the job long-term.
Now, 15 months after Jones became interim CEO, and more than a month after the June target date when Jones had told colleagues and conference crowds he wanted to step down, the Electric Reliability Council of Texas’ new board of directors still has not selected his successor.
Eight sources from across the power industry who spoke to The Texas Tribune say Gov. Greg Abbott, who has no formal role in the process, has put a stranglehold on the CEO search.
The board of directors, installed by a group of three people who are appointed by the governor, lieutenant governor and House speaker, and a contracted search firm have presented CEO candidates to Abbott for final say, according to three sources who spoke to the Tribune on the condition of anonymity to discuss the sensitive issues.
Read more from our media partners at the Dallas Morning News | https://www.nbcdfw.com/news/local/texas-news/gov-abbott-takes-control-of-choosing-who-will-lead-ercot/3045211/ | 2022-08-10T22:06:46Z | https://www.nbcdfw.com/news/local/texas-news/gov-abbott-takes-control-of-choosing-who-will-lead-ercot/3045211/ | true |
MIDLAND, Mich., Aug. 10, 2022 /PRNewswire/ -- Dow (NYSE: DOW) has declared a dividend of 70 cents per share, payable September 9, 2022, to shareholders of record on August 31, 2022.
This marks the 444th consecutive dividend paid by the Company or its affiliates since 1912.
About Dow
Dow (NYSE: DOW) combines global breadth; asset integration and scale; focused innovation and materials science expertise; leading business positions; and environmental, social and governance (ESG) leadership to achieve profitable growth and deliver a sustainable future. The Company's ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company in the world. Dow's portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated, science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility and consumer applications. Dow operates 104 manufacturing sites in 31 countries and employs approximately 35,700 people. Dow delivered sales of approximately $55 billion in 2021. References to Dow or the Company mean Dow Inc. and its subsidiaries. For more information, please visit www.dow.com or follow @DowNewsroom on Twitter.
Twitter: https://twitter.com/DowNewsroom
Facebook: https://www.facebook.com/dow/
LinkedIn: http://www.linkedin.com/company/dow-chemical
Instagram: http://instagram.com/dow_official
Cautionary Statement about Forward-Looking Statements
Certain statements in this report are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.
Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; the continuing global and regional economic impacts of the coronavirus disease 2019 ("COVID-19") pandemic and other public health-related risks and events on Dow's business; any sanction, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflict between Russia and Ukraine; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe; size of the markets for Dow's products and services and ability to compete in such markets; failure to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in consumer preferences and demand; changes in laws and regulations, political conditions or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war including the ongoing conflict between Russia and Ukraine; weather events and natural disasters; disruptions in Dow's information technology networks and systems; and risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities.
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.
View original content to download multimedia:
SOURCE The Dow Chemical Company | https://www.wbtv.com/prnewswire/2022/08/10/dow-declares-quarterly-dividend-70-cents-per-share/ | 2022-08-10T22:07:01Z | https://www.wbtv.com/prnewswire/2022/08/10/dow-declares-quarterly-dividend-70-cents-per-share/ | true |
TORONTO, Aug. 10, 2022 /PRNewswire/ - Russel Metals Inc. (TSX: RUS) announces that it has declared a dividend in the amount of CA$0.38 per share on its common shares, payable on September 15, 2022 to shareholders of record at the close of business on August 29, 2022.
Russel Metals is one of the largest metals distribution companies in North America, with a growing focus on value-added processing. It carries on business in three segments: metals service centers, energy products and steel distributors. Its network of metals service centers carries an extensive line of metal products in a wide range of sizes, shapes and specifications, including carbon hot rolled and cold finished steel, pipe and tubular products, stainless steel, aluminum and other non-ferrous specialty metals. Its energy products operations carry a specialized product line focused on the needs of energy industry customers. Its steel distributors operations act as master distributors selling steel in large volumes to other steel service centers and large equipment manufacturers mainly on an "as is" basis.
If you would like to unsubscribe from receiving Press Releases, you may do so by emailing info@russelmetals.com; or by calling our Investor Relations Line: 905-816-5178.
View original content:
SOURCE Russel Metals Inc. | https://www.1011now.com/prnewswire/2022/08/10/russel-metals-declares-82nd-consecutive-quarterly-common-share-dividend/ | 2022-08-10T22:11:42Z | https://www.1011now.com/prnewswire/2022/08/10/russel-metals-declares-82nd-consecutive-quarterly-common-share-dividend/ | true |
CARNEGIE, Pa. (AP) _ Ampco-Pittsburgh Corp. (AP) on Wednesday reported second-quarter earnings of $403,000.
On a per-share basis, the Carnegie, Pennsylvania-based company said it had net income of 2 cents.
The steel maker posted revenue of $102.6 million in the period.
In the final minutes of trading on Wednesday, the company's shares hit $4.45. A year ago, they were trading at $5.60.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AP at https://www.zacks.com/ap/AP | https://www.seattlepi.com/business/article/Ampco-Pittsburgh-Q2-Earnings-Snapshot-17365326.php | 2022-08-10T22:11:52Z | https://www.seattlepi.com/business/article/Ampco-Pittsburgh-Q2-Earnings-Snapshot-17365326.php | false |
NEW YORK, Aug. 10, 2022 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or traceable to the offering documents issued in connection with the Company's initial public offering conducted on or about June 16, 2021 (the "IPO"); and/or (ii) between June 16, 2021 and April 26, 2022, both dates inclusive (the "Class Period"), of the important September 12, 2022 lead plaintiff deadline.
SO WHAT: If you purchased Molecular Partners securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Molecular Partners class action, go to https://rosenlegal.com/submit-form/?case_id=7548 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 12, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, the IPO documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, the complaint alleges that, throughout the Class Period, defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the IPO documents and defendants made false and/or misleading statements and/or failed to disclose that: (1) ensovibep was less effective at treating COVID-19 than defendants had led investors to believe; (2) accordingly, the U.S. Food and Drug Administration ("FDA") was reasonably likely to require an additional Phase 3 study of ensovibep before granting the drug Emergency Use Authorization ("EUA"); (3) waning global rates of COVID-19 significantly reduced the Company's chances of securing EUA for ensovibep; (4) as a product candidate, MP0310 (AMG 506), in development for the treatment of certain types of cancer, was less attractive to Amgen Inc. ("Amgen") than defendants had led investors to believe; (5) accordingly, there was a significant likelihood that Amgen would return global rights of MP0310 to Molecular Partners; (6) as a result of all the foregoing, the clinical and commercial prospects of ensovibep and MP0310 were overstated; and (7) as a result, the IPO documents and defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Molecular Partners class action, go to https://rosenlegal.com/submit-form/?case_id=7548 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View original content to download multimedia:
SOURCE Rosen Law Firm, P.A. | https://www.wbrc.com/prnewswire/2022/08/10/rosen-leading-investor-rights-law-firm-encourages-molecular-partners-ag-investors-with-losses-excess-100k-secure-counsel-before-important-deadline-securities-class-action-moln/ | 2022-08-10T22:13:03Z | https://www.wbrc.com/prnewswire/2022/08/10/rosen-leading-investor-rights-law-firm-encourages-molecular-partners-ag-investors-with-losses-excess-100k-secure-counsel-before-important-deadline-securities-class-action-moln/ | true |
Sign up
Log in
How it works
Discuss
Latest
Articles
Critique
General
Themes & Competitions
Tips n Tricks
Blog
Browse
Latest
Popular
New Faces
Trending
Curated
Who to Follow
By Day
By Tag
Log in
Sign up
Browse
Blog
Discuss
Ace Membership
Invite Friends
Search
Previous
Next
Photo 1221
Evening walkies
…to the nature reserve to take advantage of the shade from the trees. The birds on the pond were basking in the late sunshine, and the dogs even got a paddle in the little stream that feeds the lake.
10th August 2022
10th Aug 22
1
1
Share
Embed Code
Subscribe to RSS feed
Lesley
ace
@tinley23
Hello, I’m Lesley and live in the Heart of England. I will attempt to upload a photo most days, if only to remind myself...
2312
photos
116
followers
108
following
334% complete
View this month »
1214
1215
1216
1217
1218
1219
1220
1221
Latest from all albums
1216
567
1217
1218
1219
1220
568
1221
Photo Details
Views
5
Comments
1
Fav's
1
Album
365
Exif
View Info
Sizes
View All
Privacy
Public
Flashback
View
Tags
lake
,
walkies
,
evening
Corinne C
ace
I can feel the warmth of the sun rays. A beautiful capture
August 10th, 2022
Leave a Comment
Sign up
for a free account or
Sign in
to post a comment.
close
365 Project
close | https://365project.org/tinley23/365/2022-08-10 | 2022-08-10T22:13:51Z | https://365project.org/tinley23/365/2022-08-10 | true |
NASHVILLE, Tenn., Aug. 10, 2022 /PRNewswire/ -- XLCS Partners, Inc., a leading middle market investment bank, is pleased to announce it served as exclusive advisor to Tower Fasteners (Tower) in its sale to All Integrated Solutions (AIS), a subsidiary of MSC Industrial Supply Co. (NYSE:MSM).
Tower is a second-generation value-added distributor of OEM fasteners and other components to a diverse set of industrial, medical equipment, aerospace, military, electronics, and security/fire & safety sectors. Founded in 1967, the company operates eight distribution centers along the East Coast and in the Southwestern regions of the United States, Mexico, and Europe. In 2018, Tower opened its first European distribution center in Dublin, Ireland. Tower will continue to operate under its current name after becoming an MSC company. Mark Shannon, President of Tower, will continue to lead the business, which has approximately 100 associates.
MSC's acquisition of Tower, made through its AIS subsidiary, expands the company's presence in the OEM fastener market, which it entered in 2018 with the acquisition of AIS, a leading value-added distributor of industrial fasteners and components, MRO supplies and assembly tools based in Wisconsin. Similarly, MSC will extend Tower's production fastener solutions to its manufacturing customers. Founded in 1941, MSC is a leading North American distributor of a broad range of metalworking and maintenance, repair and operations (MRO) products and services. As a $3.2 billion company with more than 6,500 associates and 3,000-plus suppliers, MSC helps its customers drive greater productivity, profitability and growth with approximately 2 million products, inventory management and other supply chain solutions.
"We could not have been more pleased with the job XLCS Partners did advising us during the sale of our business," said Bryan Shannon, Tower CEO. "From the introductory call with Anthony Contaldo to the final closing call, every person who worked with us was professional, thorough, and pleasant. This was our first experience in the M&A world and Anthony and his team guided us every step of the way. XLCS was the perfect advisory firm for the Shannon family."
XLCS acted as the exclusive M&A advisor to Tower and the transaction was led by Anthony Contaldo, Managing Partner and Jay Cremer, Vice President. The transaction was completed August 1, 2022.
XLCS Partners is an investment banking firm providing M&A advisory services to select clients globally. More information is available at www.xlcspartners.com.
Kendra Span
kspan@xlcspartners.com
615-379-7783
View original content to download multimedia:
SOURCE XLCS Partners, Inc. | https://www.wbrc.com/prnewswire/2022/08/10/xlcs-partners-advises-tower-fasteners-sale-msc-industrial-supply-co/ | 2022-08-10T22:13:56Z | https://www.wbrc.com/prnewswire/2022/08/10/xlcs-partners-advises-tower-fasteners-sale-msc-industrial-supply-co/ | true |
ATLANTA, Aug. 10, 2022 /PRNewswire/ -- The Aaron's Company, Inc. (NYSE: AAN), a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.1125 per share and declared such dividend payable October 4, 2022, to shareholders of record as of the close of business on September 15, 2022.
Headquartered in Atlanta, The Aaron's Company, Inc. is a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions of appliances, electronics, furniture, and other home goods across its brands, Aaron's, BrandsMart U.S.A., BrandsMart Leasing, and Woodhaven. Aaron's offers a direct-to-consumer lease-to-own solution through its approximately 1,300 company-operated and franchised stores in 47 states and Canada, as well as its e-commerce platform. BrandsMart U.S.A. is one of the leading appliance and consumer electronics retailers in the southeast United States and one of the largest appliance retailers in the country with ten retail stores in Florida and Georgia. BrandsMart Leasing offers lease-to-own solutions to customers of BrandsMart U.S.A. Woodhaven is our furniture manufacturing division.
For more information, visit investor.aarons.com.
View original content to download multimedia:
SOURCE The Aaron's Company, Inc. | https://www.kait8.com/prnewswire/2022/08/10/aarons-directors-declare-cash-dividend/ | 2022-08-10T22:14:08Z | https://www.kait8.com/prnewswire/2022/08/10/aarons-directors-declare-cash-dividend/ | false |
The biggest argument in Wednesday’s debate between Democratic candidates seemed to center on how the campaigns were being paid for.
All three candidates — former Boston City Council President and Mayoral Candidate Andrea Campbell, Millionaire labor attorney Shannon Liss-Riordan, and former Obama White House official and Assistant Attorney General Quentin Palfrey — seem to agree on most other issues.
The question comes down to who footing the bill.
“I am really proud of what our campaign has done and created. We’ve raised close to $1.5 million from the people,” Campbell said. “My opponents: Quentin is receiving taxpayer state money to fund his campaign, Shannon put in $3 million dollars. She will probably put up to $12 million to buy this election. I’ve always been accountable to the people.”
Liss-Riordan has so far covered most of her campaign’s spending with her own fortune. She is a renowned class action attorney, she said, who has taken on the largest corporations in the country and won. The fact that she has, and isn’t taking money from them, according to Liss-Riordan, means that she isn’t beholden to them.
“It’s a very cynical view that Andrea has that the people of Massachusetts can be bought. They are going to vote for who they think is most experienced and will fight and win for them. I am beholden to the voters. Andrea’s donor list is a who’s who of lobbyists for fossil fuel industries, the Koch brothers,” she said.
Campbell’s 2021 campaign for mayor was supported by a Super PAC called Better Boston. Donations to that PAC by the likes of a member of the Walton Family and the the CEO of Netflix has led both of her opponents to demand to know if she will recuse herself from cases involving those clients.
Palfrey, in particular, spent the majority of the debate hammering on that point, saying it would be impossible for Campbell to deal with those large donors without a clear conflict of interest.
“I’ll never take special interest money,” he said during his opening remarks. “As a former assistant Attorney General I know we need an attorney general who doesn’t have conflicts of interest from millions of dollars in Super PAC contributions. We need an AG who can stand up for the people. The Attorney General’s Office is not for sale.”
Campbell was recently endorsed by outgoing Attorney General Maura Healey and was the party’s nominee at their June convention.
The winner of the September 6 primary race will face Republican Cape Cod lawyer Jay McMahon in November’s general election. McMahon is running unopposed in the primary.
The debate was sponsored by WBUR, The Boston Globe and WCVB, and moderated by Radio Boston host Tiziana Dearing and WCVB reporter Sharman Sacchetti. It was the candidates second debate.
Join the Conversation
We invite you to use our commenting platform to engage in insightful conversations about issues in our community. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable to us, and to disclose any information necessary to satisfy the law, regulation, or government request. We might permanently block any user who abuses these conditions. | https://www.bostonherald.com/2022/08/10/dem-ags-debate-who-is-paying-for-campaigns-generally-agree-on-issues/ | 2022-08-10T22:15:19Z | https://www.bostonherald.com/2022/08/10/dem-ags-debate-who-is-paying-for-campaigns-generally-agree-on-issues/ | false |
IGT PlaySports™ grows leadership in Washington State with Olympia's premier casino
LONDON, Aug. 10, 2022 /PRNewswire/ -- International Game Technology PLC ("IGT") (NYSE: IGT) announced today that it is expanding its sports betting leadership in Washington State via a multi-year contract with Nisqually Red Wind Casino. Under the terms of the agreement, Nisqually Red Wind Casino in Olympia, Wash. will leverage the award-winning IGT PlaySports platform, deploy IGT PlaySports betting kiosks and partner with the IGT trading advisory team.
"Nisqually Red Wind Casino is excited to offer our guests additional gaming entertainment and elevated fan engagement by introducing an IGT PlaySports-powered sportsbook," said Conrad Granito, Nisqually Red Wind Casino, General Manager. "Given IGT PlaySports' leadership across Washington State and the turnkey nature of their solution, we are confident that we've found the ideal sports betting growth partner."
"In adding a sportsbook to its already impressive casino, Nisqually Red Wind Casino can leverage sports betting as a powerful player acquisition tool and a driver of extended property visitation," said Joe Asher, IGT President of Sports Betting. "IGT PlaySports has significant experience powering sportsbooks at tribal casinos throughout the U.S. and we look forward to helping Nisqually Red Wind Casino create a must-visit destination for sports fans in Olympia and the surrounding areas."
IGT PlaySports is powering sports betting at 70+ gaming venues across the U.S. and Canada. Nisqually Red Wind Casino will be the eighth casino in Washington State to deliver world-class sports betting using IGT PlaySports technology. To learn more visit igt.com/playsports or follow us on LinkedIn.
About IGT
IGT (NYSE:IGT) is a global leader in gaming. We deliver entertaining and responsible gaming experiences for players across all channels and regulated segments, from Lotteries and Gaming Machines to Sports Betting and Digital. Leveraging a wealth of compelling content, substantial investment in innovation, player insights, operational expertise, and leading-edge technology, our solutions deliver unrivaled gaming experiences that engage players and drive growth. We have a well-established local presence and relationships with governments and regulators in more than 100 countries around the world, and create value by adhering to the highest standards of service, integrity, and responsibility. IGT has approximately 10,500 employees. For more information, please visit www.igt.com.
Cautionary Statement Regarding Forward-Looking Statements
This news release may contain forward-looking statements (including within the meaning of the Private Securities Litigation Reform Act of 1995) concerning International Game Technology PLC and its consolidated subsidiaries (the "Company") and other matters. These statements may discuss goals, intentions, and expectations as to future plans, trends, events, dividends, results of operations, or financial condition, or otherwise, based on current beliefs of the management of the Company as well as assumptions made by, and information currently available to, such management. Forward-looking statements may be accompanied by words such as "aim," "anticipate," "believe," "plan," "could," "would," "should," "shall", "continue," "estimate," "expect," "forecast," "future," "guidance," "intend," "may," "will," "possible," "potential," "predict," "project" or the negative or other variations of them. These forward-looking statements speak only as of the date on which such statements are made and are subject to various risks and uncertainties, many of which are outside the Company's control. Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may differ materially from those predicted in the forward-looking statements and from past results, performance, or achievements. Therefore, you should not place undue reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include (but are not limited to) the factors and risks described in the Company's annual report on Form 20-F for the financial year ended December 31, 2021 and other documents filed from time to time with the SEC, which are available on the SEC's website at www.sec.gov and on the investor relations section of the Company's website at www.IGT.com. Except as required under applicable law, the Company does not assume any obligation to update these forward-looking statements. You should carefully consider these factors and other risks and uncertainties that affect the Company's business. All forward-looking statements contained in this news release are qualified in their entirety by this cautionary statement. All subsequent written or oral forward-looking statements attributable to International Game Technology PLC, or persons acting on its behalf, are expressly qualified in their entirety by this cautionary statement.
Contact:
Phil O'Shaughnessy, Global Communications, toll free in U.S./Canada +1 (844) IGT-7452; outside U.S./Canada +1 (401) 392-7452
Francesco Luti, +39 06 5189 9184; for Italian media inquiries
James Hurley, Investor Relations, +1 (401) 392-7190
© 2022 IGT
The trademarks and/or service marks used herein are either trademarks or registered trademarks of IGT, its affiliates or its licensors.
View original content to download multimedia:
SOURCE International Game Technology PLC | https://www.kait8.com/prnewswire/2022/08/10/igt-nisqually-red-wind-casino-team-up-multi-year-sports-betting-agreement/ | 2022-08-10T22:15:51Z | https://www.kait8.com/prnewswire/2022/08/10/igt-nisqually-red-wind-casino-team-up-multi-year-sports-betting-agreement/ | false |
‘Uncharted’ is #1 on Netflix, but is it any good?
CHICAGO - Editor's note: This review originally ran on Feb. 16, 2022 as "Uncharted" hit theaters. It has been republished in light of the film's recent premiere on Netflix, where it swiftly became one of the most watched movies on the streamer. Should you add it to your queue? Read on to find out.
Here’s the assorted loot you’ll find in the treasure chest of "Uncharted": Two slam-bang action set-pieces, some lackluster plotting, a charming leading man turn from Tom Holland, an ensemble of wasted supporting players and a woefully miscast Mark Wahlberg. Does that add up to a hidden treasure or a disappointing haul? Well, that lies in the eyes of the fortune hunter.
"Uncharted" isn’t bad enough to be a bad movie, but not good enough to be a good one either. And for a highly anticipated video game adaptation that’s been in development for over 12 years (long enough for Wahlberg to have originally been cast as the young upstart rather than the mentor), that makes its long-awaited arrival a bit of an anticlimax.
WATCH FREE ON TUBI: 1990’s "Teenage Mutant Ninja Turtles" movie
About "Uncharted": An homage to every adventure movie ever made
For better or for worse, what "Uncharted" does succeed at is evoking other, more accomplished action-adventure movies. This is Bond meets "Indiana Jones" meets "Tomb Raider" meets "Pirates of the Caribbean," all heavily filtered through the history-based comedic banter of the "National Treasure" franchise.
There’s even a touch of the Tom Cruise classic "Cocktail" in there too. When we first meet Holland’s Nate Drake, he’s a full-time bartender, part-time pickpocket with charisma to spare. Soon enough, however, his small-scale crimes get a big-scale upgrade when he’s roped into a global-hopping adventure alongside Victor "Sully" Sullivan (Wahlberg), a selfish fortune hunter on a quest to find Magellan’s lost gold.
Mark Wahlberg and Tom Holland star in Columbia Pictures' UNCHARTED.
There’s ostensibly a personal connection at play too. The heart of the film hinges on Nate’s long-lost older brother Sam, who instilled a love of treasure hunting in his kid sibling before disappearing in the wind for 15 years. Sully claims he was friends with Sam and can help Nate find him if they locate the gold. But in a cutthroat world where everyone is just out for themselves, does Sully actually see Nate as a true teammate or just a pawn to be used?
Of course, it’s hard to imagine anyone on Earth heading to see an "Uncharted" movie primarily for its emotional character drama, which is good because there isn’t really any — at least not any that’s successful.
WATCH FREE ON TUBI: Mark Wahlberg in "Planet of the Apes"
In what could be a fun role for a game, grizzled actor, Wahlberg comes across more as one of the villain’s lunkheaded goons than a smart, self-possessed treasure hunter steeped in 16th century Spanish history. It’s as if the producers never told him whether he was filming a swashbuckling adventure, another "Transformers" movie or "Ted 3," so he just decided to lean into his usual comedic schtick to be safe. And while the film does sort of try to lampshade what an odd fit Wahlberg is for this world, that mostly just leads to cringe-worthy comedy masquerading as banter.
See "Uncharted" for: Tom Holland and the action
Holland, thankfully, fares a bit better — and not just because his "Spider-Man" training comes in handy for Nate’s parkour fighting style. Though this younger, origin story take on Nathan Drake might not entirely fit the vibe of the hit PlayStation video game series (this reviewer hasn’t played it), Holland succeeds at aging up his Peter Parker persona without diminishing its appeal. This version of Nate is a confident charmer who’s also just a little less cool than he thinks he is, a choice that underlines the lighthearted tone of the whole project. Holland is an actor with major "kid brother" energy, and "Uncharted" wisely leans into that even as Holland tries to launch himself as a bulked-up adult leading man.
RELATED: ‘Spider-Man: No Way Home’ review: The ultimate Spiderman sequel
Still, that’s not always enough to carry the movie in the (brief) stretches of downtime between its action scenes. The treasure hunting/heist plotting is about half as clever as it should be. And supporting players Sophia Ali (as reluctant ally treasure hunter Chloe Frazer) and Tati Gabrielle (as a sexy femme fatale mercenary enemy) are underserved by the material — although not as much as Antonio Banderas, who seems to have spent no more than two days filming his role as the film’s aristocratic big bad.
Tom Holland and Antonio Banderas star in Columbia Pictures' UNCHARTED. photo by: Clay Enos
Yet just when "Uncharted" starts to become a slog, it throws in an action sequence that perks things up considerably. Yes, a lot of these setpieces come from the video game, and, yes, most of them have been spoiled by the film’s trailers. But for pure, dumb "turn off your brain and enjoy" fun, "Uncharted" has something to offer – particularly when it takes to the sky for its two biggest showstoppers.
While one offers a demented sky-set riff on "Frogger," the other evokes "Peter Pan" in a wonderfully unexpected way. In an era where giant apes and massive superhero battles regularly fill our screens, it’s easy to take this kind of CGI spectacle for granted. But in its best moments, "Uncharted" succeeds at conjuring a sense of awe and creativity, if not exactly originality.
WATCH FREE ON TUBI: The cult classic sci-fi favorite "The Fifth Element"
The film’s goofy, playful sense of self-awareness also works better in its action moments than its purely comedic ones. There’s winking fun to a climax that’s half helicopter chase, half old-fashioned swashbuckling swordfight, as old and new combine in a way that feels distinct to this world.
"Uncharted" isn’t great cinema. It’s not even great action-adventure cinema. But if there are better ways to spend two hours, well, there are worse ones too.
Grade: C+
Rated PG-13. 116 minutes. Dir: Ruben Fleischer. Featuring: Tom Holland, Mark Wahlberg, Sophia Ali, Tati Gabrielle,Antonio Banderas.
Make it a double feature with "Inception," streaming free on Tubi
Inception (2010): Christopher Nolan turned action filmmaking on its head in 2010 with this delightfully trippy, instantly iconic sci-fi thriller. Leonardo DiCaprio is Dom Cobb, a professional "extractor" who specializes in infiltrating dreams and stealing corporate secrets. Hired to pull off a nearly impossible "inception" job (i.e. planting an idea instead of stealing one), he must assemble a crack team and plan a multi-level dream heist — oh, and try not to let the haunting memory of Marion Cotillard ruin the whole thing. With its stunning visuals and hotly debated ending, "Inception" remains one of the influential blockbusters of the 21st century.
Rated PG-13. 148 minutes. Dir: Christopher Nolan. Featuring: Leonardo DiCaprio, Joseph Gordon-Levitt, Marion Cotillard, Tom Berenger, Michael Caine, Elliot Page, Tom Hardy, Cillian Murphy.
"Inception" is streaming free on Tubi — get the app
How to watch "Uncharted"
"Uncharted" is currently streaming on Netflix. It is also available to rent or buy digitally, and can be purchased on DVD/BluRay/4K.
About the writer: Caroline Siede is a film and TV critic in Chicago, where the cold never bothers her anyway. A member of the Chicago Film Critics Association, she spent four years lovingly analyzing the romantic comedy genre one film at a time in her column When Romance Met Comedy for The A.V. Club. She also co-hosts the movie podcast, Role Calling, and shares her pop culture opinions on Twitter (@carolinesiede).
About Tubi: Tubi has more than 40,000 movies and television series from over 250 content partners, including every major studio, in addition to the largest offering of free live local and national news channels in streaming. The platform gives fans of entertainment, news and sports an easy way to discover new content that is available completely free.
Tubi is available on Android and iOS mobile devices, Amazon Echo Show, Google Nest Hub Max, Comcast Xfinity X1, Cox Contour, and on OTT devices such as Amazon Fire TV, Vizio TVs, Sony TVs, Samsung TVs, Roku, Apple TV, Chromecast, Android TV, PlayStation 5, Xbox Series X | S, and soon on Hisense TVs globally. Consumers can also watch Tubi content on the web at http://www.tubi.tv/.
Tubi and this television station are both owned by the FOX Corporation. | https://www.fox5ny.com/news/uncharted-movie-tom-holland-how-to-watch-netflix | 2022-08-10T22:24:08Z | https://www.fox5ny.com/news/uncharted-movie-tom-holland-how-to-watch-netflix | true |
LAVAL, Quebec, Aug. 10, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the company's July 28, 2022, press release, the U.S. District Court of Delaware has issued a decision in the matter of Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc. finding certain XIFAXAN® (rifaximin) 550 mg HE patents valid and infringed and certain XIFAXAN composition and IBS-D patents invalid. As previously stated, the Company will appeal this decision to the U.S. Court of Appeals for the Federal Circuit and it expects an appeal decision to issue within 12 to 18 months.
To date, Norwich has not received tentative or final approval of its ANDA from the FDA. Unless and until FDA approves a revised Norwich ANDA that omits the XIFAXAN HE indication, and any injunction issued by the Court is modified, Norwich is not permitted to launch a generic equivalent of XIFAXIN.
About XIFAXAN
XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.
About Salix
Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases. For more than 30 years, Salix has licensed, developed and marketed innovative products to improve patients' lives and arm health care providers with life-changing solutions for many chronic and debilitating conditions. Salix currently markets its product line to U.S. health care providers through an expanded sales force that focuses on gastroenterology, hepatology, pain specialists and primary care. Salix is headquartered in Bridgewater, New Jersey. For more information about Salix, visit www.Salix.com and connect with us on Twitter and LinkedIn.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our approximately 90% ownership of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
Forward-looking Statements This news release may contain forward-looking statements about the future performance of Bausch Health, which may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions, including statements about the Company's intentions to file an appeal with respect to, and take actions to vigorously defend, its intellectual property. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular, Bausch Health can offer no assurance as to the timing of any approval by the FDA of any ANDA or amended ANDA and as to the outcome of any appeal. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian securities administrators, which factors are incorporated herein by reference.
View original content to download multimedia:
SOURCE Bausch Health Companies Inc. | https://www.wagmtv.com/prnewswire/2022/08/10/bausch-health-appeal-xifaxan-patent-decision-us-court-appeals-federal-circuit/ | 2022-08-10T22:26:24Z | https://www.wagmtv.com/prnewswire/2022/08/10/bausch-health-appeal-xifaxan-patent-decision-us-court-appeals-federal-circuit/ | false |
JEFFERSON CITY, Mo. (AP) _ The winning numbers in Wednesday afternoon's drawing of the Missouri Lottery's "Pick 4 Midday" game were:
8-4-2-3
(eight, four, two, three)
JEFFERSON CITY, Mo. (AP) _ The winning numbers in Wednesday afternoon's drawing of the Missouri Lottery's "Pick 4 Midday" game were:
8-4-2-3
(eight, four, two, three) | https://www.sfchronicle.com/lottery/article/Winning-numbers-drawn-in-Pick-4-Midday-game-17365441.php | 2022-08-10T22:26:26Z | https://www.sfchronicle.com/lottery/article/Winning-numbers-drawn-in-Pick-4-Midday-game-17365441.php | false |
3 killed, 39 homes damaged from house explosion in Indiana
EVANSVILLE, Ind. (WFIE/Gray News) - Authorities confirmed that three people were killed as a result of a house explosion in Indiana on Wednesday afternoon.
Officials say the call originally came in just before 1 p.m.
Evansville Fire Department Chief Mike Connelly says that a special collapse unit was requested to the scene.
Officials say that most surrounding houses were unoccupied except for pets.
Fire crews on the scene said the street intersection nearby had been closed but was about to reopen.
During an earlier news conference, Connelly said 39 homes were damaged as a result of the explosion, and four homes were destroyed. He said two people had been in the house that exploded, while a third individual was inside a neighboring house.
The number of people displaced is unknown at this time.
Connelly says eight fire units are currently on scene, while an arson investigation is now underway.
Copyright 2022 WFIE via Gray Media Group, Inc. All rights reserved. | https://www.kxii.com/2022/08/10/3-killed-39-homes-damaged-house-explosion-indiana/ | 2022-08-10T22:27:41Z | https://www.kxii.com/2022/08/10/3-killed-39-homes-damaged-house-explosion-indiana/ | true |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.